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ABSTRACT 
In mice given a single vaccination with optimally irradiated S. mansoni cercariae, cell- 
mediated mechanisms operating against lung-stage larvae are highly effective in reducing 
challenge worm burden by 60-70%, relative to those in control mice. Therefore, the 
proteins secreted from the live schistosomula are a potential source of novel candidates 
for a recombinant vaccine. Only minute quantities of protein are secreted by the larval 
parasites making their identification difficult. Therefore, several methods to identify and 
clone the genes encoding such proteins, based on recombinant DNA technology, were 
developed in this study. 
Initially, 106 expressed sequence tags (ESTs) were produced from a lung-worm 
cDNA library. By analysis of the sequences in the schistosome protein database, using 
the computer algorithm, SignalP, 27 distinct open reading frames encoding membrane 
and/ or secreted (WS) proteins were identified. Following this, all the S. mansoni ESTs 
were translated into protein sequences, the longest open reading frame selected, and 
analysed by SignalP. Out of a total of 7102 ESTs, 218 were found to encode for putative 
NVS proteins; only five were derived from the lung-worm. Three of these five ESTs and 
the one larval ORF, CLI, were transferred to high level expression vectors. Recombinant 
protein was purified for only CL1 and antiserum was raised against it. Analysis of this 
recombinant protein indicates that the protein is secreted from the developing 
schistosomulum. 
To identify those proteins that are stage-specifically expressed by the lung-worm, the 
technique of random arbitrarily-primed PCR (RAP-PCR) was used. The mRNAs of 
cercariae, lung and adult-worms were compared in parallel. In total 9 stage-specific 
bands and 4 differentially expressed bands were excised from gels. Several of these 
represent single copy genes as determined by Southern blotting; the gene-expression 
profiles remain to be verified. 
Finally, a functional assay that selects ORFs based on the ability of the corresponding 
proteins to direct secretion of invertase in yeast was established. The system was 
validated using schistosome cDNAs coding for known WS proteins, namely p48, 
superoxide dismutase and antigen 10-3. Schistosome cDNAs coding for cytosolic 
proteins, calpain and phosphoglycerate kinase, were used as negative controls. These 
experiments show that the system readily discriminates between schistosome NVS and 
cytosolic proteins and can now be applied to cDNA mixtures that have been generated by 
random-hexamer primed reverse-transcription. 
CONTENTS 
page 
Acknowledgements I 
Declaration 2 
Abbreviations 3 
Chapter 1 Introduction 5 
1.1 Background 6 
1.2 The life-cycle of S. mansoni 6 
1.3 Current control measures 7 
1.4 Vaccine development 9 
1.5 Can naturally acquired immunity form the basis of a protective vaccine? 11 
1.6 The Radiation-Attenuated (RA) vaccine model 16 
1.7 Candidate vaccine antigens 22 
1.8 Aims of this study 31 
Chapter 2 General materials and methods 33 
2.1 Preparation of parasite material 34 
2.2 Microbiological techniques 35 
2.3 Preparation, manipulation and analysis of nucleic acids 37 
2.4 Screening for recombinant bacterial colonies 42 
2.5 Analysis of proteins 42 
Chapter 3 The use of computational biology and the S. mansoni genome 
database to identify MIS proteins 44 
3.1 Introduction 45 
3.2 Materials and methods 48 
3.3 Results 54 
3.4 Discussion 61 
Chapter 4 The identification of differentially expressed genes using 
random-arbitrarily primed PCR (RAP-PCR). 67 
4.1 Introduction 68 
4.2 Materials and methods 72 
4.3 Results 76 
4.4 Discussion 84 
Chapter 5 The signal sequence trap 89 
5.1 Introduction 90 
5.2 Materials and methods 93 
5.3 Results 98 
5.4 Discussion 102 
Chapter 6 Concluding discussion. 105 
Appendixl ill 
Appendix 2 113 
References 114 
ACKNOWLEDGEMENTS 
I would like to thank the following: 
Prof. D. S. C. White and Prof A. Fitter in whose department this work was 
carried out. 
The BBSRC and The Dept. of Zoology, The Natural History Museum, London 
for providing funding for the project. 
Friends and colleagues at the Biology Dept., The University of York and at The 
Natural History Museum. 
The CRU and NHM sequencing facilities for the endless numbers of gels that had 
to be run. 
I would like to extend special thanks to the following people: 
Alan for all his scientific guidance, enthusiasm and perseverance. 
David for all his helpful advice and confidence. 
Rich, Gui, David J, Matthias, Adrian and Rachel for putting up with my 
sometimes incessant questioning and for their technical expertise. 
Benika and Andrea for their friendship over the last three years. 
Sue and Mike for all those much needed evening tipples. 
My family, especially Jagumasi and Rekhamasi, for all their support through 
some trying times. 
Finally, my parents, for being so patient, and it is to them that this thesis is 
dedicated. 
DECLARATION 
All of the work contained in this thesis is my own except for the following: 
Chapter 2: Perfusion of mice to obtain adult worms was carried out by Dr. A. 
Mountford and Miss C. Sadler 
Chapter 3: All injections to immunise mice were done by Dr. P. Coulson 
2 
ABBREVIATIONS 
7 gamma 
x lambda 
0C degrees centigrade 
ýtMT B-cell deficient 
0-3h RP 0-3 hour released proteins 
I-D one dimensional 
A absorbance 
aa amino acids 
ADCC antibody dependent cell-mediated cytotoxic 
APCs antigen-presenting cells 
BCG Mycobacterium bovis bacillus Calmette-Guerin 
BCIP 5-bromo-4-chloro-3-indolyl phosphate 
BLASTN basic local alignment search tool for nucleotides 
BLASTX basic local alignment search tool for peptides 
bp base pairs 
BSA bovine serum albumin 
cDNA complementary DNA 
CFA Complete Freunds Adjuvant 
Ci curies 
cm centimetres 
d6-8 RP days 6-8 released proteins 
DD differential display 
DEPC diethylpyrocarbonate 
DLC dynein light chain 
DNA deoxyribonucleic acid 
dNT? s deoxynucleotides 
DTH delayed-type hypersensitivity 
DTT dithiothreitol 
ELISA enzyme linked immunosorbent assay 
ER endoplasmic reticulum 
EST expressed sequence tag 
FACS fluorescence activated cell sorter 
9 gravitational force 
gDNA genomic DNA 
GPCR G-protein coupled receptor 
GST glutathione-S-transferase 
IFNy interferon-y 
IFNY'4 IFNy gene disrupted 
IFNyRý- IFNy receptor knockout 
IL Interleukin 
IMAC immobilised metal affinity chromatography 
NOS inducible nitric oxide synthase 
IPTG isopropyl-p-D-thiogalactopyranoside 
kb kilobase pairs 
kDa kilodaltons 
krad kilorads 
M/S membrane and/or secreted 
MAb monoclonal antibody 
MAP multiple antigenic peptide 
Mb megabase pairs 
M_MLV Moloney murine-leukaemia virus 
MPLM thrombopoietin receptor mutant 
3 
mRNA messenger RNA 
Mw molecular weight 
NBT nitroblue tetrazolium 
NCBI National Centre for Biotechnology Information 
run nanometers 
NO nitric oxide 
nt nucleotides 
OCT optimum cutting compound 
OD optical density 
OMP outer membrane protein 
ORF open reading frame 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate-buffered saline 
PCR polymerase chain reaction 
pfu plaque forming units 
PLAP placental alkaline phosphatase 
r. p. m. revolutions per minute 
RA radiation-attenuated 
RAP-PCR random-arbitrarily primed PCR 
RNA ribonucleic acid 
rRNA ribosomal RNA 
RT reverse-transcription 
SAGE serial analysis of gene expression 
SCAP soluble cercarial antigen preparation 
sdH20 sterile distilled water 
sdLNs skin draining lymph nodes 
SDS sodium dodecyl sulphate 
SEA soluble egg antigen 
SLAP soluble lung-worm antigen preparation 
SOD superoxide dismutase 
SRP signal recognition particle 
SS signal sequence 
SST signal sequence trap 
SUC_ invertase gene deleted 
SWAP soluble adult-worm antigen preparation 
TAE tris-acetate electrophoresis buffer 
TALEST tandem arrayed ligation of expressed sequence tags 
TBE tris-borate electrophoresis buffer 
TBS tris buffered saline 
TBS-T tris-buffered saline with Tween 
Th T-helper 
TMB 3,3', 5,5'-tetramethylbenzidine 
TNF tumour necrosis factor 
TPI triose-phosphate isomerase 
U units 
V volts 
V/v volume per volume 
W/V weight per volume 
WHO World Health Organisation 
X-gal 5-bromo-4-chloro-3-indolyl P-D-galactopyranoside 
YSST yeast signal sequence trap 
L litre 
mi millilitre 
gl microlitre 
mg milligram 
R microgram 
ng nanogram 
P9 picogram 
molar 
mM millimolar 
gm micromolar 
PM picomolar 
4 
CHAPTER 1 
INTRODUCTION 
1.1 Background 
Infection by blood dwelling flukes belonging to the family Schistosomatidae results in 
a debilitating disease known as schistosomiasis. Of the genera in this family, seven are 
confined to birds and five to mammals, but only the genus Schistosoma is associated with 
humans. The greatest geographical distribution and diversity of the definitive hosts 
parasitised, has been achieved by this genus. 
With three hundred million individuals at risk of infection and around 200 000 deaths 
each year (VMO, 1993), schistosomiasis is one of the most widespread parasitic diseases 
of humans, and is currently endemic in 76 countries. Seven species of Schistosoma 
parasitise humans; S. mansoni, S. haematobium and S. japonicum are the most 
widespread, while S. intercalatum and S. mekongi have a more localised distribution. In 
humans, symptoms range from fever, anaernia and diarrhoea to hepatosplenornegaly; 
eventually death may result. 
Due to the relative ease with which the life-cycle of S. mansoni is maintained in the 
laboratory, this species has received most attention. Thus, this thesis will refer almost 
exclusively to S. mansoni. 
1.2 The Life-cycle of S. mansoni 
The life-cycle of this parasite is complex, involving a number of morphological 
changes and including two hosts, the intermediate mollusc and the definitive mammal. 
The miracidium, is the free larval stage ensuring transmission between the vertebrate and 
the snail. After penetration, the miracidium, develops into the mother sporocyst, which 
reproduces asexually to produce daughter sporocysts. Further amplification of parasite 
numbers occurs following the differentiation of daughter sporocysts into cercariae. 
Therefore, the penetration and development of one miracidium leads to the production of 
several thousand cercariae (Theron, 1986) thereby counterbalancing the significant 
reduction in parasite number during snail location. The development process of cercariae 
from daughter sporocysts takes up to one week, after which mature cercariae, consisting 
of a head and a bifurcated tail, leave the snail in response to sunlight. 
Under optimal conditions, the free swimming cercariae have 5 to 8 hours after 
shedding, in which to find and penetrate an appropriate host before infectivity is impaired 
(Lawson and Wilson, 1983). Penetration of host skin requires the co-ordination of 
muscular contraction and secretory processes in the cercaria. Coincident with the release 
of proteases, the cercaria sheds its outer glycocalyx and tail, thereby allowing it to 
penetrate the host and concurrently transform into a schistosomulum. 
The vast majority of information concerning the migratory pathway of S. mansoni, 
and the accompanying biochemical and morphological changes undergone by the parasite 
in the mammalian host comes from studies in laboratory rodents. This is described in 
more detail in section 1.6.2. The parasites continue to move through the host skin and 
eventually the majority penetrate a blood vessel. A combination of active migration 
through capillary beds and passive carriage in larger blood vessels takes a proportion of 
the schistosomula, to the liver via the lungs. Once in the liver, the schistosomula, undergo 
further biochemical and morphological changes transforming them into liver worms. 
Pairing of the adult worms takes place in the liver followed by their migration to the 
mesenteric veins where the female begins egg-laying. The majority of the eggs, which 
are deposited in blood vessel walls, pass through to the lumen of the gut and are 
eventually voided in the faeces. When the environmental conditions are appropriate, the 
eggs hatch in fresh water releasing the miracidia. which are capable of infecting snails, 
and the life-cycle is thus perpetuated. 
The life-span of an adult worm, in humans, is estimated to average between 3.5 to 12 
years. Therefore, schistosomiasis is a chronic disease and the host immune response to 
the eggs can cause severe pathology. Approximately 300 eggs are produced per day by 
an adult female but many are never voided from the host; instead they are washed into, 
and lodge in, the liver. The host delayed-type hypersensitivity (DTH) reaction to these 
trapped eggs results in the formation of granuloma. This eventually leads to disruption of 
hepatic tissue and can result in portal hypertension and splenomegaly. 
1.3 Current Control Measures 
The provision of safe and adequate water supplies and sanitation is a major control 
strategy for schistosomiasis. This can be effective, as water is the medium through which 
the free-living stages of the parasite life-cycle locate and infect their respective hosts. 
Latrines reduce faecal and urinary contamination of water, preventing the miracidia 
locating the snail host, and thereby lowering transmission levels. Clean water for 
drinking and washing reduces the level of human contact with parasite-contaminated 
water and again this reduces the levels of parasite infection and transmission. Any such 
modifications have to be accompanied by a health education programme aimed at not 
only informing communities about the biology of the parasite but also emphasising the 
role of the individual in spreading schistosomiasis. However, such measures require 
substantial amounts of money, which at present is not forthcoming in most endemic 
countries. 
Control of the intermediate host snail populations using molluscicides, such as 
niclosamide, has not always produced the desired effects. Furthermore, the eradication of 
snail populations has only been possible in extreme situations such as in oases in Tunisia 
(Klumpp and Chu, 1987). This approach, as well as being expensive and impractical, is 
potentially damaging to the environment and could lead to the evolution of molluscicide- 
resistant snails. In addition, snail populations exhibit an impressive potential for 
regeneration and re-invasion of an area, re-establishing thriving populations in a period of 
months. 
Chemotherapy plays a leading role in the control of schistosomiasis with the use of 
three basic treatment strategies. Mass treatment refers to the administration of drugs to 
entire populations without prior individual diagnosis. In selective treatment, only those 
individuals that are infected (determined by either serum sampling or faecal egg counts) 
are chosen for chemotherapy, whereas in targeted therapy only those individuals with 
high egg counts are treated. Although the mass treatment of infected human populations 
with chemotherapeutic drugs has been effective in reducing the prevalence and incidence 
of disease (Mahmoud et aL, 1983), diagnosis followed by chemotherapy is presently the 
control measure of choice. Praziquantel is the main drug used for such treatment 
programmes as it has few side effects, is administered as a single dose and is relatively 
cheap (WHO, 1985). However, the drug does not reverse pathological damage in 
patients; this can be a major problem as infection with schistosomes can go undetected 
for many years by which time the internal organs of the patient are badly damaged. In 
addition, the high chance of re-infection in endemic areas means that repeated treatment 
is necessary. This is not only costly but increases the risk of the evolution of a drug- 
resistant strain of parasite. Indeed, reduced parasite susceptibility to praziquantel has 
been reported both in experimental animals (Fallon et aL, 1994) and in populations living 
in endemic areas (Ismail et aL, 1996; Fallon et aL, 1995). 
Relatively successful control, through the integration of complementary strategies, has 
been achieved in several countries, e. g., Brazil (WHO, 1993). However, recent 
environmental changes, closely linked to the development of water resources and 
increases in population densities, have led to the spread of disease to previously low or 
non-endemic areas, e. g., Senegal (Talla et A, 1990). Here, the first cases of 
schistosomiasis were reported one and a half years after completion of the Diama Dam 
on the Senegal river. Such water development programmes, together with the increase in 
drug-resistant strains of the parasite, have major implications for control of transmission 
throughout populations. Given the socio-economic climate of the endemic countries, it 
seems unlikely that the control strategies currently available will be effectively 
implemented and/or sustained. 
All of the control measures discussed so far have shortcomings, therefore, the 
development of a schistosome vaccine would provide a durable, long-term control 
measure, relieving the suffering of many millions of people. A single-shot vaccine, 
composed of recombinant molecules and presented in the appropriate manner, that 
provided total immunity would be ideal. If administered before exposure to the parasite, 
such a vaccine would prevent egg-induced pathology associated with schistosomiasis and 
consequently reduce the prevalence, morbidity and rates of transmission and infection. 
However, as schistosomes do not replicate in the mammalian host, the requirement for a 
vaccine that induces sterile immunity is not absolute. Partial protection, which resulted 
in reduced worm burdens, would in turn reduce the number of people developing severe 
clinical disease and hence morbidity, as well as decreasing transmission levels. 
1.4 Vaccine Development 
An ideal vaccine is considered to be a modified, non-pathogenic form of an infectious 
agent, not as capable of replication and spread as the wild type but still able to stimulate 
the immune system, e. g. the Sabin polio vaccine. By following the same route of 
infection as the pathogen, the live vaccine encounters the same host defence systems and 
cells as the infectious agent and thus stimulates them to react in a manner similar to that 
seen in a natural infection. Unfortunately it is not always possible to develop such a 
vaccine for all pathogens, for many reasons, e. g. reversion to virulence, appropriate 
attenuation, storage and transport costs due to required refrigeration. One alternative is to 
use killed organisms as vaccines, but these, while useful in the short term, often fail to 
induce long-lasting immunity. In addition, there are numerous other disadvantages such 
as potential side effects due to the considerable amount of material administered, 
incomplete inactivation of the organism, and potential hazard posed to personnel and 
environment. Therefore, to induce immunity to eukaryotic parasites it is necessary to 
generate vaccines based on subunits of the organism e. g. peptides, DNA, synthetic 
fragments or purified components. It is in this context that the majority of schistosome 
vaccine research is being directed, with emphasis on defining candidate antigens for a 
vaccine and determining the mechanisms of protective immunity. In addition, as the 
disease is associated with egg induced pathology, some workers have focused on the 
manipulation of the host immune response to parasite eggs and/or anti-fecundity 
vaccines. The different approaches being pursued are discussed here briefly. The 
research falls into two areas; cytokine intervention and identification of candidate 
antigens to reduce pathology and determining factors that influence anti-fecundity 
effects. 
Anti-pathology vaccines 
In mice, the immune response to schistosome eggs results in the formation of 
eosinophil-rich granulomas around them. CD4' T cells are crucial for the development 
of these granulomas (Mathew and Boros, 1986). However, conflicting views exist 
regarding the role of the two T helper (Th) cell subsets. On the one hand Thl cells have 
been shown to mediate granuloma formation (Chikunguwo et aL, 199 1). On the other, 
studies indicate that Th2 cells are the principal mediators of granuloma formation (Wynn 
and Cheever, 1995). Nevertheless, Cheever et aL (1994) showed that the co- 
administration of interleukin-4 (IL-4) and parasite eggs leads to an increase in granuloma 
size, while anti-IL-4 suppresses granuloma formation. Moreover, administration of IL- 
12 to egg-injected mice leads to an impaired granulomatous response on intravenous egg 
challenge (Wynn et aL, 1994a) as does the neutralisation of interferon gamma (IFNy; 
Wynn et aL, 1995a). Subsequently, Wynn et aL (1995a) showed that sensitisation with 
eggs and IL-12 reduces granuloma formation and tissue fibrosis induced by a natural S. 
mansoni infection. This last result indicates that it might be possible to reduce pathology 
by downmodulation of a subset of immune responses to the parasite egg. 
Although the CD4' T cell response to total soluble egg antigens (SEA) has been well 
studied, there is very limited information about the individual components of SEA. Those 
molecules that have been identified include SmE 16 (Moser et aL, 1992), Smp40 (Nene et 
al., 1986), the 44.7/56.8 kDa antigens (Hirsch et aL, 1997) and a 62kDa antigen (Asahi et 
aL, 1999). The most abundant component of SEA is Smp40 and consequently this 
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molecule has been studied extensively. Upon sequencing Smp40 fully, it was found to 
be a small heat shock protein with homologies to cc-crystallins (Nene et aL, 1986). Cai et 
aL (1996) demonstrated that Smp40 is a potent immunogen, which elicits Thl type 
responses. The T-cell epitopes of this antigen have been mapped; one of these epitopes is 
immunodominant (Chen and Boros, 1998) and is important for granuloma formation. 
Anti-fecundity vaccines 
An alternative approach is to formulate an anti-fecundity vaccine that would act by 
preventing/reducing egg production by the female schistosome and thereby decrease the 
level of pathology in infected individuals. In the long term this would reduce the rate of 
transmission throughout the treated population. Such an anti-fecundity effect was 
demonstrated using the 28kDa recombinant antigen glutathione-S-transferase (GST) to 
immunise baboons (Boulanger et aL, 1991) and Patas monkeys (Boulanger et aL, 1995; 
see section 1.7.1). 
A multifactorial vaccine designed to polarise a beneficial immune response would 
comprise of larval antigens, which elicit partial protection, and egg antigens, which 
reduce the egg induced pathology caused by the worms that escape the protective 
response. The vaccine would also contain appropriate adjuvants that would 
enhance/neutralise specific cytokines, thereby optimising the method of presentation to 
the immune system. The recent advances in molecular biology techniques, the 
identification of cytokines and their functions, and in antigen presentation and delivery, 
makes the development of a vaccine against schistosomes more feasible. 
1.5 Can naturally acquired immunity form the basis of a protective vaccine? 
Much effort has been directed towards understanding the immune responses 
associated with infection in the hope that a vaccine may be developed based on naturally 
acquired immunity. Evidence for the development of acquired resistance to 
schistosomiasis comes from studies monitoring intensity of reinfection after curative 
chemotherapy at the same time as measuring the levels of exposure to infected water in 
humans (Fulford et aL, 1992; Kabatereine et aL, 1999). The data showed a decreased 
prevalence and intensity of infection in adults compared to children, independent of water 
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contact. The authors attribute these differences to the development of acquired immunity 
with age. Furthermore, adult newcomers to an endemic area are as susceptible to 
infection as young children, in contrast to adults resident in the same area (Kloetzel and 
daSilva, 1967). This observation supports the idea that immunity to schistosomiasis can 
develop in humans, as do studies on the immunology (Rihet et aL, 1991; Dunne et aL, 
1992) and genetics (Marquet et aL, 1996) of infection. However, the age-intensity data 
has been reinterpreted to suggest that other factors associated with puberty, such as 
hormonal changes, may be responsible for the reduced rate of infection in older 
individuals (Fulford et aL, 1998). More recent studies of acquisition of infection with 
age in a previously unexposed population have been carried out in Senegal (Stelma et aL, 
1993) and in Kenya (Ouma et aL, 1998). Both of these studies showed that acquired 
immunity was not the only factor effecting a reduction in infection intensities with age. 
The inherent difficulties in investigating and describing immunological events in the 
human host has necessitated the use of animal infection models. The most commonly 
used models are the mouse and rat and, to a lesser extent, the guinea-pig and non-human 
primates. Each animal model has its advantages and disadvantages. Primates provide 
good experimental models but, due to the high maintenance costs and lack of specific 
reagents, not much is known about schistosome infections in such hosts. The laboratory 
rat clears a primary schistosome infection after four to six weeks before the majority of 
worms have matured. This makes the rat model inappropriate for the study of egg- 
induced pathology. The self-cure phenomenon seen in laboratory rats has been attributed 
to increased levels of parasite-specific IgE and the subsequent activation and 
degranulation of mast cells (Cutts and Wilson, 1997). Dunne et aL (1992) showed a 
similar correlation in human resistance to reinfection in which the IgE reactivity was 
directed against adult worm antigens. Thus, the schistosome infection in the rat could be 
a model for human immunity. However, it is difficult to envisage the design of a vaccine 
based on this protective effector response that does not carry the risk of dangerous side- 
effects such as increased allergy. 
S. mansoni infection in the mouse has been the focus of attention of most 
schistosomiasis researchers. This is because the murine model provides good parallels 
with human infections in that mice develop egg-induced liver pathology and develop 
resistance to infection. Also mice are widely available and relatively cost-effective. 
Chronically infected mice are totally resistant to challenge infection (reviewed by Dean, 
1983). The immune mechanism operating in this model appears to be directed against the 
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migrating larvae of the challenge infection, whilst the adult worms from the primary 
exposure remain unharmed. The term 'concomitant immunity' was coined to describe 
this phenomenon (Smithers and Terry, 1969). However, it has been demonstrated that a 
major component of this mechanism is a result of pathological changes in the hepatic 
portal vasculature due to egg deposition by adult worms of the primary infection (Wilson, 
1990). Therefore, it is difficult to attribute resistance to reinfection entirely to an 
acquired immune response. 
Overall, there is no one model of a normal schistosome infection that provides any 
clear immune mechanisms upon which a vaccine can be based. 
1.6 The radiation-attenuated (RA) vaccine model 
An alternative route would be to design a vaccine based on a novel host immune 
response not normally encountered by the parasite and against which it has no defence. 
Optimally irradiated cercariae induce consistently high levels of acquired immunity to 
challenge infection in mice, rats and primates (Coulson, 1997). Gamma (y) or LJV 
irradiation of infective larvae attenuates the parasites such that, depending on the 
radiation dose, they fail to develop to maturity (discussed in more detail in section 1.6.3). 
Therefore, there is no egg deposition and hence no cgg-associated pathology. Due to 
practical and ethical reasons this attenuated vaccine cannot be used in humans. However, 
it does provide a paradigm upon which a vaccine can be designed (Wilson and Coulson, 
1998). As the majority of infonnation available on schistosome infections has been 
obtained from studies in mice, the rest of this thesis will refer to the RA vaccine model in 
mice, unless otherwise stated. 
1.6.1 Conditions for immunisation with irradiated parasites 
Several methods have been used to attenuate parasites and induce resistance in 
laboratory hosts. These include the use of y-irradiation (Villella et aL, 1961), UV light 
(Dean, 1983), X-rays (HsU et aL, 1981) and chemicals (Bickle and Andrews; 1985). 
However, the use of y-radiation is most widespread. 
The dose of radiation applied to the parasite strongly influences the extent of 
migration of, and the level of protection induced by the attenuated larvae. Over the years 
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there has been a dispute over the optimal amount of irradiation. Bickle et aL (I 979a) 
demonstrated that parasites irradiated with 20 kilorads (krad) induced greater levels of 
protection than higher or lower doses of radiation. However, Minard et aL (1978) found 
that the highest levels of resistance were induced when a radiation dose of 50 krad was 
used. This disagreement is thought to reflect differences in parasite maintenance and/or 
irradiation conditions (James and Dobinson, 1985). More recently, irradiation doses of 
15-20 krad have consistently resulted in higher levels of protection than doses of 50 krad 
or more (Richter and Ham, 1993). At York, the optimal irradiation dose was found to be 
20 krad (Coulson, unpublished observations). 
If mice are vaccinated once, the number of applied parasites does not appear to affect 
the levels of resistance (Bickle et aL, 1979b), with optimal levels of immunity achieved 
using as few as 50 attenuated cercariae (Dean et aL, 1983). In addition, the resistance 
stimulated by vaccination with irradiated parasites seems to be species-specific. Mice 
vaccinated with irradiated S. mansoni cercariae and subsequently challenged with other 
Schistosoma species are not protected (Agnew et aL, 1989). However, geographically 
distinct isolates of S. mansoni are able to cross-protect indicating that the antigens 
relevant to protection are common to these isolates (Hackett et aL, 1987). A single dose 
of optimally y-irradiated cercariae reduces worm burdens from challenge infections by 
60-80% as compared to non-vaccinated control mice. 
Before the mechanisms of immunity in this model can be discussed, and particular 
antigens pinpointed, the development of the normal parasite and its interaction with the 
immune system must be considered. 
1.6.2 The normal infection in laboratory mice. 
Migration and development 
Upon penetration of the mouse skin, the cercarial tail is lost and the parasite undergoes 
several biochemical and further structural changes as it transforms into the next larval 
stage, the schistosomulum. The parasite then negotiates the epidermis, basement 
membrane and dermis. On average, the skin phase of migration takes between two and 
five days (Miller and Wilson, 1978). During the first three hours post-transformation the 
trilaminate outer membrane of the cercaria is replaced by a heptalaminate membrane. 
14 
The new membrane is formed as membranous vesicles, which originate in the 
subtegumental cells, pass into the tegument (Hockley and McLaren, 1973). The parasite 
continues its migration until it eventually enters a blood vessel aided by lytic secretions 
from the head gland (Crabtree and Wilson, 1985). Whilst most of the schistosomula 
leave via the blood, 10-20% exit via the lymphatic vessels (Mountford et aL, 1988). The 
parasites migrate in the direction of blood/lymph flow, using a combination of active 
migration and passive carriage, via the pulmonary artery to the lungs. There is a period 
of development of three to four days in the lungs, during which the parasites elongate 
(Wilson et aL, 1978). Additionally, the mid-body spines are lost progressively (Crabtree 
and Wilson, 1980), accompanied by an increase in tegumental pits, which are responsible 
for extending the surface area of the membrane. A new inclusion body, the 
homogeneous body, is also first seen at this stage (Crabtree and Wilson, 1986a). These 
changes are thought to adapt the parasite for onward migration. 
The parasites that successfully migrate through the lungs pass into the left side of the 
heart and are distributed, in the same proportion as cardiac output, to the systemic organs 
of the body. Those parasites that gain access to the splanchic organs negotiate capillary 
beds, enter the hepatic portal system and are eventually retained in the liver. Those 
distributed to the other systemic organs traverse the capillaries and re-enter the heart to 
be carried back to the lungs. Trapping of schistosomula in the liver is not totally efficient 
and an estimated 14-30% may return to the lungs (Wilson et aL, 1986). Wilson and 
Coulson (1986) speculated that three circuits of parasites around the pulmonary-systemic 
vasculature were required to recruit the entire hepatic population. The high nutrient 
content of the hepatic portal system, lower blood pressure or oxygen tension may be the 
triggers required for parasite shortening and thus termination of migration (Wilson et aL, 
1978). Accumulation of parasites in the liver levels off by day 21 after infection (Wilson 
et aL, 1986). The parasites begin to feed on blood and increase in mass, and between 
days 28 and 35 post-penetration they pair and migrate up the hepatic vessels to the 
mesenteric veins where egg laying commences. 
Elimination ofparasites during a primary infection 
Only 30-50% of the parasites that penetrate the skin mature to adult worms. The 
failure of the remaining skin penetrants to reach the hepatic portal system has been the 
focus of much debate (Wilson and Coulson, 1989) and was only clarified by the 
autoradiographic tracking of isotopically labelled schistosomula in the compressed 
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organs of infected mice (Georgi, 1982). It was found that up to 78% of penetrants had 
migrated as far as the lungs of mice by day 7 (Mangold and Dean, 1983). Also, by day 
14 post-infection more than 90% of the parasites detected in the skin at day 0 were 
present in other sites (Wilson et aL, 1986). Mangold et aL (1986) demonstrated that the 
number of maturing parasites did not differ significantly when lung-stage schistosomula 
were injected directly to the lungs intravenously, compared to a normal percutaneous 
infection. Therefore, it would seem that only a very small proportion of parasites are 
eliminated at the skin stage of migration. 
The transit time of the parasite through the lungs is considerably longer than through 
other organs (Wilson and Coulson, 1986), suggesting that the larvae find this a difficult 
organ to negotiate. Ultrastructural examination of infected lungs supports this hypothesis 
as the lung worms were seen to cause considerable distension of the vessels (Crabtree 
and Wilson, 1986a). It was found that 80% of parasites present in the lungs had been 
diverted into the alveoli by day 20 post-infection (Crabtree and Wilson, 1986b). It has 
also been shown that schistosomula delivered to the alveoli, via the trachea, had a limited 
capacity to re-enter the tissues and mature, whereas parasites removed from the alveoli 
and transferred to the hepatic portal system matured normally (Coulson and Wilson, 
1988). This suggests that despite adaptive changes, the parasites find the pulmonary 
capillaries difficult to negotiate, and a large proportion of them rupture the narrow blood- 
air barrier and enter alveoli. It is assumed that the schistosomula starve to death here as 
they are unable to re-enter tissues. Thus, taken together, these studies indicate that the 
majority of parasite loss occurs in the lungs. It seems that parasite attrition in the naYve 
mouse is a consequence of physical constraints in the lungs rather than immunological 
mechanisms. 
1.6.3 The effect of radiation on the parasites and their ability to migrate. 
The migratory pattern of attenuated larvae is affected by the radiation dose applied. A 
dose of 2-10 krad results in decreased worm recoveries from the lungs; 20 krad reduces 
this even further, while 40 krad results in almost no parasites reaching the lungs 
(Mangold and Dean, 1984). Most 90 krad irradiated parasites fail to leave the skin 
indicating that irradiation diminishes the parasite's ability to migrate. Optimally- 
irradiated parasites (20 krad) migrate more slowly through the host compared to their 
normal counterparts. Only 13% of normal parasites are found in the skin by day 5 
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whereas 43% of applied parasites remain in the skin of vaccinated mice (Mountford et 
A, 1988). Migration through the skin-draining lymph nodes (sdLNs) was also more 
rapid for normal parasites. Mastin et aL (1983) showed that the migration of the 
attenuated parasites terminated in the lungs of vaccinated mice. 
Irradiation of larvae does not seem to cause a change in their ultrastructure (Mastin et 
aL, 1985) or in the surface antigens of the larvae (Simpson et aL, 1985). Vierra et al. 
(1987) demonstrated that there was no difference in the ability of normal or irradiated 
larvae to induce proliferation of peripheral blood mononuclear cells from human patients 
with a chronic infection. Wales et aL (1992) showed that protein synthesis in the first 24 
hours post-irradiation is inhibited but is completely normal by 72 hours. Thus, no 
difference can be detected between irradiated and normal cereariae. However, 
examination of the morphological differences between irradiated and normal larvae at the 
lung stage of development showed impaired neuromuscular co-ordination in the former 
(Harrop and Wilson, 1993a). The irradiated parasites exhibited random constrictions at 
intervals along the length of the body, probably resulting from over-constriction of 
muscle fibres. The authors suggest that this may account for the truncated migration by 
y-irradiated parasites. 
1.6.4 Induction of protective immunity 
There is ample evidence to suggest that resistance in the irradiated cercaria model is 
the result of a specific immune response. For example, the immunity generated in 
vaccinated mice, but not those with chronic infections, was transferred to nSfve animals 
across a parabiotic union (Dean et aL, 1981). Also, athymic mice fail to develop 
resistance following exposure to irradiated cercariae, indicating that T cells are important 
(Sher et aL, 1982). 
The precise reason why exposure to attenuated cercariae elicits protection in mice is 
not fully understood. However, their altered migration kinetics, as compared to normal 
parasites, may provide one explanation. Attenuated parasites undergo a protracted 
migration from the site of skin penetration to the lungs where they die between days 14 
and 21 post-vaccination. Following vaccination, a proportion (10-15%) of parasites enter 
and persist in the skin-draining lymph nodes. In addition greater amounts of parasite- 
released material were detected in the sdLNs of vaccinated mice than in those from 
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control mice (Mountford et aL, 1988). Thus, greater quantities of parasite proteins are 
exposed to the host's immune system than after infection with normal cercariae. 
The removal of the draining lymph nodes before vaccination reduces the level of 
resistance. The same is true when draining lymph nodes are removed a week after 
vaccination, whereas lymphadenectomy at later times does not abrogate resistance 
(Mountford and Wilson, 1990). Furthermore, Constant et aL (1990) showed that 
lymphocytes derived from the draining lymph nodes of vaccinated mice proliferate more 
than those derived from the spleens of the same mice, thereby confirming that parasite 
persistence in the sdLNs is essential for the induction of protective immunity. Taken 
together, these studies suggest that optimally attenuated parasites persist in the lymph 
nodes, where antigenic processing is intense, and release greater amounts of material, 
thus priming those lymphocytes required for successful vaccination. 
Incomplete ablation of resistance when the draining lymph nodes are removed 
suggests that there is another site important for the induction of protection. Coulson and 
Mountford (1989) found that intra-dermal administration of attenuated 8 day old 
schistosomula results in high levels of protection, comparable to percutaneous 
vaccination. However, only intermediate levels of protection were elicited by delivery of 
parasites directly to the lungs (intra-tracheal), whilst intravenous injection yielded little or 
no resistance. This indicates that the arrested migration of irradiated schistosomula in the 
lungs and their subsequent death there is also important for the induction of immunity. 
Thus, it seems that the irradiated larvae must persist in both the lungs and in the draining 
lymph nodes to elicit optimal levels of protection. The arrival of attenuated parasites in 
the lungs triggers an inflammatory response which recruits CD4" T cells to the 
pulmonary parenchyma (Aitken et aL, 1988). These cells are important for the initiation 
of the host response to a subsequent challenge infection (Smythies et aL, 1992b). The 
immune response in the lymph nodes involves the expansion of CD4' Th cells, 
specifically of the Thl -cell subset as determined by the secretion of abundant IFNy after 
in vitro stimulation (Pemberton et aL, 1991; Mountford et aL, 1992). This is supported 
by the finding that the co-administration of recombinant IL-12 with the attenuated 
cercariae boosts both the secretion of IFNý and the levels of protection (Wynn et aL, 
1995b; Anderson et aL, 1998). The Thl bias of the immune response in the sdLNs and 
lungs is corroborated by cytokine mRNA expression patterns in these tissues (Betts and 
Wilson, 1998; Wynn et aL, 1995b). 
18 
1.6.5 The effector response 
It is now generally accepted that the majority of challenge parasites are eliminated in 
the lungs via a Thl -cell mediated mechanism (reviewed by Coulson, 1997). A rapid 
inflammatory response is triggered when normal challenge schistosomula reach the 
pulmonary vasculature of a vaccinated mouse. The schistosomulum is stationary for 2-3 
days as it undergoes morphological adaptations for onward migration and it is within this 
time that the individual challenge parasites become surrounded by a dense cellular focus, 
characteristic of a DTH response (Crabtree and Wilson, 1986b). In contrast, parasites in 
a non-vaccinated lung do not attract a focus unless they enter alveoli. 
The mechanism of parasite elimination remains unresolved. Macrophage-mediated 
killing, involving the production of nitric oxide (NO) has been suggested (James and 
Nacy, 1993). Wynn et aL (1994b) demonstrated that levels of inducible nitric oxide 
synthase (iNOS) mRNA were elevated in the lungs of vaccinated mice suggesting that 
NO activity was increased. However, studies using mice genetically deficient for iNOS 
showed only -30% abrogation of protection, indicating that NO is not a major 
component in parasite elimination (Coulson et aL, 1998; James et aL, 1998). 
As mentioned above, many of the parasites arriving in the lungs attract a focus of 
inflammation. By day 11 post-challenge the foci have increased in size and surround the 
parasites trapped in capillaries and alveoli. Ultrastructural studies show no visual 
damage to the schistosomula (Crabtree and Wilson, 1986a). Moreover, trapped 
schistosomula recovered from the lungs of vaccinated mice are able to migrate and 
mature fully when introduced into a naYve host (Coulson and Wilson, 1988). This 
suggests that the effector mechanism does not harm the parasites but in fact acts to block 
onward migration of the challenge worms. 
The pro-inflammatory cytokine IFNy has been shown to play a key role in the effector 
response (Sher et aL, 1990). More recently in vivo ablation studies (Smythies et aL, 
1992a) and experiments using IFNy gene disrupted mice (IFNy ') (Wilson et aL, 1996) 
have confirmed these data, as protection levels were reduced in both studies. Indeed, the 
pulmonary foci formed in the IFNy' mice were different in their architecture and cellular 
composition; they were larger, contained more giant cells and were not as compact as 
foci from genetically intact mice (Wilson et aL, 1996). The authors suggest that the 
larger, more diffuse inflammatory foci do not prevent the parasites from migrating 
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through the lungs. Further studies using gene-disrupted mice have shown that the lack of 
tumour necrosis factor (TNF) completely abrogates protection (Street et al., 1999). 
However, the mechanism through which TNF acts is unknown. 
Although the precise mechanisms responsible for parasite elimination in the lungs 
remain unclear, it has been demonstrated that the radiation-attenuated vaccine induces a 
Thl biased immune response which is protective. The serum from singly-vaccinated 
mice confers only low levels of protection on transfer into naYve mice, supporting the 
hypothesis that antibodies are not important in this vaccine model. More recently, two 
studies using B-cell deficient (pMT) mice have been carried out to investigate the role of 
B cells in the lx vaccinated mouse model (Anderson et al., 1999; Jankovic et al., 1999). 
Although the data in the two studies is similar the authors reach very different 
conclusions. Anderson et al. (1999) found that two-thirds of the PMT mice had 
protection levels similar to their wild type counterparts, indicating that cell-mediated 
mechanisms alone are adequate for protection. In contrast, the remaining PMT mice had 
worm burdens identical to the challenge control group. The authors suggest that there is 
a genetic basis for the observed differences between individual pMT mice and that cell- 
mediated immunity confers substantial protection against challenge infection. However, 
Jankovic et al. (1999) found that protection levels were lower in gMT mice than in wild 
type controls suggesting that the protective mechanism in operation in the lx vaccinated 
mouse is likely to involve humoral antibodies. 
In contrast, serum from multiply vaccinated mice is capable of transferring a degree of 
resistance (Mangold and Dean, 1986). Multiple vaccination has been shown to result in 
modest increases in the level of immunity compared to that elicited by a single 
vaccination (Caulada-Benedetti et al., 1991). The latter authors also show that multiple 
vaccination predisposes towards a Th2 response, suggesting that there may be qualitative 
and quantitative changes in antibody titres as compared to those in Ix vaccinated mice. 
This was demonstrated by Dalton and Strand (1987), as antibodies from singly- 
vaccinated mice were directed against glycoproteins of molecular weight (Mw) from 
>300 to <lOkDa while antibodies from twice-vaccinated mice were directed towards high 
Mw glycoproteins. Additionally, multiple vaccination of IFNY' mice, in which Thl 
responses are absent, results in increased protection with each successive vaccination and 
serum from these animals will confer up to 60% protection on nsfve C57BL/6 recipients 
(Wilson et al., 1999). Furthermore, triple vaccination of pMT mice fails to increase the 
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protection levels above those reached after the primary vaccination, indicating that 
antibody-mediated responses are critical in multiply vaccinated mice (Anderson et aL, 
1999; Jankovic et aL, 1999). It should also be noted that these experiments show that the 
cell-mediated effector response is not boosted by multiple vaccination with irradiated 
parasites. The site and mechanism of challenge parasite elimination in the multiple 
vaccination model is unclear. 
1.6.6 What kind of antigens make good vaccine candidates? 
Given that the radiation-attenuated vaccine will elicit either Thl or Th2 mediated 
responses, depending on the vaccination protocol, several deductions can be made about 
the antigens involved. 
When normal challenge parasites reach the lungs of aIx vaccinated mouse they 
provoke an inflammatory response which is mediated by Thl cells. Therefore, the 
antigens involved in the induction phase of immunity must by processed by antigen- 
presenting cells (APCs) and presented to the T cells in the context of MHC class II. 
Antigens released from the schistosomulum (as opposed to somatic or membrane- 
associated molecules) are the most likely candidates as they are the most readily available 
material for uptake by APCs. Although it can be argued that dead or dying 
schistosomula can also prime immune cells, the target of the immune response is the live 
schistosomulum and it would therefore be logical to assume that only those antigens 
derived from the live parasite are important. It has been suggested that irradiation may 
modify antigen conformation which means that the immune system is primed by 
abnormal or non-native antigens (Wales and Kusel, 1992). However, this would not help 
as the T cells primed against such antigens would not be able to recognise the unmodified 
peptides from challenge larvae. Thus, antigens released by the lung-stage parasites are a 
rich source of potential vaccine candidates. More recently, Riengrojpitak et aL, (1998) 
have shown that there is contact between immune cells, which have characteristics of 
macrophages and dendritic cells, and the parasite surface in the sdLNs. This indicates 
that proteins found on the surface of the parasite tegument are a key source of protective 
antigens. 
Biosynthetic labelling of larvae grown to the lung-stage in vitro has revealed a pattern 
of proteins that are synthesised and secreted during this stage of development (Harrop 
and Wilson, 1993b). Approximately 15 proteins of diverse molecular weight were 
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detected in vitro between days 6-8. The day 6-8 larval secretions, in comparison with 
soluble parasite preparations, were more potent stimulators of proliferation of 
lymphocytes from vaccinated mice (Mountford et aL, 1995). Therefore, one or more of 
these 15 proteins is likely to be the key antigen(s) in this model of protective immunity. 
The minute amount of material released from 6-8 day schistosomula makes the isolation 
of these proteins difficult. Indeed, there has only been one published study directed 
specifically at identifying these antigens (Harrop et A, 1999). This is discussed in more 
detail in section 1.7.7. 
1.7 Candidate vaccine antigens 
Although it is possible to protect mice, rats and primates against a challenge infection 
by prior immunisation with radiation-attenuated cercariae, this vaccine strategy cannot be 
used in humans for ethical and safety reasons. Therefore, much attention has focused on 
the identification of particular parasite antigens that may be responsible for inducing the 
protective immune responses. Following the recent advances in molecular biology 
technologies and vaccinology, a vast number of schistosome antigens have been 
described and their potential as vaccine candidates tested. To discuss all of these 
antigens is beyond the scope of this thesis; I have therefore concentrated on those 
antigens which have received most attention. In 1991 the WHO selected a panel of six 
antigens for independent vaccine trials in experimental animals (Bergquist, 1995); each 
of these is discussed in more detail. 
1.7.1 Glutathione S-Transferases 
The 28kDa glutathione S-transferase of S. mansoni (GST) is by far the best 
characterised vaccine candidate. This antigen was first described by Balloul et aL 
(1985). A 28kDa fraction of S. mansoni soluble adult worm antigens was found to elicit 
a protective antibody response in Fischer rats and BALB/c mice. In addition, the antigen 
could be detected in the in vitro translation products of adult worm mRNA and in ... I 
labelled surface antigens of schistosomula. The purified antigen could elicit protective 
immunity in rats (50-70%) and mice (40-43%) by direct immunisation (Balloul et aL, 
1987a). At the same time the cDNA encoding the antigen was cloned, sequenced and 
expressed in E. coli and yeast (Balloul et aL, 1987b). The recombinant protein also 
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elicited protective immunity in rats, hamsters (Balloul et A, 1987b) and mice (Boulanger 
et aL, 1991). The major epitopes eliciting T and B cell responses in mice and rats have 
been identified (Wolowczuk et aL, 1989; Auriault et aL, 1988). Subsequently a peptide 
(115-13 1) from GST was shown to have both T and B-cell epitopes and, when delivered 
as an octameric construct, resulted in 40-50% protection in rats (Wolowczuk et A, 
1991). 
Taylor et aL (1988) have characterised the 28kDa protein as a glutathione S- 
transferase and have demonstrated that the enzyme is present in the adult worm 
tegument, protonephridial cells and subtegumental parenchymal cells. GSTs form a large 
multigenic family of isoenzymes, which play a major role in detoxifying various 
electrophiles and oxidative free radicals in eukaryotes. There is no cross-reactivity 
between parasite and human and rat GSTs thus, it was thought that inhibition of enzyme 
activity might have a protective effect. To investigate this, a monoclonal antibody 
(MAb) against GST (S 13) was passively transferred into rats and mice. Whilst treatment 
significantly reduced worm burden in rats, there was no effect on worm burden in mice 
but tissue egg load was decreased (Xu et aL, 1991). The authors suggest that this 
difference may be due to distinct effector mechanisms in operation against GST in the 
two animal models. The response in rats generates high levels of IgE antibodies, whereas 
in the mouse model the protective immunity involves antibody-independent cellular 
mechanisms (Wolowczuk et aL, 1989; Damonneville et aL, 1988). In addition, 
Boulanger et aL (199 1) demonstrated a decrease not only in worm burden but also in 
faecal egg output (by 66%) and female worm fecundity (by 33%) in baboons immunised 
with GST. Taking all these data together, it was proposed that GST might function as 
part of an anti-fecundity vaccine. More recently, the anti-fecundity effect of S. 
haematobium GST was also seen in Patas monkeys infected with S. haematobium 
(Boulanger et aL, 1999). The S 13 MAb was shown to recognise the C-terminal (190- 
211) and N-terminal (10-43) peptides of GST. Immunisation of mice with the C-terminal 
peptide reduced worm burdens and egg deposition (Xu et aL, 1993). The authors 
postulate that a peptide construct containing the C-terminal and N-terminal peptides, 
together with the 115-131 amino acids, could be used to decrease both worm burden and 
female fecundity. 
The data reviewed so far emphasise the role of antibodies in anti-fecundity but it 
should be noted that IFNy produced by CD4' and CDS' T cells also has an effect on 
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levels of hepatic tissue damage (Pancr6 et aL, 1994). Grezel et A (1993) have suggested 
that IgA antibodies are important for influencing parasite fecundity, whereas IgE is 
responsible for affecting protection against challenge worms. With regard to the design 
of a vaccine strategy, enhanced secretory IgA production may be achieved using mucosal 
immunisation. Consequently, various mucosal vaccine delivery systems, which increase 
the immunogenicity of the antigen and stimulate the required immune profile, have been 
investigated. 
Ivanoff et al. (1996) delivered SmGST, incorporated into liposomes, orally to mice 
and found elevated levels of IgA in gut washes, and IgG I and IgG2b antibodies in serum, 
as well as decreases in worin burdens. Similarly, single dose nasal administration of 
biodegradable microparticles containing recombinant SmGST (rGST) gave a specific 
mucosal immune response (Baras et al., 1999). Experiments by Mielcarek et al. (1997), 
in which mice had been immunised intranasally with Bordetella pertussis expressing 
rGST fused to filamentous haemagglutinin, showed high levels of IgA in the lungs and 
IgG in serum as well as a decrease in wonri burdens. Other live expression systems such 
as Salmonella typhimurium (Khan et al., 1994a+b) and Mycobacterium bovis bacillus 
Calmette-Guerin (BCG; Kremer et al., 1996) have also been used successfully to induce 
anti-GST antibodies. Most recently, Sun et A (1999) have demonstrated that 
administration of rGST conjugated to cholera toxin B subunit induces strong mucosal 
IgA immune responses and T cell hyporesponsiveness, as well as consistently 
suppressing granuloma formation and inhibiting parasite development. 
Experiments have also been carried out using plasmid DNA encoding SmGST (Dupre 
et al., 1997). Following intradermal administration to rats, the antigen could be detected 
in skin cells by immunohistochemistry; long-lasting IgG2a and IgG2b antibodies were 
also detectable in sera. These sera were able to mediate antibody dependent cell- 
mediated cytotoxic (ADCQ killing of larvae in vitro, and a parasite challenge of 
inimunised mice induced a strong and rapid boost of specific IgG antibodies. No 
protection data was reported. The S. japonicum GST has also been tested for 
immunogenicity using a similar plasmid construct but failed to elicit specific antibodies 
(Waine et al., 1997). 
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1.7.2 Paramyosin (Sm97) 
Intradermal vaccination of mice with thawed adult worms, using BCG as an adjuvant, 
produced unusually monospecific antibodies to a 97kDa antigen (Pearce et al., 1986). 
The antigen was identified as the myofibrillar protein paramyosin (Lanar et al., 1986) 
and localised to the tegument and muscle of adult worms (Matsumoto et al., 1988). 
Immunisation of mice with either native or recombinant paramyosin conferred significant 
resistance (26-33%) against challenge infection (Pearce et al., 1988). In addition, 
paramyosin was shown to stimulate T-cells from vaccinated mice to produce IFNy in 
response to living schistosomula (Pearce et al., 1988; Flanigan et al., 1989). Paramyosin 
is a non-surface protein, in contrast to the other vaccine candidates that are thought to be 
surface expressed or secreted. It has been suggested that cell-mediated killing of the 
parasites could be due to paramyosin that was released from the parasite as part of normal 
protein turnover (Gobert, 1998). 
DNA vaccination with plasmid encoding paramyosin has also been tested; although 
antibodies to paramyosin were generated, the mice were not protected against cercarial 
challenge (Waine et al., 1997). 
1.7.3 Triose-phosphate Isomerase (TPI) 
This protein was identified using a MAb (M I) from mice vaccinated with detergent 
extracts of mechanically transformed schistosomula (Ham et aL, 1985). The 28kDa 
protein is found in all developmental stages of the parasite; perhaps most intriguingly it is 
transiently expressed on the surface of newly transformed schistosomula. Immunisation 
of mice with immune complexes containing the 28kDa antigen bound to MI gave a 38% 
reduction in worm burden (Ham et aL, 1992). 
Shoemaker et aL (1992) cloned the full length cDNA, and the recombinant protein 
was found to have enzymatic activity that was typical of a TPI; the T and B cell epitopes 
have been mapped and four-armed multiple antigenic peptides (MAP) have been 
constructed. The recombinant protein induces lymph node cells from infected mice to 
secrete IL-2 and IFNy and immunisation with the MAP-4 construct leads to specific T 
cell proliferation and IFNy production by lymph node cells upon restimulation with full 
length TPI in vitro (Reynolds et aL, 1994). 
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Ferru et aL (1997) constructed a MAP, termed MAP DA, containing 3 peptide 
sequences, two from TPI and one from GST. Subcutaneous immunisation of mice with 
MAP DA elicited aT cell response against the TPI components and aB cell response 
against the GST peptide. This study is the first to demonstrate the use of one construct to 
immunise a host against two distinct antigens. 
1.7.4 Sm23 
This molecule was first reported as the target of a MAb that bound to the surface of 
cultured lung-stage schistosomula (Ham et aL, 1985) and the cDNA clone was identified 
by several groups (Dalton et aL, 1987; Wright et aL, 1990). Sm23 is part of a 
superfamily of membrane proteins all of which have unknown function. The structure of 
Sm23 is believed to consist of four transmembrane domains and two extracellular 
domains. The T and B cell epitopes in the predicted external domains have been mapped 
and shown to be highly immunogenic (Reynolds et aL, 1992). Although this antigen was 
tested in the WHO vaccine trials there is no other published data on its protective 
efficacy. 
1.7.5 IrV-5 
As discussed earlier, mice exposed to radiation-attenuated cercariae are highly 
resistant to challenge infection, and sera from multiply vaccinated mice can confer partial 
resistance when transferred to na7fve recipients (see section 1.6.5). A polyclonal serum 
from twice vaccinated mice recognises a restricted subset of antigens. Hence, a 
polyclonal serum raised in rabbits against this subset of antigens was used to screen a 
cDNA library. A cDNA clone encoding a fragment of one of these glycoproteins was 
isolated, sequenced and designated IrV-5 (Soisson et aL, 1992). The clone shows a high 
degree of homology to mammalian P-myosin heavy chain and the native protein 
homologous to IrV-5 is a 200kDa antigen. 
Immunisation of mice with recombinant IrV-5 (rIrV-5) complexed to outer membrane 
protein of meningococcus (OMP) gave up to 72% protection in mice, 97% in rats 
(Soisson and Strand, 1993) and up to 54% in baboons (Soisson et aL, 1993). 
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1.7.6 Sm14 
This antigen was identified and cloned following the analysis of the antigens in a 
protective saline extract of adult worms (Moser et A, 1991). The recombinant molecule 
protected mice by up to 67% against a challenge infection, even in the absence of an 
adjuvant (Tendler et aL, 1996). The recombinant Sm14 also protected mice against a 
challenge with Fasciola hepatica, suggesting that similar parasite proteins could mediate 
immune reactivity and therefore represent a basis for a vaccine against both species. 
Surprisingly, despite the induction of protective responses by each of the antigens in 
the stipulated formulations in the originators' laboratories "the stated goal of consistent 
induction of 40% protection or better was not reached" in the independent WHO trials 
(TDR News, 1995). In addition, detailed analyses of the responses of peripheral blood 
leukocytes from infected humans, stimulated in vitro with each of the candidates, failed 
to highlight any obvious correlation between resistant and susceptible individuals 
(Bergquist and Colley, 1998). This has prompted a re-evaluation of the antigen 
formulations in use. It is in this context that most research on these six antigens is being 
directed, with GST, paramyosin, MAP-4/TPI and Sml4 being moved towards Phase I 
clinical trials, and IrV-5 and MAP-3/Sm23 being developed for DNA vaccination 
(Bergquist and Colley, 1998). 
1.7.7 Other Vaccine Candidates 
Although the antigens discussed so far represent the most intensively studied 
schistosome proteins, a number of other antigens have been proposed as vaccine 
candidates. Some of these are potent stimulators of the immune system and warrant 
further discussion. 
Most of the antigens currently being investigated were originally identified under the 
premise that proteins presented at the surface, or associated with the tegument, of the 
parasite would be the best vaccine candidates as such molecules are in close contact with 
the host immune system. Two main approaches have been used to identify such proteins. 
One method made use of surface radio-labelling techniques, followed by membrane 
isolation, electrophoresis and autoradiography. Sera from vaccinated or infected mice 
were then used to assess the immunogenicity of the labelled proteins. The second 
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method identified antigens by immunoprecipitation, affinity chromatography or Western 
blotting of surface components with monoclonal or polyclonal sera. 
Two labelling techniques, lactoperoxidase (Dissous et aL, 1981) and lodogen (Knight 
et A, 1984) have been used, and both gave identical results. Human or animal infection 
sera precipitate six major polypeptide surface antigens of Mr 92,38,32,20,17 and 
l5kDa (Simpson and Smithers, 1985). Since then many more surface antigens have been 
described, several of which can be precipitated by either chronic mouse serum or 
vaccinated mouse serum. 
Gryzch et al. (1982) produced a rat monoclonal antibody which transferred significant 
levels of protection to rats (53-61%) and which immunoprecipitated the 38kDa surface 
antigen seen by Dissous et al. (1981). Many other studies have shown that monoclonal 
antibodies that recognise schistosomula surface antigens are protective (Zodda and 
Phillips, 1982; Ham et al., 1984; Bickle et al., 1986) suggesting that these antigens can 
mediate immunity. Further evidence that surface antigens induce protection was 
provided by Smith and Clegg (1985). They vaccinated mice with a surface antigen, 
purified using a protective monoclonal antibody, and demonstrated low but significant 
levels of protection. Furthermore, Tarrab-Hazdai et al. (1985) purified antigen 9B using 
a highly protective monoclonal antibody and achieved 45% protection in mice 
immunised with the antigen in Complete Freunds Adjuvant (CFA). This level of 
protection was elevated to 65% when the antigen was delivered within proteosome 
vesicles. One protective B cell epitope of 9B has been identified (Tarrab-Hazdai et al., 
1998) and shown to give -40% protection in mice when delivered either subcutaneously 
conjugated to bovine serum albumin (BSA), or intranasally, expressed in flagella of 
Salmonella dublin (Ben-Yedidia et al., 1999). 
Sera from mice protectively vaccinated with adult worm surface membranes 
precipitated a 25kDa glycoprotein (Sm25); this protein has been characterised 
independently in several laboratories (Knight et al., 1989; Ali et al., 1991) and is 
principally located subtegumentally in adult worms. Although there are currently no 
protection data available for this antigen, vaccination with the recombinant protein 
induces high antibody titres (Suri et al., 1997). 
Yet another tegument associated protein, SmlO, has been identified as a putative 
vaccine candidate based on its properties as a potent stimulator of T cells from adults 
living in an endemic area (Couissinier-Paris et al., 1995). Significant protection is 
induced by the recombinant antigen in mice (Henri et al., 1998). The authors describe 
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the molecule as a dynein light chain (DLC) and there is indeed significant sequence 
identity to the DLC described by Hoffmann and Strand (1996). These molecules seem to 
be members of a family of tegumental proteins as they both display sequence similarity 
to the 20.8KDa tegumental antigen (Hoffinann and Strand, 1997) which is in turn related 
to Sm22.6 (Webster et aL, 1996; Jeffs et aL, 1991), and Sm2l. 7 (Francis and Bickle, 
1992). A comparison of the levels of anti-recombinant Sm22.6 (rSm22.6) antibodies 
with intensities of reinfection after treatment of human patients showed a negative 
correlation between IgE responses to rSm22.6 and infection intensity (Webster et aL, 
1996); this is similar to protection data obtained with recombinant SmI 0 in mice (Henri 
et aL, 1998). 
Human responses correlated with resistance to reinfection have been used to identify 
other protective antigens. Thus, a study of a Brazilian population showed that the 
susceptibility of those individuals who became rapidly reinfected after treatment could be 
correlated to the absence/reduced levels of anti-37kDa IgG antibodies (Dessein et aL, 
1988). The cDNA encoding the antigen, Sm37, has been cloned and sequenced (Goudot- 
Crozel et aL, 1989). Of the five B cell and two T cell epitopes found on the molecule, 
one B cell epitope, 37-5, was shown to be highly antigenic in human infections (Argiro et 
aL, 1999). A synthetic peptide corresponding to 37-5 coupled to ovalbumin and 
administered in CFA to mice induced 25% protection. 
Several studies have attempted to characterise the proteins released by the parasite 
(McKerrow and Doenhoff, 1988; Harrop and Wilson, 1993; Lewis and Strand, 1991; 
Atkinson and Atkinson, 1982). However, the serine protease, elastase, is the only 
molecule from these studies that has been postulated as a potential vaccine candidate. 
Elastase was described by several groups simultaneously (Marikovsky et aL, 1988, 
Newport et aL, 1988) and has been characterised as crucial for skin penetration by 
cercariae (McKerrow et aL, 1985). The enzyme elicits a transient immune response 
during a natural infection. Darani et aL (1997) immunised mice with material that 
contained the protease as the main constituent and showed that in animals that did 
produce antibodies to elastase there was a 40% reduction in worm burden. Doenhoff 
(1998) has suggested that this protease, or recombinant derivatives of the enzyme, could 
be used as an effective vaccine in accordance with Waksman's postulate which states that 
"rather than examining parasite antigens recognised by infected animals and patients as 
potential vaccine immunogens, we should focus an those molecules against which little 
or no response was directed" (Sher, 1989). 
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All of the vaccine candidates discussed so far have been identified on the basis of their 
reactivity with antibodies. However, as mice given a single immunisation with radiation 
attenuated cercariae develop protective immunity associated with Thl-type responses it 
would be logical to identify antigens based on their ability to stimulate Thl reactivity. 
This has proved to be a difficult task, and to date the only antigen thus identified is 
calpain (Jankovic et aL, 1996). A protective Thl cell clone was derived from mice that 
had been vaccinated with freeze-thawed adult worms using BCG as an adjuvant. An 
adult worm cDNA expression library was screened with the clone and its target 
identified. The antigen was found to be the large subunit of calpain, surface expressed 
and immunogenic in natural infections (Andresen et aL, 199 1). The recombinant protein 
elicited 29-39% protection and DNA vaccination using gene gun vectors expressing the 
protein gave up to 60% protection (Hota-Mitchell et aL, 1999). More recently, a 
screening system to identify antigens based on their T cell reactivity has been developed 
(Eberl et aL, 1999). Initial results have led to the identification of a fragment of 0- 
myosin heavy chain. This fragment does not overlap with IrV-5, but is adjacent to it in 
the DNA sequence of myosin heavy chain. 
All of the vaccine candidates discussed above are intracellular except for elastase and 
Sm23. These intracellular antigens are unlikely to come into contact with the host 
immune system unless the parasite is first damaged by a non-immune process. As the 
proposed immune effector mechanisms for the elimination of schistosomes require the 
secretion/excretion of antigens from the intact parasite it is essential to continue the 
search for such antigens. The dearth of secreted antigens is highlighted by the fact that 
by October 1996 only 9 open reading frames (ORFs), of the 300 deposited on the 
schistosome databases, had been annotated as having a characteristic secretory signal 
peptide at the N-terminus. 
As mentioned earlier, Harrop et al. (1999) have attempted to identify proteins released 
from developing schistosomula by antibody screening of cDNA libraries but have had 
limited success. The serum raised against the released proteins identified predominantly 
genes encoding somatic antigens from the cDNA libraries screened, for example, 
paramyosin, fructose 1-6-bisphosphate aldolase and myosin. This may be due to the 
presence, in the sera, of high titre and high affinity antibodies to these immunogenic 
molecules. It is difficult to envisage that these proteins (given their functions) are 
30 
released from the parasite as part of its normal biological processes. These proteins are 
probably derived from dead/damaged larvae and therefore do not represent the true 
secretions of the parasite. In addition, random sequencing of the cDNA libraries used in 
these studies has revealed that the genes encoding calcium binding protein and aldolase 
are highly represented (Franco et al., 1997; Santos et al., 1999). Therefore, both random 
sequencing and antibody screening of cDNA libraries are biased towards the isolation of 
abundant, immunogenic, somatic constituents and are ineffective approaches for the 
identification of putative vaccine candidates. 
1.8 Aims of this study 
From the preceding introduction it should be evident that T cells play a major role in 
the protective immune response seen in mice vaccinated once with optimally irradiated 
cercariae. One can infer from this that the immune response must be triggered by 
antigen(s) expressed on the surface of, or released from the live schistosomula to enable 
processing by APCs and subsequent presentation to T cells. It should also be clear that 
the antigens involved are most likely to be released from the developing schistosomula as 
these correspond to the challenge larvae eliminated in the lungs of vaccinated mice. As 
conventional approaches to identify these proteins have been inefficient the aim of this 
study was to devise strategies that would isolate the genes coding for the membrane 
and/or secreted (NVS) proteins of S. mansoni. The work presented here describes three 
distinct approaches that have been developed. 
Chapter 3 describes a computational biology approach. The large number of 
expressed sequence tags (ESTs) in the schistosome genome database represents a 
significant resource which was exploited to identify NVS proteins. As there was a 
relatively small number of ESTs derived from the lung worm approximately 100 ESTs 
were initially generated from a lung worm cDNA library. Following this, an algorithm 
was used to screen the entire database for cDNAs encoding NVS proteins. Those ESTs 
potentially encoding NVS proteins and derived from the larval stages of development 
were analysed further. A number of clones were transferred into a high level expression 
system. Antibodies were raised against a purified recombinant protein and 
immunocytochernistry used to localise the antigen to the parasite. 
In the second approach, the technique of RNA arbitrarily primed PCR (RAP-PCR) has 
been used to identify genes expressed either uniquely of preferentially by lung-stage 
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schistosomula. Chapter 4 describes the technique leading to the identification, cloning 
and sequencing of several cDNAs. Analysis of these cDNAs by Southern and Northern 
blotting was carried out. 
Finally, Chapter 5 describes a screening system which identifies cDNAs encoding 
WS proteins based on a single-step genetic selection in a mutant strain of yeast. To 
establish the system, several controls to test that the system could recognise and process 
schistosome cDNAs were carried out. 
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CHAPTER 2 
GENERAL MATERIALS AND METHODS 
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2.1 Preparation of parasite material 
A Puerto Rican isolate of S. mansoni was maintained by passage through MF1 mice 
and albino Biomphalaria glabrata water snails. 
Cercariae: Infected, patent snails were exposed to bright light inducing them to shed 
cercariae. The parasites were concentrated by sedimentation on ice followed by brief 
centrifugation. The pellet of parasites was then washed several times in sterile phosphate 
buffered saline (PBS; 150mM NaCl, 8mM Naý111`04,2.6mM KCI, 1.5mM KH, P04) to 
remove any traces of snail material. 
Lung Schistosomula: Eight day schistosomula were obtained by in vitro culture 
essentially as described by Harrop and Wilson (1993b). Briefly, a concentrated cercarial 
suspension was taken up in 2-3mls RPMI medium (Gibco BRL, Life Technologies, 
Paisley, UK) and the parasites mechanically transformed by vortexing for 90 seconds. 
The resulting heads and tails were incubated at 37*C for 2-3 hours before the heads were 
isolated by centrifugation on a discontinuous percoll gradient (70-40%). The heads were 
washed six times in I Oml RPMI medium to remove any remaining tails and then 
resuspended in medium 169 (M169; Basch, 1981) for eight days at 37'C, 5% COV 
Those cultures containing more than 85% viable larvae were then pooled, the parasites 
pelleted and washed several times in sterile PBS to remove any traces of M 169. 
Adult Worms: MF I mice were infected with approximately 200 cercariae. Adult 
worms were obtained by perfusion of the hepatic portal system of six week-infected 
mice, with RPMI medium containing heparin. Any contaminating debris and mouse 
tissue was removed by hand and by washing the worms several times in sterile PBS. 
Eggs: The livers and small intestines of mice that had been infected with 200 cercariae 
six weeks previously were removed, homogenised in a small volume of buffer (0.06M 
Na2HPOO 0.003M KH2PO4) and digested with trypsin for 3 hours at 37"C. the 
trypsinised tissues were passed through a 300ýtin mesh, followed by a 180gm mesh to 
remove any undigested tissue debris. The filtrate was allowed to settle and the liquid 
then gently poured off leaving behind the eggs. These were then washed in 0.9% saline, 
collected into a small crystallising dish, and pelleted by gentle agitation of the dish. Any 
visible debris was removed using a Pasteur pipette and the eggs washed vejY briefly in 
sterile PBS prior to storage. 
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All the parasite material was pelleted by brief centrifugation and stored at -70"C until 
required. 
Soluble Parasite Antigen Preparations: The soluble proteins of cercariae (SCAP), lung 
worms (SLAP) and adult worms (SWAP) were obtained by thawing the parasites to room 
temperature and sonicating for 2 minutes on ice (2lkHz at 6.5ýtrn amplitude). The 
sonicates were then centrifuged at 100 OOOg for I hour at 4'C. The resulting supernatant 
was aliquoted and stored at -20'C. 
0-3 hour Released Proteins (0-3h RP): A concentrated cercarial suspension was 
mechanically transformed as described above and the resulting heads and tails incubated 
in 30ml RPMI for 3 hours. After this time the culture supernatant was centrifuged at 
1000 r. p. m. to remove any remaining parasite bodies and then concentrated using an 
Ultrafree- 15 centrifugal filter column (Millipore, Watford, UK). 
2.2 MicrobioIogical techniques 
2.2.1 Growth, maintenance, selection and preservation of E. coli 
E. coli strains were grown in LB liquid medium (1% w/v Bacto-tryptone, 0.5% w/v 
Bacto-yeast extract, 1% w/v NaCl per litre; pH 7.0) at 37'C with agitation (200 r. p. m. ) 
for preparative procedures. Isolation of single colonies was achieved by streaking cells 
onto LB-agar plates (as for LB medium with the addition of 1.5% w/v agar) followed by 
incubation at 37C. 
Antibiotic selection of cells was achieved by supplementing the growth medium with 
the appropriate antibiotic (Carbenicillin, 5ogg mr,; Chloramphenicol, 34gg ml'; 
Kanamycin, 25ptg ml'; Tetracycline, 12gg mr). For long term preservation, glycerol 
stocks (15% v/v) were prepared from overnight cultures and stored at -70"C. 
2.2.2 Transformation of E. coli by heat shock 
E. coli cells were prepared for transformation by inoculation of fresh LB medium with 
0.01 volume of an overnight culture and grown to an optical density at 600 run (OD600) of 
0.5 to 0.6. The cells were pelleted by centrifugation at 30OOg for 5 minutes at 4"C and 
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the resulting pellet resuspended in 0.5 volume ice-cold I OOmM CaCl2. The cells were 
incubated on ice for 30 minutes followed by centrifugation at I OOOg for 5 minutes. The 
pellet was resuspended evenly in 0.05 volume ice-cold I OOmM CaCl2and subsequently 
the cells were aliquoted and used directly. For long term storage the cells were diluted 
with an equivalent volume of 20% (v/v) glycerol for storage at -80*C. 
The DNA to be transformed into the cells was added to the competent cells and the 
mixture incubated at 4"C for 30 minutes. The DNA/cell mixture was then placed in a 
42*C water bath for exactly 45 seconds, followed immediately by a two minute 
incubation on ice. The cells were incubated at 37"C with gentle shaking in Iml of SOC 
medium (0.5% w/v yeast extract, 2% w/v tryptone, lOmM NaCl, 2.5mM KCI, lOmM 
MgC'2,20mM glucose) for I hour before plating onto LB agar plates containing the 
appropriate antibiotics. 
2.2.3 Transformation of E. coli by electroporation 
E. coli cells were prepared for transformation by inoculation of fresh LB medium with 
0.01 volume of an overnight culture and grown to an OD600 of 0.5 to 0.6. The cultures 
were chilled on ice for 15 minutes prior to harvesting by centrifugation at 50OOg at 4"C 
for 20 minutes. The pellets were washed twice in ice-cold sterile distilled water (sdH20). 
After the final wash the cells were resuspended evenly in a volume of ice-cold sdH20 
equivalent to the estimated packed cell voluine. Aliquots of the cells were used directly 
or diluted with an equivalent volume of 20% (v/v) glycerol and stored at -700C. 
Electroporation of competent cells was carried out using the Bio-Rad Gene Pulser 
apparatus (Bio-Rad Laboratories Ltd, Hemel Hempstead, UK). The DNA was added to 
the cells and the mixture incubated on ice for 20 minutes before pulsing. A field strength 
of 25kV cm-' was applied to 40pti of cells in a 0.1 cm gap electroporation cell with the 
instrument resistance set at 20OK2 and a capacitance setting of 25 ýIF. After the pulse, 
cells were incubated at 37"C with shaking in Iml of SOC medium for I hour before 
plating onto LB agar plates containing the appropriate antibiotics. 
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2.3 Preparation, manipulation and analysis of nucleic acids 
2.3.1 Standard nucleic acid purification 
Organic extraction and alcohol precipitation 
Nucleic acids were deproteinised. by single or multiple rounds of extraction with 
buffered phenol: chloroform: iso-amyl alcohol (25: 24: 1) as described in Current 
Protocols in Molecular Biology (1997). 
Precipitation with ethanol or isopropanol in the presence of monovalent cations was 
used routinely to recover nucleic acids from aqueous solution. In all cases 0.3M sodium 
acetate (pH 5.2) was the salt of choice, and for very dilute solutions commercially 
available glycogen was used as a carrier. Precipitated nucleic acids were washed in 70% 
ethanol to remove residual salts and/or phenol. Pellets were dried under a mild vacuum 
and dissolved in sdH20or TE buffer (lOmM Tris-Cl, lmM EDTA, pH 8.0). 
Non-organic extraction 
The QIAquick PCR purification kit (Qiagen, Crawley, UK) was used, according to the 
manufacturer's instructions, to purify up to I Opg of single or double stranded DNA 
between 50 base pairs (bp) and 10 kilo base pairs (kb). 
2.3.2 Isolation of DNA 
Isolation of Genomic DNA (gDNA) 
S. mansoni gDNA was extracted from cercariae, and mouse gDNA from mouse 
spleens. Approximately 5ml minced tissue/pelleted parasites were resuspended in 10ml 
extraction buffer (lOmM Tris-Cl pH 8.8, O. IM EDTA, 20ýtl ml-'RNase, 0.5% sodium 
dodecyl sulphate; SDS) and incubated at 37*C for 1 hour with shaking. Proteinase K was 
added to a final concentration of 100ýtg mr' and the suspension incubated at 50"C for 3 
hours. Following this, several extractions with phenol: chloroform: iso-amyl alcohol 
(25: 24: 1) were carried out. The DNA was then ethanol precipitated and resuspended in 
TE buffer. 
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Isolation ofplasm id DNA from E. coli 
Plasmid mini-preparations (5ml overnight cultures) were made using the QIAprep 
spin miniprep kit (Qiagen) according to the manufacturer's instructions. 
Large scale, high purity plasmid preparations were made using the QIAfilter plasmid 
kit (Qiagen) following the manufacturer's guidelines. 
In all cases the plasmid DNA was dissolved in an appropriate volume of TE buffer. 
2.3.3 Isolation of RNA 
When working with RNA all glass and plasticware used was sterile and RNase free 
and all solutions and reagents were treated with diethylpyrocarbonate (DEPC) to inhibit 
any RNase activity. 
All samples from which RNA was to be extracted were frozen in liquid nitrogen as 
soon as they were obtained, and stored at -70*C. The samples were thawed on ice 
immediately prior to extraction and homogenised by passing through various hypodermic 
needles of increasing gauge several times. 
Total RNA was extracted from parasites and mouse tissues using TRIzol reagent 
(Gibco BRL) as per the manufacturer's instructions. Total RNA was stored in 20pl 
aliquots at -70'C. 
The Micro-Fast Track mRNA isolation kit (Invitrogen, Groningen, The Netherlands) 
was used, according to the manufacturers instructions, to extract mRNA from parasites 
and mouse tissues. As with total RNA the mRNA was stored as 10ýtl aliquots at -70'C. 
All RNA samples were treated with DNase directly after extraction. 
2.3.4 Analysis of nucleic acids by gel electrophoresis 
Agarose gel electrophoresis ofDNA 
DNA was size-fractionated on agarose to detennine the quality and success of its 
isolation and manipulation, or for further analysis by Southern blotting. Molecular 
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biology grade agarose was dissolved in Tris-Acetate electrophoresis buffer (TAE; 0.04M 
Tris acetate, 0.001M EDTA, pH 8.1). The concentration of the gel used was determined 
by the size of the DNA fragments of interest, and varied between 0.5 and 1.5%. Samples 
were diluted with 0.2 volume loading buffer (20% Ficoll 400 X, 0.1 M EDTA pH 8.0, 
1.0% SDS, 0.25% bromophenol blue) prior to loading into preformed wells. Gels were 
run at 5V cm' in TAE. The DNA was then stained by soaking the gels in TAE 
containing ethidium. bromide at 0.5ýtg ml-' and subsequently visualised by exposure to 
UV transillumination. Images were recorded digitally using an Alphalmager (Alpha 
Innotech Corporation, California, USA). The size of the DNA was estimated by 
comparison with commercially available marker DNA of known size. 
Agarose-formaldehyde gel electrophoresis of RNA 
Total RNA was size fractionated on 1% agarose-formaldehyde gels as described in 
Current Protocols in Molecular Biology (1997) to determine the quality and success of its 
isolation. 
2.3.5 Recovery of DNA from agarose gels 
The QIAquick gel extraction kit was used routinely, according to the manufacturers 
instructions, for fragments between 100 to 5000bp. 
For larger fragments the QIAEX II Gel extraction kit (Qiagen) was used according to the 
manufacturer's instructions. 
2.3.6 Quantification of nucleic acids 
Nucleic acid concentrations were calculated from absorbance readings at 260nm (A260) 
determined by UV spectroscopy using a Beckman DU 650 spectrophotometer (Beckman, 
High Wycombe, UK). In all cases the A26ýA280 ratio was also calculated to ensure that 
the preparation was clean (values between 1.7 and 2.0 were acceptable for DNA and >1.8 
for RNA). 
Alternatively, DNA concentrations were estimated for samples separated on agarose 
gels by comparison to known concentrations of standard DNAs. 
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2.3.7 Enzymatic manipulation of nucleic acids 
Restriction enzyme digests 
Digests of DNA were carried out in the appropriate minimum volume, for 2 hours at 
the defined temperature, with an excess of enzyme at 2 units per gg of DNA. All of the 
restriction endonucleases were supplied by New England Biolabs (NEB, Hitchin, UK), 
and the recommended buffers used as directed. When two enzymes were used in 
combination, a buffer was selected in which both enzymes would have high activity. 
When a compatible buffer could not be found for double digests, buffer exchange was 
achieved by ethanol precipitation of DNA. Reactions were terminated by the addition of 
Na2EDTA to a final concentration of I OmM, heat inactivation for thermolabile enzymes, 
or by the addition of DNA loading dye if the samples were to be analysed by 
electrophoresis. 
Ligation of DNAfragments 
Ligation reactions were carried out in the minimum volume possible. Inserts (0.1 - 
1.5kb) were added at 2 to 5-fold molar excess over the vector and T4 DNA ligase 
(Promega, Southampton, UK) was present at a final concentration of 5-20 units [tl-' in the 
supplied buffer. The ligation reactions were incubated at 16*C for up to 15 hours. 
To increase ligation efficiencies, the 5' termini of lincarised vectors were 
dephosphorylated using calf intestinal alkaline phosphatase (Promega). The reaction was 
carried out as per the manufacturer's instructions. 
Polymerase Chain Reaction (PCR) 
Taq polymerase (Promega), a thermostable polymerase, was used routinely to amplify 
specific DNA sequences by repeated rounds of primer extension. Matched primer pairs 
were designed with the aid of the Williamstone Enterprises Primer Design package 
(www. williamstone. com/primers), and synthesised by Genosys Biotechnologies Ltd 
(Pampisford, UK). Reactions (10,20 or 50[11 volume, overlaid with mineral oil) were 
carried out in the supplied buffer observing the manufacturer's guidelines for use of the 
enzyme. Generally, dNTPs (Promega) were at a final concentration of 200gM and the 
primers at 0.5-IpM each depending upon the application. Thermal cycling conditions 
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were determined with the following parameters in mind: in each cycle I minute at 95*C 
was allowed for template denaturation; primer annealing was 45 seconds at 5'C below 
the lowest calculated melting temperature of the primers; I minute at 72C for 
polymerisation was allowed for each kilobase pair of the anticipated product. The 
number of cycles was varied between 20 and 35 depending on the nature of the target 
sequence and all reactions were terminated by a5 minute incubation at 72"C. A Perkin 
Elmer 480 Thermal cycler (Perkin Elmer, Warrington, UK) was used throughout this 
study. In general the PCR products were resolved on agarose gels and the enzyme and 
excess nucleotides and primers removed using the QIAquick PCR purification kit 
(Qiagen) before any further molecular modifications/analyses were carried out. 
Reverse transcription (RT) ofRNA 
Total RNA was denatured by heating to 65*C for 10 minutes before being added to a 
reverse transcription reaction containing I OOpg ml-' of oligo (dT), , (Promega), I OOPM 
dNTPs, 1 OmM dithiothreitol (DTT) and 100 units Moloney murine leukaemia virus 
reverse transcriptase (M-MLV; Promega) in the supplied buffer to give a final volume of 
20pl. This was incubated at 37*C for 45 minutes and the resulting single strand DNA 
stored at -20"C. 
Double stranded cDNA was prepared by adding an aliquot of the single-stranded 
DNA to a lOgI PCR mixture containing lpM of each of two sequence specific primers 
and amplifying through a number of cycles. 
2.3.9 DNA Sequencing 
DNA was sequenced by the dideoxynucleotide termination method (Sanger et aL, 
1977) using the Dye Terminator sequenase sequencing system (Perkin Elmer). 
Templates were prepared by either PCR or mini-preparation of plasmids from E. coli. 
The manufacturer's guidelines were observed and the resulting reactions were run on a 
373A automated sequencer (Perkin Elmer). 
The quality of each sequencing reaction was checked by analysis of the chromatogram. 
from the automated sequencer. The sequences were then manually edited to remove 
vector and/or primer regions and subsequently compared to all DNA and protein 
sequences at the National Centre for Biotechnology Information (NCBI) using the Basic 
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Local Aligmnent Search Tool for nucleotides (BLASTN) and peptides (BLASTX) 
comparisons. 
2.4 Screening for recombinant bacterial colonies 
PCR, using gene or vector specific primers, was used as a rapid screening method for 
correct insert prior to growing colonies for plasmid isolation. Colonies were picked 
using sterile 10ýtl pipette tips, concomitantly re-streaked onto LB agar plates and 
inoculated into 20gl sdH20. The tubes were vortexed to disperse the bacteria, heated to 
95"C for 5 minutes and chilled rapidly on ice. An aliquot of this suspension was used for 
PCR amplification. All putative recombinants were further characterised by isolation of 
plasmid DNA and DNA sequencing. 
2.5 Analysis of proteins 
2.5.1 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein preparations were analysed by size fractionation under reducing conditions 
within polyacrylamide gels based on the method of Laemmli (1970). The samples were 
diluted with 0.25 volume of 4x sample buffer (250mM Tris-Cl pH 6.8,20% P- 
Mercaptoethanol, 40% glycerol, 8% SDS, 0.1 % methylene blue) and boiled for 5 
minutes before being loaded into pre-formed wells of the stacking gel (4.5% acrylamide, 
0.12% bis-acrylamide in 0.125M Tris-Cl pH 6.8 containing 0.1 % SDS) which overlaid 
the 15-18% separating gel (15-18% acrylamide, 0.4%-0.48% bis-acrylamide in 0.375M 
Tris-Cl pH 8.8 containing 0.1% SDS). Gels were run in electrode buffer (25mM Tris, 
192mM glycine, 0.1% SDS) at IOOV constant voltage. The proteins were visualised by 
staining in Coomasie Blue [0.1% (w/v) Coomasie Brilliant Blue, 40% (v/v) methanol, 
10% (v/v) glacial acetic acid] for 1 hour and then destaining in 40% methanol, 7.5 % 
glacial acetic acid. Molecular weight standards (NEB) were treated in the same manner 
and included on all gels to allow protein molecular weight to be estimated. 
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2.5.2 Western Blotting 
Aliquots of protein preparations were separated by SDS-PAGE and transferred to 
Immobilon membranes (Millipore). Transfers were generally for I hour at I OOV 
constant voltage, using the Bio-Rad Mini Trans-blot cell in transfer buffer (25mM Tris, 
192mM glycine, 12% methanol) at 4*C. The non-specific sites on the membranes were 
blocked with 5% non-fat dried milk (Marvel) in PBS containing 0.05% Tween-20 (v/v) 
for 2 hours at room temperature or overnight at 4'C prior to incubation with the primary 
serum, diluted as required in 0.01% dried milk in PBS-T for 2 hours at room temperature. 
Membranes were then washed in a large excess of PBS-T for 30 minutes with several 
changes of buffer before incubation, for 2 hours at room temperature, in an appropriate 
peroxidase labelled antibody, diluted as required in 0.01% dried milk in PBS-T. The 
membranes were washed as before and developed by adding the peroxidase substrate, 
3,3', 5,5'-tetrainethylbenzidine (TMB; Kirkegaard & Perry Laboratories, Dynex 
Technologies, Billingshurst, UK). The reaction was stopped by washing the membrane 
in a large excess of H20, 
2.5.3 Quantification of proteins 
All protein concentration measurements were determined by the Bio-Rad protein 
assay which is based on the Bradford assay (Bradford, 1976). 
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CHAPTER3 
THE USE OF COMPUTATIONAL BIOLOGY AND THE S. MANSONI 
GENOME DATABASE TO IDENTIFY NVS PROTEINS 
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3.1 INTRODUCTION 
3.1.1 The S. mansoni genome and the generation of ESTs 
The DNA of mammalian schistosomes is contained within eight pairs of chromosomes 
of which one pair is heterologous in females (Short, 1983). Characterisation of 
schistosome DNA by Simpson et al. (1982) showed that the haploid genome is 
approximately 2.7xlO'bp in size with abase composition of 64% AT. Thismakesthe 
schistosome genome approximately ten times larger than that of protozoan parasites 
(Plasmodium falciparum -30Mb; Trypanosoma brucei -53Mb) and a tenth of the size of 
the human genome (-3000 Mb). CJ analysis predicts that about 40% of the genome is 
composed of repetitive sequences. Only 30% of the genome is protein coding and it is 
estimated to contain 20 000 expressed genes (Franco et al., 1995). By October 1998, 
largely as a result of conventional cDNA library screening, 427 ORFs had been deposited 
in the S. mansoni database. These ORFs represent approximately 1% of the total number 
of genes (taking into account redundant ORFs). Therefore, the remaining 99% of the 
genetic information must be unravelled before the parasite biology and host-parasite 
relationships can be understood and drug and vaccine development advanced effectively. 
Thus, genome analysis is an important aspect of schistosome research (Johnston et al., 
1999). 
The generation of ESTs by sequencing of cDNA libraries has been described as a fast 
and efficient approach to the discovery of new coding regions within genomes (Adams et 
al., 1991) and the method is effective for S. mansoni (Franco et al., 1995). From the 
initiation, by WHO, of the Schistosome Genome Project to 1998 approximately 7000 
cDNA sequences were deposited in the databases (Genbank, October 1998). Cluster 
analysis of this data set showed that approximately 18-25% of the predicted genes have 
been tagged in this manner (Williams and Johnston, 1999). However, a large proportion 
of these ESTs has no significant homology to genes encoding proteins of known 
structure/function (Rollinson and Johnston, 1999). Therefore, there now exists a large 
database of sequences to be analysed if the full potential of genome sequencing is to be 
realised. 
45 
N-terminus C-terminus 
n-region h-region c-regIMI 
mature 
positively hydrophobic polar protein 
charged non-polar 
cleavage 
site 
Figure 3.1: Schematic diagram of a signal peptide. 
3.1.2 Membrane/secreted (M/S) proteins and signal peptides 
As discussed in Chapter 1, those proteins that are released (i. e. secreted) from the 
larval stages of development as part of normal biological processes or those exposed on 
the parasite surface (designated earlier as M/S proteins), are the most likely targets of the 
protective immune response elicited by the radiation-attenuated vaccine. Entry of 
proteins into the secretory pathway in eukaryotic cells usually requires the translocation 
of the protein across the membrane of the endoplasmic reticulum (ER). In all eukaryotes 
there are two pathways by which most M/S proteins are transported across the ER, the 
co- and post-translational pathways. Both translocation. modes require that polypeptides 
destined for the secretory pathway be specifically targeted to the ER. This is mediated by 
a N-terminal signal sequence on the nascent polypeptide and can be dependent on the 
signal recognition particle (SRP) or be SRP-independent (Rapoport et aL, 1996). 
Transport to the cell surface then proceeds via the 'ER to Golgi intermediate 
compartment' followed by the typically stacked Golgi apparatus and trans-Golgi 
network. Therefore, the vast majority of NVS proteins, which are very diverse in 
structure and function, have a N-terminal signal peptide (Blobel and Dobberstein, 1975). 
This short peptide sequence is the only factor common to NVS proteins. 
Signal peptides lack primary sequence homology (Watson, 1984) which renders more 
traditional molecular methods of searching for NVS proteins ineffectual. However, they 
share a common physical structure, shown in Figure 3.1, divided into a positively 
charged n-region, followed by a hydrophobic h-region and a neutral but polar c region 
which also contains the cleavage_ site for a signal peptidase (von Heijne, 1985). 
Analysis of signal sequence mutants showed that the h-region, comprising six to 
fifteen amino acids, is the most essential part of the leader peptide, required for targeting 
and membrane insertion (von Heijne, 1985). The polar c-region often contains helix- 
breaking proline and glycine residues as well as small uncharged residues in positions -3 
and -1 (relative to the first amino acid of the mature protein) that determine the site of 
signal peptide cleavage (von Heijne, 1990). Comparative analysis of a large number of 
signal peptides shows that there is substantial variability in their length, ranging from 15 
to more than 50 amino acids; the n-region contributes most to the overall variation in 
length (von Heijne, 1986). 
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3.1.3 Identification of signal peptides 
Over the past few years the complete genome sequence has been determined for a 
number of organisms e. g. Haemophilus inj7uenzae (Flieschmann et al., 1995), 
Mycobacterium tuberculosis (Cole et al., 1998) and S. cerevisiae (Mewes et al., 1997). 
This means that a large number of sequences, which encode putative proteins with 
unknown functions, are being entered onto databases. Computational biology using 
various algorithms and statistical tools is the most efficient method to interpret all these 
sequence data. 
Several protein sorting prediction methods have been developed recently. Some 
workers have attempted to predict subcellular localisation of proteins on the basis of 
amino acid composition (Cedano et aL, 1997; Reinhardt and Hubbard, 1998). This is 
based on the study by Nakashima and Nishikawa (1994) who showed that it is possible to 
discriminate between intra- and extracellular proteins using amino acid composition and 
residue-pair frequencies. Others have developed methods based on prediction of sorting 
signals (McGeoch, 1985; Von Heijne, 1983). This is possible because the majority of 
proteins destined for locations other than the cellular cytoplasm have a characteristic 
signal peptide. The secretory signal peptide is the most intensively studied of all such 
signal sequences. 
The SignalP algorithm (Nielsen et aL, 1997) has been designed for the identification 
of secretory signal peptides. The algorithm relies on the shared physical characteristics 
of signal peptides to identify putative signal peptides using a combined neural network 
approach. One network is trained to recognise the cleavage site at the C-terminal end of 
the signal peptide and the other network is trained to classify each amino acid as either 
belonging or not belonging to a signal peptide. Output from the algorithm consists of 
one score from each neural network and one combined score. There are three versions of 
the algorithm, each trained on different data sets (eukaryotes, Grain-negative and Grain- 
positive bacteria). These three versions account for the differences in the characteristics 
of signal peptides from these groups of organisms. To date, the SignalP algorithm is the 
most accurate prediction method for signal peptides publicly available. 
The aim of this chapter was to use the SignalP algorithm to putatively identify NVS 
proteins from the sequences deposited on the schistosome genome database. Initially, 
sequences of proteins of known localisation and/or function would be run through the 
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algorithm to test its ability to discriminate between NVS and non-M/S schistosome 
proteins. Following a successfid outcome, the schistosome EST database would then be 
analysed to identify novel NVS proteins. In order to do this, candidate cDNA clones 
would be transferred to high level expression vectors and recombinant protein produced. 
This would then be used to raise antiserum, which would allow for immunocytochemical 
localisation of the protein with the parasite, which in turn would verify the data output 
from the Signall? algorithm. As there were only 166 lung-stage ESTs on the database 
when this work was initiated (October 1996), it was necessary to generate ESTs from a 
lung-worm cDNA library. This life-cycle stage was of particular interest as it is the 
target of protective immunity in the radiation attenuated-vaccine model. 
3.2 MATERIALS AND METHODS 
3.2.1 Generation of ESTs 
A lung-stage schistosomular cDNA library (provided by Dr Harrop), constructed in 
the XZAP II vector (Stratagene, Amsterdam, The Netherlands), was diluted in SM buffer 
(I OOmM NaCl, 50mM Tris-Cl pH 7.5,5MM MgS04) to give a titre of approximately Ix 
10' plaque forming units per ml (pfu ml-'). An overnight culture of E. coli XL- I Blue 
cells (Stratagene) was pelleted and resuspended in' OMM MgS04. A 100 ýtl aliquot of 
cells was mixed with 1 gl of diluted cDNA library and incubated at 37C for 30 minutes. 
To this was added 1.4ml top agar (LB medium with 0.7% agar) and after brief mixing, 
the agar was poured evenly onto pre-warmed agar plates containing tetracycline (I 2gg 
ml-'). The plates were incubated at 37"C until phage plaques were approximately 2mm in 
diameter. Well separated plaques were picked at random using a sterile toothpick and 
each one was placed in 500gl SM buffer for 2 hours at room temperature or overnight at 
4'C. 
The phage insert was amplified by PCR using 1 ýLl of the phage suspension as the 
template and primers to the flanking regions of the vector, MI 3R and T7 (see Appendix I 
for primer sequences). The products were analysed on 1% agarose gels and sequenced 
from the 5' end. 
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Figure 3.2: Prokaryotic Expression Vector pET-30a 
The prokaryotic expression vector pET30a has the bacteriophage T7 promoter, which is 
inducible by isopropyl-p-D-thiogalactopyranoside (IPTG), followed immediately by the lac 
operator. The operator sequence binds the lac repressor which is provided on the same 
plasmid. Foreign ORFs can be inserted in frame downstream of the promoter into the 
multiple cloning site. The vector contains both a N-terminal and a C-terminal 'His-Tag' 
which is a poly-histisdine tag that facilitates protein purification by immobilised metal 
affinity chromatography (IMAC). The presence of a C-terminal tag is important for the 
purification of proteins whose N-terminal sequences may be processed during expression. 
3.2.2 Searching the S. mansoni database for putative signal peptides using the SignalP 
algorithm 
In all cases the prediction method was applied using networks trained on the 
eukaryotic data set. 
All the ORFs in the S. mansoni database were run through SignalP and the data 
analysed. Only those sequences that gave positive results for all three scores were 
classified as having a typical cleavable signal peptide. 
All the ESTs in the database were first translated in all six reading frames, the longest 
ORF selected using specifically written computer programs (P. Ashton), and the first 70 
amino acids of each selected ORF run through the algorithm. The sequences without an 
initiator methionine were removed by screening all SignalP-positive sequences manually. 
3.2.3 Sub-cloning of S. mansoni ORFs into the prokaryotic expression vector, pET30. 
The expression vector, pET30 (Novagen, Beeston, UK) and the T7 expression system are 
described in Figure 3.2. 
Oligonucleotide primers were designed to amplify the sequences containing the 
required S. mansoni ORFs. The primers incorporated restriction enzyme sites to facilitate 
molecular manipulations and were designed to ensure that appropriate translation of the 
ORF would be maintained when ligated into the vector (see Appendix I for primer 
sequences). 
Inserts were generated by PCR amplification using primers at 0.5pM, dNTPs at 
200ýM and the plasmid template at 0.5ng pt'. The enzyme and excess dNTPs were 
removed after successful amplification and the inserts digested with the appropriate 
restriction enzymes followed by ligation into the appropriate vector that had been 
linearised with the corresponding restriction enzymes. Competent HB101 E. coli cells 
(Stratagene) were transformed with the ligation products and transformants were selected 
on LB agar plates containing kanamycin (25pg ml-'). 
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3.2.4 Expression and purification of recombinant proteins 
The host E. coli strain BL2 1 (DE3)(pLysS) was used for recombinant protein 
production as it contains the bacteriophage T7 RNA polymerase gene as aX lysogen 
under the control of the lac operon which is inducible by IPTG (Studier and Moffat, 
1986). In addition, as an E. coli B strain, BL21 lacks the Ion protease and the ompT 
outer membrane protease that can degrade proteins during purification. Therefore, target 
proteins should be more stable in BL21 than in K12 strains of E. coli. The presence of 
the plasmid, pLysS, provides a small amount of T7 lysozyme which inhibits T7 RNA 
polyinerase and so increases the tolerance of BL21 (DE3) for expression plasmids with 
toxic inserts. 
Growth, induction and optimisation ofprotein expression 
Plasmid pET30 and its derivatives containing genes encoding S. mansoni ORFs were 
used to transform BL21(DE3)(pLysS) cells. Single colonies were grown in liquid culture 
and glycerol stocks prepared for storage at -70*C. Bacterial cultures for protein 
expression were inoculated with 0.01 volume of an overnight culture and grown at 37"C 
to an 013,00 of 0.5 prior to induction by the addition of IPTG to a final concentration of 
I mM. For evaluation of optimum expression, protein production was monitored as a 
function of time at various different temperatures (25,30,37*C). Total protein 
expression was analysed at each time point by resuspending 50ý11 of cells in SDS-PAGE 
sample buffer for electrophoresis. In addition, a crude purification of the recombinant 
protein was carried out at each time point. Briefly, 5ml of culture was centrifuged, the 
pelleted cells resuspended in 200ýtl GHC (6M guanidine hydrochloride, 100mM 
Na2HPO,, pH 8.0), vortexed and incubated for 10 minutes at room temperature. The 
suspension was centrifuged for 5 minutes in a microfuge and 25ýtl TALON metal affinity 
resin (Clontech) was added to the supernatant. TALON is an IMAC resin that uses 
cobalt ions for purifying recombinant polyhistidine tagged proteins. After a 30 minute 
incubation with gentle agitation at room temperature, the resin was washed once with 8M 
urea (8m urea, I OOmM Na2HP04,50mM NaCl, pH 8.0). Subsequently 25gl SDS-PAGE 
sample buffer was added to the resin and the sample prepared for electrophoresis. 
A duplicate gel was transferred to Immobilon membrane (Millipore) by Western 
blotting and probed using a Ni-NTA alkaline phosphatase conjugate (Qiagen). As this 
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was an alkaline phophatase conjugate it was necessary to use Tris-buffered saline (TBS- 
T; 20mM Tris-Cl, pH 7.5,500mM NaCl, 0.05% Tween-20) and the 5-bromo-4-chloro-3- 
indolyl phosphate/Nitroblue tetrazoliurn (BCIP/NBT) substrate solution (Sigma-Aldrich, 
Poole, UK). 
Preparativefermentation qfE. coli 
Bacterial cultures were scaled up to 500ml in 2.5L baffled conical flasks for those clones 
expressing recombinant S. mansoni proteins. Bacterial fermentation and the induction of 
protein expression was carried out under optimal conditions as determined previously. 
Cells were harvested by centrifugation (50OOg at 4"C for 20 minutes) and the supernatant 
removed completely. The cells were resuspended in 50ml GHC, vortexed and incubated 
at room temperature for 30 minutes with agitation. The suspension, containing lysed 
cells was centrifuged at 50OOg for 10 minutes at 4C and 1.25ml TALON matrix added to 
the supernatant. This was incubated at room temperature for 1.5 hours with gentle 
agitation. The matrix was allowed to settle, washed 3 times in an excess of 8M urea, pH 
8.0, followed by 2 washes with 8M urea pH 7.5. The recombinant protein was then 
eluted by washing the matrix with 2ml 8M urea containing 50mM Na2EDTA pH 7.5. 
The elution step was repeated four times. Protein samples were analysed by SDS-PAGE 
electrophoresis. 
3.2.5 Production of antisera 
Antiserum to recombinant protein was raised in IFN7R' mice. Prior to the first 
immunisation, a tail-bleed was taken to serve as a control. For the primary 
immunisation, I OýLg of the recombinant protein was mixed, by sonication, with an equal 
volume of Titremax gold adjuvant (Sigma) and injected subcutaneously at two sites on 
the back of the mouse. Subsequent immunisations were given at four week intervals and 
consisted of antigen alone. In all cases subsequent injections were given at the same 
place as the primary immunisation. Small tail-bleeds were taken before every injection 
to monitor changes in antibody titres. Each blood sample was allowed to clot for I hour 
at room temperature, ringed with a mounted needle, left to stand at 4'C for several hours, 
centrifuged at 10 OOOg for 10 minutes, the serum pipetted off, and stored at -201C. When 
sufficient antibody titres had been reached, a final bleed was obtained by cardiac 
puncture. The serum was prepared as for the test bleeds and stored in aliquots at -20'C. 
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3.2.6 Enzyme-linked immunosorbant assay (ELISA) 
The antibody titres of sera to their respective recombinant proteins or to various 
antigenic fractions of S. mansoni were determined by ELISA. In order to identify the 
appropriate antigen and antibody dilutions to be used, a matrix was set up in which sera 
were diluted down the plate and the antigen across the plate. The antigen concentration 
that gave the most clearly defined dilution curve was used to coat microtitre plates in all 
subsequent assays. The serum dilution which gave an optical density reading that fell on 
the linear part of the dilution curve was used. Microtitre immuno-plates (Nunc, Life 
Technologies, Paisley, UK) were coated with an appropriate concentration of antigen in 
carbonate coating buffer (15mM Na2C03,35mM NaHC03) by incubation at 4*C 
overnight in a humid chamber. Subsequently, the plates were washed 3 times with PBS- 
T, the serum to be analysed (diluted in PBS-T) was added to each well and the plates 
were incubated at room temperature for 2 hours. Plates were washed as before and the 
appropriate peroxidase-labelled secondary antibody, diluted in PBS-T, added to each 
well. After a2 hour incubation at room temperature the plates were washed as before and 
the enzyme substrate, TMB (Kirkegaard & Perry Laboratories) added to each well. 
When sufficient colour had developed spectrophotometric readings were taken at 690nm 
in a Dynex DIAS Microplate Reader. 
3.2.7 Immunocytochemistry on parasite sections 
Parasites were prepared for immunocytochemistry based on the method developed by 
Riengrojpitak et aL (1989). Briefly, the cercariae or lung-schistosomula were pelleted in 
Eppendorf tubes by low speed centrifugation. Ten pairs of adult worms were hand- 
counted and placed in Eppendorf tubes. The parasites were mixed into optimum cutting 
compound (OCT; Tissue-Tek, London, UK) such that each parasite was coated in it. The 
mixture was placed on a cork disc and plunged into thawing isopentane. Once frozen, the 
discs were stored at -70*C. The samples were sectioned (7prn thickness) onto Superfrost 
slides at -20'C using a cryostat (Slee, London, UK), and air dried overnight. The 
sections were fixed for 5 minutes in cold, absolute acetone and washed for 5 minutes in 
PBS three times before treatment. Sections were blocked by incubating with undiluted 
normal goat serum for I hour. The antibody was then applied at three different 
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concentrations (1: 10; 1: 20 and 1: 40) diluted in PBS with 10% normal goat serum. 4B 1 
(culture supernatant from hybridoma MBL-Sm-4Bl; Pearce et aL, 1986) and anti- 
adjuvant serum were used as positive and negative controls respectively. The slides were 
incubated at room temperature for I hour. Following two washes in PBS the secondary 
antibody, FITC-conjugated goat anti-mouse Ig (Sigma) diluted 1: 30 in PBS, was applied 
and incubated in the dark for 1 hour. The slides were washed twice in PBS and mounted 
in Citifluor (Agar Scientific, Stanstead, UK). The sections were examined under a Nikon 
fluorescence microscope. 
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3.3 RESULTS 
3.3.1 The generation of lung worm ESTs. 
As only sequences greater than 150bp in length and with less than 5% ambiguities 
were considered useful for analysis, a total of 106 ESTs was generated. On the basis of 
homology searches with all sequences in current DNA and protein databases the 
composition of the lung-stage cDNA library was evaluated. The ESTs were classified 
into the six groups shown in Table 3.1. 
E. coli, rRNA and mitochondrial sequences made up 19% of the sequences. From the 
remaining 86 sequences, 25 (29.0%) could be putatively identified, based on inatclies to 
S. mansoni entries, 56 (65.1%) matched non-schistosome entries on databases and 10 
(11.6%) had no significant matches. Nine ESTs matched known S. mansoni genes with 
more than 85% identity (Table 3.2). These represent mainly genes encoding enzymes 
(glutathione pcroxidase, phosplioglycerate kinase, cathepsin) and cytoskeletal/structural 
proteins (tropornyosin, fibrillin). Of the 16 ESTs with database matches to other S. 
mansoni ESTs (Table 3.3), 13 matched ESTs derived from adult worin cDNA libraries. 
Table 3.4 lists the 19 ESTs which have database matches to other organism entries. 
Further analysis of the remaining ESTs showed that there was no redundancy in this 
dataset implying that there is little redundancy in the library. 
EST Category No. of 
Clones 
Putatively Identified 
(a) S. m. match 25 23 
(b) Non-S. m. match 19 18 
Not Identified 
(a) Non-S. m. partial match 32 30 
(b) No database match 10 10 
E. 
_coli 
17 16 
rRNA and mitochondrial 3 3 
Total 106 100 
Table 3.1: EST categories of the S. mansoni lung-schistosomulum library. 
Average size of the ESTs: 847bp Average sequence length: 373 bases 
All useful ESTs have been deposited on public databases (Accession numbers: 
AA568097-100; AA629470-516; AW466234-265; AA499464-466). 
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EST (Accession 
number) 
Identification 
(Accession number) 
Length' 
(nt) 
Identity 
(%) 
2004 (AW466254) Glutathione peroxidase (L14328) 366 89 
2011 (AW499465) phosphoglycerate kinase (SCMPGK) 470 89.6 
2030 (AW466265) Cathepsin L (SMCATHL) 26 100 
0 19 (AW499464) Dongation initiation factor 5A 
(SMEIF5A 
103 100 
054 (AW466236) Cyclophillin (SCMCYC) 201 86.5 
063 (AW466237) Fibrillin 2 (SMU54588) 238 98 
071 (AW466239) LGG (SMLGGR) 277 99 
075(AW466240) Tropornyosin (SMTROPO) 204 1 98 
077 (AW466241) LGG (SMU 1043 1) 312 1 95 
Table 3.2: Database match of ESTs to known S. mansoni genes. 
a: refers to the niatch lengths (nuclcotidcs) 
b: indicates percentages of identical nucleotides. 
EST (Accession 
number) 
Identification (Accession number) Length 
nt 
Identity 
(%) 
2001 (AW466252) Adult won-n (T14349) 326 100 
2009 (AW466257) Adult worrn, similar to ribosomal 
protein S4 (T14380) 
204 99 
2010 (AW466258) Adult worm (N3 3 710) 2 88 
001 (AA56897) Adult worm (N28069) 228 98 
025 (AW466234) Adult worm (AA21845 1) 25S 96 
038 (AW466235) Adult worm (AA140599) 272 89 
070 (AW466238) Adult worm, similar to myosin 
light chain (T14468) 
324 99 
090 (AW466243) Adult worrn (H85669) 266 89 
103 (AW466244) Adult worm (AA218457) 185 94 
113 (AW466246) Adult worrn, similar to cysteine- 
rich intestinal protein (AA218481) 
148 100 
121 (AW466248) Adult worrn, similar to glutamine 
synthase (T14539) 165 
87 
125 (AW466249) Adult won-n (N21946) 144 85 
145 (AW466251) Adult won-n (N25397) 239 85 
2019 (AW466262) Cercaria (AA143844) 246 92 
088 (AW466242) Lung stage, similar to 40S 
ribosomal protein (A 125707) 
257 100 
109 (AW466245) Lung stage, similar to RNA 
polymerase subunit 11 (AA125704) 
273 95 
Table 3.3: Database match of ESTs to S. mansoni ESTs 
a: refers to inatch lengths (nucleotides) 
b: indicates the percentages of identical nucleotides 
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EST (Accession Identification Length ' Similarity Identity 
number) (Accession number) aa nt M) M) 
2012 Calothrix D253 gDNA 223 - 75 
(AW466259) (CSPAG13) 
2021 Human MrNA for ribosomal 232 - 62 
(AW466264) protein L32 (HSRPL32) 
0 14 (AA568099) Human ATP synthetase 344 - 75 
Beta (HSATPB) 
037 (AA629484) D. discoideum 113 - 65 
phosphatitidylinositol 
(DDU23478) 
046 (AA629486) Barstead mouse pooled 171 62 62 
organs (cDNA sequence) 
(AA266199) 
056 (AA629491) XENLA 26S protease 113 91 86 
regulatory subunit (P46470) 
059 (AA629492) human 60S ribosomal 56 83 71 
protein S27 (metallopan- 
stimulin 1) (HAU86019) 
061 (AA629494) Human SET protein 82 83 67 
(QO 1105) 
072 (AA629496) CAEEL hypothetical 9.8 100 - 85 
KD protein (CELZK652) 
089 (AA629503) Human retinoblastoma- 128 95 85 
binding protein 
(HSU35143) 
100 (AA629470) Human phosphatase 2A 374 - 63 
inhibitor (HSU51924) 
106 (AA629473) Soares retina N213hr cDNA 194 61 61 
clone (AA020798) 
I 10 (AA629506) 60S ribosomal protein 377 - 87 
(P39023) 
116 (AW466247) Human ribosomal protein 279 - 78 
S25 mRNA (HUMPRS25) 
123 (AA6295 10) D. discoidewn protein 307 - 67 
kinase (DDIPRKNGPK) 
131 (AA629512) Human DNA sequence from 200 - 60 
cosmid 203C2 (HS203C2) 
132 (AA629512) Human ankyrin, brain 185 - 87 
variant 2 (QO1485) 
133 (AA629514) Human Xq28 genomic DNA 86 63 
(HSU52112) 
135 (AA629515) D. discoideurn DNA 297 73 
(DDCPR02U) 
Table 3.4: Database match of ESTs to non-S. mansoni genes. 
a: match lengths are given in nucleotides (nt) for DNA and amino acid residues (aa) for peptide 
alignments. 
b: similarity indicates percentages of identical aa plus conservative substitutions. 
c: identity indicates the percentage of identical nt for DNA or identical aa for peptides. 
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3.3.2 Identification of putative signal peptides using SignalP 
The 427 ORF sequences in the S. mansoni genome database were run through the 
SignalP algorithm and only 79 sequences (18.5%) fulfilled the criteria set for the 
identification of signal peptides. However, once all the redundant sequences had been 
removed, of the 173 distinct proteins remaining, only 27 possessed signal peptides. Of 
these sequences, 23 have been identified by various researchers on the basis of sequence 
homology with known proteins (Table 3.5). There are 8 secreted, 6 plasma-membrane, 3 
lysosomal and 6 endoplasmic reticulum/Golgi associated proteins, all of which can be 
expected to have a leader sequence. The four remaining signal peptides identified by the 
algorithm are associated with proteins of no known homology. They are: 
CLI (gi: 263832): cercarial library 
ORF-RF2 (gi: 951431): A female-specific cDNA, adult library 
Unknown (gi: 1002620): Trans-spliced mRNA, adult library 
Female specific protein 800 (gi: J03999): adult library 
As the algorithm was able to distinguish S. mansoni signal peptides from non-signal 
peptides the entire EST data set, comprising 7102 sequences (October, 1998), was 
subjected to SignalP analysis. A total of 446 ESTs (6.3%) had putative signal peptides 
but this number was reduced to 218 (3.0%) when those without an appropriate initiator 
methionine were removed. Table 3.6 shows the distribution of the putative signal 
peptides according to different life cycle stages, bearing in mind that sequences occurring 
in more than one life cycle stage have not been removed from the data set. Thus, there 
are 62 signal peptides from the infective cercarial stage, only I from the sporocyst stage 
(where the proteins used in host invasion are synthesised), and 5 from the migrating lung 
schistosomulum, the target for the protective immune responses in mice vaccinated with 
irradiated cercariae. As a consequence of this exercise we now have 68 larval ESTs 
potentially coding for NVS proteins versus only 2 ORF NVS sequences, cercarial elastase 
and CLL 
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Identification No. of 
clones 
Accession No. of 
most complete clone 
Function 
Hemoglobinase (S. rn. 32) 3 M21308 secreted enzyme 
Elastase 7 U31768 secreted enzyme 
Superoxide Dismutase 4 M27529 secreted enzyme 
Antigen 10-3 2 M22346 oesophageal gland 
secretion 
Eggshell protein (chorion) 10 M21607_ viteiline cell secretion 
Eggshell protein 2 J03982 vitelline cell secretion 
p48 2 M74170 vitelline cell secretion 
LGG I U 10431 secreted protein 
Epidermal growth factor receptor 8 M86399 membrane receptor 
Glucose transport protein 2 2 L25067 membrane transporter 
Glucose transport protein 4 2 L25066 membrane transporter 
S. m. 13 2 AF072886 membrane protein 
gp 18-22 2 M62811 membrane glycoprotein 
S. m. 23 5 M34453 membrane protein 
Cathepsin C 3 Z32531 lysosornal enzyme 
Cathepsin B 2 M21309 lysosornal enzyme 
Cathepsin L I I U07345 lysosomal enzyme 
Calreticulm 3 _ - L24159 ER lurninal protein 
Disulphide isomerase 2 Z22933 ER luminal protein 
Cyclophillin B 2 U30874 ER luminal protein 
S. m. IrV I I L08641 ER lurninal protein 
ER luminal cysteine protemase 
ER 60 
I Z22934 ER lurninal protein 
Fucosyltransferase 
-I 
AFO 16899 Golgi protein 
Table 3.5: Summary of M/S proteins identified by Signall? analysis 
Life Cycle Stage No. of ESTs with signal 
peptides (% of total) 
No. of ESTs in 
the database 
1Y, of ESTs with 
signal peptides 
Cercaria 62 (31.3%) 2632 2.6 
Lung 
schistosomulurn 
5 (2.5%) 254 2.0 
Adult wonn 127 (64.1%) 3855 3.2 
Egg 3 (1.5%) 268 1.1 
Sporocyst 1 (0.5%) 32 3.1 
Miracidium 0 (0.0%) 61 0 
Total 198 a (100%) 
Table 3.6: Summary of signal pepticles identified by Signall' analysis of ESTs 
a: 20 clones were removed from this analysis as they were nucleotide sequences 
corresponding to peptide sequences listed in Table 3.5. 
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Figure 3.3: Iligh Level Expression of CIA; Coomasie stained SDS-PAC-E gel (a) and 
Western Blot probed with Ni-NTA alkaline phosphatase conjugate (b). 
Lanes 1-7: Expression of A26 (positive control for expression) 
Lanes 8-14: Expression of CL I 
Lanes I and 8: uninduced crude lysates 
Lanes 2 and 9: crude lysates I hr after induction of expression 
Lanes 3 and 10: crude lysates 2hrs after induction of expression 
Lanes 4 and 11: crude lysates 3hrs after induction of expression 
Lanes 5 and 12: crude purification of recombinant protein I hr after induction 
Lanes 6 and 13: crude purification of recombinant protein 2hrs after induction 
Lanes 7 and 14: crude purification of recombinant protein 3hrs after induction 
3.3.3 High level expression and analysis of recombinant proteins 
As WS proteins from schistosomula are the most likely candidates of protective 
immunity, three of the lung schistosomula ESTs with putative signal peptides (001,046, 
123) and the one unidentified larval ORF (CM) were chosen for further investigation. 
Each clone was sequenced in its entirety and the sequences analysed. None of the clones 
showed significant homology to any DNA or protein sequences in Genbank/SwissProt 
that could give any clues to the function of the proteins they each encode. The cluster 
analysis data (Williams and Johnston, 1999) was used to check if any of the chosen 
sequences formed part of any contigs. Clones 001 and CLI were not orphan sequences; 
CLI was at the 5' end of contig 0885 whereas clone 001 appeared to be in the middle of 
contig 0383 and was thus discarded. 
Clones CLI, 046 and 123 were transferred to the prokaryotic high level expression 
vector, pET30, recombinant protein expression induced and expression levels monitored 
over 3 hours. High level expression was obtained only for CLI as determined by 
Coomassie blue staining of SDS-PAGE gels and by probing of Western blots with the 
Ni-NTA alkaline phosphatase conjugate (Figure 3.3). The expression levels of CLI are 
much lower than that of the positive control A26 (a lung-stage antigen; Harrop et aL, 
1999). Recombinant CLI (rCLI) cannot be seen clearly in the crude lysates until 3 hours 
after induction (Figure 3.3A, lane 11) and it is not detectable 1 hour after induction even 
by Western blotting (Figure MB, lane 9). Separation of the bacteria into the membrane 
component, the periplasmic fraction and the cytoplasmic fraction revealed that some of 
the rCL1 was being directed into the periplasm (data not shown). 
The recombinant protein was purified from 2 litres of culture medium using TALON 
affinity matrix resin (Clontech). Serum was raised against the purified recombinant CLI 
protein (rCLl) in IFNyR7' mice and the antibody titer was analysed by ELISA (Figure 
3.4). All sera raised against mixtures of parasite proteins were produced by Dr. R 
Harrop. The serum raised against the recombinant protein recognised rCL1 strongly, 
whereas serum raised against the adjuvant alone showed only background reactivity. As 
a control for these ELISAs, serum raised against a different S. mansoni lung-worm 
antigen, 118 (B. Raybould, unpublished) was used. The serum raised against antigen 118 
showed weak recognition of rCL1 (3x more than anti-adjuvant serum). Both the 12 week 
chronic infection serum and the anti-SLAP serum recognised rCLl weakly. In contrast, 
there was little or no recognition of the recombinant protein by sera either raised against 
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Figure 3.4: Antibody titers of various antisera vs rCLI determined by ELISA 
Microtitre plates were coated with 50lil of rCLI at 0.4ýig ml-' and probed with various 
sera diluted 1: 400. The secondary antibody used was goat anti-mouse IgG horseradish 
peroxidase conjugate diluted 1: 1000. 
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Figure 3.5: Recognition of parasite preparations by various antisera as determined 
by EIASA. 
The microtitre plate wells were coated with 50ýd of SCAP, 0-3h RP, SLAP or SWAP at 
5ýtg ml-'. Each antigen preparation was probed with the four antisera (CLI, 118, 
infection, adjuvant) at a 1: 400 dilution. 
SCAP 0-3hRP SLAP SWAP 
0-3h RP or from mice vaccinated 5x with irradiated cercariae (5x vaccination serurn 
provided by Dr P Coulson). 
The anti-rCL I serum was used to probe ELISA plates coated with SCAP, SLAP, 
SWAP or 0-3h RP (Figure 3.5). The serum showed strong recognition of the 0-311 RP but 
did not recognise any component of SCAP, SLAP or SWAP. Similar data were obtained 
when the serum was used to probe Western blots of SCAP, SLAP, SWAP and 0-311 RP 
(Figure 3.6). The serum bound to the recombinant protein (approximately 8kDa) and 
what seems to be a dimer of the recombinant as well, but only to a single band in the 0-3h 
RP at approximately l2kDa. The intensity of the recognised band varied with different 
preparations of 0-3h RP (data not shown). The serum did not bind to any proteins in tile 
three soluble parasite preparations, even at high protein concentrations (up to 60[ig per 
lane). Each of these experiments has been done in triplicate. The anti rCL I serum was 
used to probe cryostat-cut sections of cercariae, lung- and adult-wornis but there was no 
recognition of the protein in any of the parasite stages (data not shown). 
Mw 
kDa 
175- 
47.5- 
32.5- 
25- 
16.5- 
'140 
6.5- i%wb 
Figure 3.6: Western blot of the target recombinant alongside various parasite 
preparations. 0-3h RP (lane 1), SCAP (lane 2), SLAP (lane 3) and SWAP (lane 4) I-CL I 
(lane 5) probed with serum against rCL 1 (1: 400). Samples of I O[Ig SOlUbIc parasite 
protein preparations and I pg recombinant protein were loaded per lane. 
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3.4 DISCUSSION 
3.4.1 The generation of ESTs 
Adams et aL (1995) state that a useful cDNA library should contain no more than 20% 
useless sequences, at least 50% new genes and a broad variety of transcripts. The 
sequencing of 100-200 ESTs is sufficient to assess the quality of the library based on 
these criteria. Overall, with respect to these parameters, the lung worm cDNA library is 
of good quality as there is no redundancy within the ESTs and the sequences have 
homology to genes encoding proteins of diverse function (enzymes from metabolic 
pathways, DNA-binding proteins, structural and regulatory proteins). The only drawback 
is the large number of E. coli sequences in the library, probably introduced by 
contamination during its construction. These sequences could be removed by 
preabsorbing the library with E. coli cDNA thereby increasing the efficiency of gene 
discovery by EST generation. 
Many of the ESTs have significant homology to previously characterised S. mansoni 
genes (23%). The majority of these genes (21/25; 84%) have been identified from 
different developmental stages of the parasite. Therefore, they are likely to represent 
genes which are necessary throughout the life-cycle, such as structural and/or 
housekeeping genes. Indeed, in a preliminary study of the gene expression profile in 
different developmental stages of S. mansoni it was found that several genes, including 
some of unknown function, can be found in all developmental stages of the parasite 
(Franco et aL, 1997). 
The ESTs with no significant matches to any entries in current databases represent 
either S. mansoni specific genes, which may be important in the development of the 
parasite, or regions of untranslated mRNA. The generation of ESTs from this lung-stage 
cDNA library has not only allowed for the analysis of its composition but has also 
increased significantly the number of ESTs on the database from this developmental 
stage. Apart from the high level of contaminating E. coll sequences the library consists 
of inserts with short poly (A) tails, no chimeric clones and a high proportion of distinct 
genes. This analysis reflects results obtained by Franco et aL (1997) in an independent 
study of the same cDNA library. 
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SignalP analysis 
The 23 well characterised proteins identified by SignalP as containing putative signal 
peptides are indeed all proteins that are targeted to the secretory pathway, as determined 
by their function (Table 3.5). It should be noted that of the six W. H. O. selected vaccine 
candidates only Sm23 features in this list, and of the other vaccine candidates discussed 
in Chapter 1 only elastase and gpl8-22 appear. As S. mansoni glucose transporter 
protein 4 localises to the tegument apical membrane and is involved in glucose uptake 
(Skelly and Shoemaker, 1996) this may represent a putative therapeutic target in 
maturing schistosomula. 
SignalP analysis of the S. mansoni protein database suggests that NVS coding 
sequences represent 16% of the genes expressed by schistosomes. This is comparable to 
the estimated frequency of secreted proteins in S. cerevisiae (15%; Mewes et aL, 1997) 
and Helicobacterpylori (23%; Tomb et aL, 1997). This result is also similar to that 
obtained when the prediction method was applied to the putative coding regions of the 
completely sequenced Haemophilus inj7uenzae genome (Nielsen et aL, 1997). Here 11% 
of the sequences contained 'typical' signal sequences. The authors note that the 
parameters set for 'typical' signal sequences are likely, on the one hand, to include 
signal-anchor like sequences of type II (single-spanning) or type IV (multispanning) 
membrane proteins. On the other hand, those signal sequences that are too long are likely 
to be missed out. Therefore, Nielsen et aL (1997) state that the data output from the 
algorithm should be analysed several times, adjusting the defined parameters each time to 
account for such variations and after such analyses of the H. inj7uenzae genome they 
estimate 15-20% NVS proteins. 
The frequency of positive hits of ESTs (3.0%) was much lower than that of ORFs 
(16%). One explanation may be that reverse transcription of mRNA with an oligo dT 
primer begins at the 3' end and frequently truncates before reaching the 5' end which 
codes for the signal peptide and is therefore likely to be under-represented (in contrast 
ORFs tend to be deposited on databases only after sequencing of longer length clones). 
In addition, a proportion of the ESTs was sequenced from the 3' end only. Thus the 
sequence data obtained from these is unlikely to extend to the 5' end of each clone due to 
limitations of current sequencing technologies. Therefore, the lower percentage of intact 
5' ends in the EST data set may account for the reduced frequency of hits in comparison 
with the ORF data set. The percentage of hits is approximately the same for each life- 
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cycle stage (2-3%) irrespective of absolute numbers of ESTs analysed. Unfortunately, 
the distribution of ESTs reflects the effort made in obtaining sequences from the various 
life-cycle stages of the parasite, resulting in very few signal peptides derived from larval 
ESTs. 
Both Schneider et aL (1999) and Nielsen et aL (1999), using different prediction 
methods, found very few sequences encoding signal peptides in the genome of 
Methanonccocusjannaschii. In both cases, the authors state that the number found is 
unexpectedly small and suggest that this may have arisen because the secreted protein 
precursors from the archaebacterium might contain signal peptide features that were not 
taken into account in the training sets. Therefore, to get an accurate estimation of the 
number of secreted proteins, the algorithm would have to be trained using a set of signal 
peptides that had been experimentally determined specifically from the organism of 
interest. Therefore, other schistosome signal sequences in the dataset may have been 
missed altogether due to the set of sequences used to train the predictive algorithm. 
Those ESTs that had been predicted to contain signal peptides but that lacked an 
appropriate initiator methionine may correspond to an entirely untranslated region of 
RNA or to an internal stretch of a protein. In the latter case, this can lead to false positive 
predictions as non-cytoplasmic ends of transmembrane helices are often rather similar to 
signal peptide cleavage sites. In the former, wrong start codon assignments can produce 
false negatives, since the resulting sequence may contain only a partial signal peptide or a 
signal peptide plus a stretch of an irrelevant amino acid sequence (derived from RNA that 
is untranslated in vivo). The N-terminus of the preproteins is often difficult to assign and 
where protein coding regions are predicted by gene-finding algorithms there are often 
numerous errors. For example, in Caenorhabditis elegans automatic assignment methods 
alone predict less than 70% of the start codons correctly (Reinhardt and Hubbard, 1998). 
This is exacerbated by the fact that ESTs are obtained by single pass sequencing and 
errors in the DNA sequence which generate false stop codons (or conversely, remove true 
stop codons) are possible, leading to the selection of the wrong reading frame for 
analysis. 
As discussed by Bhattacharya et aL (2000), many gene identification tools exist, but 
these would all require modification using information derived from individual parasite 
species before being applied to the sequence data generated by the genome projects of 
many of these organisms. Thus, the results of this first analysis of the schistosome EST 
database using the SignalP algorithm represent an initial screen. Further analyses using 
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other prediction tools have to applied to the sequences to take into account the possible 
occurrence of signal anchor sequences, transmembrane helices and incorrect reading 
frame selection. A further refinement may be to use the schistosome contigs that have 
been constructed. This would be more efficient as redundant sequences would be 
removed, and also more accurate as sequence errors would be reduced and ORF 
prediction would be more accurate. 
3.4.3 High level expression of recombinant proteins 
As none of the clones (CM, 046,123) showed any significant homology to any 
informative entries in Genbank or SwissProt to date, they are likely to represent novel 
schistosome genes. It is possible to infer that each clone codes for a NVS protein as all of 
them have a cleavable signal peptide sequence as determined by the SignalP algorithm. 
Difficulty was experienced in getting expression of the three clones. Recombinant 
protein was purified only for CLI. The presence of a signal peptide can be problematic 
in some bacterial expression systems with the recombinant protein accumulating in the 
periplasm, often as an inclusion body (StUber et aL, 1990). This may account for the low 
expression levels of rCL1 in comparison with rA26, which does not have a signal 
sequence (Harrop et aL, 1999), particularly as rCL1 was detected in the periplasmic 
fraction of the bacteria. Expression levels might be improved by removing the CLI 
signal peptide. Alternatively, a eukaryotic high level expression system might process 
schistosome signal peptides more efficiently leading to higher productivity of 
recombinant proteins, e. g. a baculovirus expression system. Insect cells, as well as 
directing proteins to the appropriate subcellular compartments, utilise many of the post- 
translational modifications present in eukaryotic cells allowing production of protein that 
is antigenically, immunogenically and also functionally similar to the native protein 
(Miller, 1988). Eukaryotic expression systems also offer the advantage that any secreted 
proteins are exported into the culture medium making purification of the recombinant 
protein relatively simple. 
There may be many reasons, other than the presence of a signal peptide, for the lack of 
recombinant protein production from clones 046 and 123, including toxic gene products, 
rapid breakdown of protein by cellular proteases, excessive rare codon usage, no 
translation due to a region of sequence that interferes (at the RNA level) with the 
interaction between E. coli ribosomes and the ribosome binding site. To circumvent 
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these problems it would be necessary to clone the cDNAs without their signal sequences 
and try using various bacterial host strains and expression vectors. Failing this, a 
eukaryotic expression system might be considered. If no recombinant protein can be 
produced an alternative would be to generate a synthetic peptidc which was designed to 
include the most antigcnic portion of the protein sequence of interest. 
3.4.4 Analysis of the recombinant CL1 protein 
The anti-CLI serum contains antibodies specific to rCL1 as determined by ELISA and 
Western blotting. However, the control serum, anti-I 18, cross-reacts with rCL1 as 
determined by ELISA. This is possibly due to trace amounts of some E. coli proteins that 
co-purify with recombinant proteins during IMAC. This cross-reactivity is likely to be 
more prominent in cases where the recombinant protein expression levels were low. This 
necessitates the use of much larger culture volumes to produce sufficient quantities of 
recombinant protein and in turn leads to higher levels of contaminating proteins. In this 
case both rCL1 and rl 18 expression levels were relatively low, so accounting for the 
cross-reactivity in the sera. One solution to this problem would be to absorb the sera 
with E. coli proteins thereby removing the common antibodies. 
A difference in molecular weight between the recombinant CLI protein (-8kDa) and 
the native molecule (12kDa) was observed; this may be attributed to the glycosylation of 
the native molecule. The cDNA clone encoding CM appears to be complete, with a start 
codon surrounded by the appropriate sequence signatures and a poly A tail preceded by 
the appropriate stop codon. Although there is only one predicted N-glycosylation site 
(0-linked glycosyaltion sites are very difficult to predict) glycosylated proteins do not 
run to their true molecular weight on SDS-PAGE gels, often running slightly higher 
(Hames and Rickwood, 1990), thus providing an explanation for the discrepancy in size. 
The data obtained using the anti-rCLI serum indicates that CM is a component of the 
0-3h RP. This suggests that it is a secreted protein that is released from the parasite 
during transformation. In addition, CLI was originally identified by screening of a 
cercarial cDNA library with anti-d6-8 RP serum (Harrop et al., 1999). This implies that 
CLI is also a constituent of the d6-8 RP (the d6-8RP were not used in the analyses 
reported here due to the difficulty in obtaining sufficient quantities of material). This is 
not surprising as the majority of the proteins in the 0-3h RP are also seen in culture 
supernatants taken at daily intervals up to day 7 post-transformation (Harrop and Wilson, 
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1993b). CLI is not detected in SCAP and SLAP as would be expected, because the 
majority of proteins in the released protein preparations are a subset of the proteins in the 
soluble parasite preparations. However, as there are many more proteins in these soluble 
preparations CLI may be present but at a much lower relative concentration and therefore 
be undetectable. 
The data obtained by probing rCL1 with various sera does not correlate with the above 
findings. Only chronic infection serum and that raised against SLAP recognised the 
recombinant antigen. The fact that the anti-0-3h RP serum showed no recognition of the 
recombinant protein was surprising. However, the variation in concentration of CLI in 
different 0-3h RP preparations may provide an explanation. If the concentration of CLI 
was low in the particular preparation used to raise the antiserum. it is unlikely that 
sufficient antibodies to CL1 would have been produced. This varying concentration of 
CLI in 0-3h RP may have arisen as there are several random variables in the protocol 
used to produce the protein preparation. For example, the time that the cercariae are left 
on ice, in order to concentrate the parasites after shedding, is arbitrary. It is possible that 
such inconsistencies may cause subtle differences in gene expression levels leading to 
variation of relative protein concentrations. This is unlikely to affect the general pattern 
of bands seen on a Coomassie stained gel as only the abundant proteins are visualised, 
and slight changes in their concentrations would not be detectable. However, the 
concentration of proteins expressed at low levels, which are not seen on the gels but that 
are detectable by Western blotting, are likely to be affected to a greater extent. 
It was hoped that immunolocalisation of the protein to the parasite would provide 
more information regarding the expression pattern of CLI. However, as the protein was 
not recognised in any of the parasite sections this remains open to debate. An 
explanation for the lack of detection of CLI may be that the protein is secreted from a 
particular structure in the parasite through which no section was obtained e. g. small 
secretory vesicles. 
Overall, although the results obtained are contradictory, there is some indirect 
evidence to suggest that CLI is released from developing schistosomula post- 
transformation. These experimental results also show that the use of algorithms such as 
SignalP can be used to mine the schistosome genome database effectively. 
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CHAPTER 4 
THE IDENTIFICATION OF DIFFERENTIALLY EXPRESSED GENES USING 
RANDOM-ARBITRARILY PRIMED PCR (RAP-PCR) 
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4.1 INTRODUCTION 
As discussed in Chapter Ia single immunisation of mice with optimally-irradiated 
cercariae results in the elimination of a subsequent challenge infection in the lungs, via a 
cell-mediated effector mechanism. As the targets of the effector response are the lung- 
schistosomula, the antigens derived from this developmental stage must be essential for 
restimulation of the relevant immune cells. Therefore, such antigens represent a rich 
source of potential vaccine candidates. It is also implicit that the antigens derived from 
the vaccinating and challenge parasites must be identical. 
As irradiated parasites die before or at the lung-stage of migration (Mountford et al., 
1988), antigens produced only by the adult worm are unlikely to be involved in the 
induction of immunity in the RA vaccine model. In addition, Coulson and Mountford 
(1989) showed that high levels of protective immunity are induced when ax vivo lung- 
stage larvae (derived from irradiated cercariae) are administered intradermally, indicating 
that antigens specific to the cercariae, or newly-transformed larvae are not crucial. 
Indeed, Mountford et al. (1995) showed that the highest levels of IFNY secretion were 
obtained by restimulation of lymph nodes cells of Ix vaccinated mice with SLAP in 
comparison to SCAP and SWAP. In fact, the released proteins from the lung-worms (d6- 
8 RP) were the most potent inducers of a Thl -type immune response. 
The use of one-dimensional (I-D) and two-dimensional (2-D) SDS-PAGE analysis of 
protein preparations from various developmental stages has revealed sex and stage- 
specific proteins (Atkinson and Atkinson, 1982; Yuckenberg et al., 1987). A comparison 
of the proteins in SCAP, SLAP and SWAP by I-D SDS-PAGE showed that whilst many 
proteins were common to all preparations, several appear to be specific to one life cycle 
stage (Mountford and Harrop, 1998). In addition, a comparison of the 0-3h RP and d6-8 
RP reveals significant differences in protein composition (Harrop and Wilson, 1993b) 
suggesting that stage-specific proteins are also released from the parasite. 
Several genes encoding differentially expressed proteins have been reported, for 
example, p14 (Bobek et al., 1986), f§800 (Reis et al., 1989) and F-10 (Giannini et al., 
1995), that are specific to the female worm. These genes are of interest as the proteins 
they encode are thought to be involved in the sexual maturation of the female worm. 
Other differentially expressed genes include those coding for elastase (Pierrot et al., 
1996), 8kDa calcium binding protein (Ram et al., 1989), hsp70 (Neumann et al., 1993) 
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and SmSPO-1 (Ram et aL, 1999). The expression of each of these genes is thought to be 
transcriptionally regulated with the amount of protein being directly proportional to the 
levels of the corresponding mRNA in each of the developmental stages studied. 
However, the number of stage-specific/differentially expressed genes described is small 
in comparison with the number of differentially expressed proteins seen on SDS-PAGE 
gels. In addition, considering the biochemical changes that the parasite undergoes 
throughout its life-cycle, many more differentially expressed genes would be expected. 
Therefore, the aim of the work described in this chapter was to develop a method to 
identify those schistosome genes whose transcription is developmentally regulated, 
without prior knowledge of their sequence and/or protein product. In this way, a subset 
of lung-worm specific proteins could be isolated from which putative vaccine candidates 
might be identified. 
Traditional methods to identify differentially expressed genes include differential 
screening of cDNA libraries (Okubo et aL, 1992) and subtractive hybridisation (Sargent, 
1987). However both of these techniques require large amounts of starting material 
which is a limiting factor when working with certain lifc-cycle stages of schistosomes. 
Analysis of the ESTs in the S. mansoni genome database by Franco et aL (1997) suggests 
that several of these may represent stage-specific genes. However, this cannot be 
confirmed until a representative number of ESTs is generated from all of the life-cycle 
stages of the parasite. The study by Santos et aL (1999) showed that the ESTs derived 
from two different cercarial cDNA libraries corresponded to quite different sets of genes, 
with the exception of the highly abundant genes related to energy metabolism. This 
highlights the fact that the quality of the cDNA libraries used for EST generation is 
important, especially when looking for stage-specifically expressed genes. 
The techniques of differential display (DD, Liang and Pardee, 1992) and RAP-PCR 
(Welsh et aL, 1992) have been used to successfully isolate differentially expressed genes 
in a wide range of organisms and experimental systems (McClelland et aL, 1995; Sager, 
1997). The main advantage of DD and RAP-PCR over techniques such as subtractive 
hybridisation and differential screening, in addition to being technically relatively simple 
and low cost, is that more than two RNA samples can be compared in parallel using 
significantly less starting material. The basis of DD and RAP-PCR is as follows: 
(i) pools of cDNA fragments are produced from the RNA samples being compared. 
(ii) the analogous pools obtained are resolved side by side on a polyacrylamide gel giving 
fingerprints. 
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(iii) fragments that are present in only one sample (or are much more abundant in one 
than in others) are excised from the gel and investigated. 
(iv) many different pools of cDNA fragments are produced by changing the parameters 
of pool generation, thereby allowing many RNA species to be compared. 
The only difference between DD and RAP-PCR is the primer used for reverse 
transcription of RNA. An oligo d(T)-based primer is used in DD whereas an arbitrary 
primer is used in RAP-PCR. This means that for DD, during reverse transcription 
priming occurs mainly at the 3' end of mRNA molecules. After reverse transcription, 
denaturation and second-strand synthesis, the majority of the cDNAs are derived from the 
3' end of mRNAs. However, the RAP-PCR protocol samples anywhere in the RNA 
molecules as the arbitrary primer used for reverse transcription can anneal to regions of 
RNA that have 6-8 base matches with its 3' end. Therefore, the advantage of RAP-PCR 
is that regions of mRNA that are towards the 5' end are more likely to be sampled. This 
represents an added bonus when looking for genes which encode NVS proteins as the 
signal sequence is usually located at the 5' end of coding regions. 
Neto et aL (1997) showed that arbitrarily primed cDNA can be used to generate ESTs 
from very small amounts of starting material. The ESTs generated in this way showed 
little redundancy and a large proportion represented new schistosome genes. The fact 
that several of the RAP-ESTs had homology to other schistosome ESTs in the databases 
shows that the bands in each profile do in fact represent different genes and are not 
simply lots of fragments of the same gene. This chapter describes the use of RAP-PCR, 
based on the protocol of Neto et aL (1997), to compare the mRNA profiles of cercariae, 
lung-schistosomula and adult worms. A general outline of the method used in this study 
is shown in Figure 4.1. 
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Figure 4.1: A general outline of RAP-PCR 
71 
4.2 MATERIALS AND METHODS 
4.2.1 RAP-PCR 
For each set of fingerprints generated, a 10ýtl aliquot of mRNA (equivalent to I gg) from 
each of the life cycle stages (cercariae, lung-schistosomula and adult worms) was 
denatured by heating to 65*C for 10 minutes and then added to a reverse transcription 
reaction containing 1.28pM of an arbitrarily selected primer (see Appendix 1), 1 OOgM 
dNTPs, 25mM Tris-HCI, 3mMMgC'2, I OmM DTT and 100 units M-MLV RT 
(Promega) to give a final volume of 20gl. This was incubated at 37*C for 45 minutes 
and the resulting single-stranded DNA stored at -20*C. 
Double stranded cDNA was prepared by adding an aliquot of single-stranded DNA into a 
lOgI PCR mixture containing IpM of a second arbitrary primer and incubating at 95'C 
for 3 minutes, 50'C for 2 minutes and 72"C for I minutes. The cDNA was then PCR- 
amplified under the following conditions: 33 cycles of 95"C for 45 seconds, 50"C for 1 
minute, 72'C for 1 minute, followed by a final extension at 72*C for 5 minutes. 
4.2.2 Polyacrylamide gel electrophoresis of DNA 
DNA mixtures were resolved on 6% polyacrylamide gels (19: 1 acrylamide: 
bisacrylamide; National Diagnostics) as described by Sanguinetti et aL (1994). 
Generally gels were cast in Tris-Borate electrophoresis buffer (TBE; 0.9M Tris-borate, 
20mM EDTA, pH 8.1) and allowed to polymerise at room temperature and run at I OV 
cm-' in TBE. The DNA was visualised by silver staining. Briefly, the gel was fixed in 
10% ethanol, 0.5% acetate for five minutes followed by a five minute incubation in 
staining solution (0.2% AgNOP 10% ethanol, 0.5% acetate). The gel was then washed in 
sdH20for 2 minutes before the developer was added (LIM NaOH, 0.75% formalin). 
Once sufficient colour had developed the reaction was stopped by washing the gel in H20 
several times. 
4.2.3 Recovery of DNA from acrylamide gels 
A sterile scalpel blade was used to excise the specific band of interest, the gel slice 
transferred to an eppendorf and rinsed several times in sdH20. The slice was the boiled 
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Figure 4.2: The pCR 2.1 TA cloning vector (Invitrogen) 
for 20 minutes in 50ýd elution buffer (10mM Tris-Cl, 5OmM KCI, 1.5mmMgC'2,, 
0*10/0 
Triton X-100), followed by a2 hour incubation at 37*C. Once cooled to room 
temperature, the solution was spun briefly to remove any remaining pieces of gel and the 
DNA ethanol-precipitated and amplified by PCR. 
4.2.4 Cloning of PCR products into the vector pCR2.1 
PCR products were cloned directly into the vector, pCR2.1 (Figure 4.2), after their 
purification and the ligation reaction was transformed into INV(xF' E. coli cells 
(Invitrogen) using the TA cloning kit (Invitrogen). The transformants were selected on 
LB agar plates containing Carbenicillin. In addition, the plates also contained 5-bromo- 
4-chloro-3-indolyl P-D-galactopyranoside/IPTG (X-gal/IPTG) to allow for selection on 
the basis of the blue/white colony phenotype. 
4.2.5 Southern Blotting 
Digested genomic DNA was resolved by agarose gel electrophoresis and an image 
recorded. Gels were incubated sequentially in an excess of depurinating solution (0.25M 
HCI) for 15 minutes, denaturing solution (1.5M NaCl, 0.5M NaOH) for 30 minutes, and 
neutralising solution (1.5M NaCl, 0.5M Tris-Cl, ImM EDTA, pH 8.0) for 30 minutes. 
The DNA was then transferred from the gel to a nylon membrane (Hybond N, 
Amersham, Little Chalfont, UK) by capillary blotting as described by Southern (1975) 
using 20x SSC (3M NaCl, 03M tri-sodium. citrate) as buffer. The DNA was fixed onto 
the membrane by exposure to a UV crosslinker for 5 minutes. 
Labelling ofDNA probes 
Radioactively labelled DNA probes were prepared by random-primer labelling using 
the Megaprime DNA labelling system (Amersham) following the manufacturer's 
instructions. The target template was a defined restriction fragment containing the 
sequence of interest at a final concentration of 25ng pl-' and the radiolabelled dNTP used 
was generally ot-"P dCTP (specific activity: 300OCi mol'). Excess dNTPs were 
removed by passing the probes through a G-50 sephadex spin column (Boehringer 
Mannheim, Lewes, UK). Probes were thermally denatured and snap cooled before use. 
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Membrane hybridisation and washing 
Membranes were incubated in hybridisation buffer (5x Denhardts solution, 5x SSC, 
I% w/v SDS, I 00ýtg ml' denatured herring sperm DNA) for 2 hours at 65"C prior to 
addition of the probe. Once the probe was added the membrane was incubated at 65*C 
overnight. Any unhybridised probe was removed by washing the membrane in 2x SSC, 
0.1 % (w/v) SDS for 20 minutes at room temperature. The stringency of the washes was 
increased by reducing the salt concentration of subsequent washes to 0. Ix SSC, 0.1% 
(w/v) SDS and increasing the temperature of each wash to a final temperature of 60'C. 
The membrane was then prepared for autoradiography. 
Autoradiography 
Autoradiography film (Kodak BioMax MS-1 film) was placed in contact with 
hybridised membrane in a X-ray cassette incorporating an intensifying screen. The 
cassettes were stored at -70'C for a suitable exposure time. The films were then 
developed using X-ograph Compact X2 (Xograph Imaging Systems which uses Rapid X- 
ray developer and fixer from Photosol). 
4.2.6 Northern Blotting 
Total RNA (10ýtg) from cercariae, lung-schistosomula and adult worms was resolved 
by agarose-formaldehyde gel electrophoresis (see section 2.3.4). Gels were incubated 
sequentially in an excess of denaturing solution (1.5M NaCl, 0.05M NaOH) for 30 
minutes, neutralising solution (0.5M Tris-Cl pH 7.4,1.5M NaCl) for 20 minutes and 20x 
SSC for 45 minutes. The RNA was then transferred from the gel to a nylon membrane 
by capillary action as described by Southern (1975) using 20X SSC as buffer. The RNA 
was fixed onto the membrane by exposure to a UV crosslinker for 3.5 minutes. 
DNA probes were prepared as described for Southern blotting (4.2.5). 
Membrane hybridisation and washing 
The membrane was wetted in 6x SSC prior to washing in formamide hybridisation 
buffer (5X Denhardt's solution, 5x SSC, 50% formarnide, 1% w/v SDS, 100ýtg ml-1 
denatured herring sperm DNA) for 3 hours at 50"C, with rotation, after which the probe 
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was added and incubated overnight. Any unhybridised probe was removed by washing 
the membrane in 2x SSC, 0.1% SDS for 10 minutes at room temperature. This was 
repeated twice, followed by two higher stringency washes in 0.2X SSC, 0.1% SDS for 5 
minutes. The membrane was then prepared for autoradiography, which was carried out 
as for Southern blotting (4.2.5). 
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Figure 4.3: Comparison of RAP-PCR products of mRNA from cercariae (c), lung- 
worms (L) and adult-worms (A) using the primer combination C2 for reverse 
transcription and SI for subsequent PCR. The two gels (a and b) represent 
amplification of the same cDNAs on two separate occasions. 
4.3 RESULTS 
4.3.1 RAP-PCR 
To identify genes that are differentially regulated between cercariae, lung- 
schistosomula and adult worms, RNA fingerprints of the three life-cycle stages, 
generated by RAP-PCR, were compared. Twenty-four different primer combinations 
were used with each reaction being performed in duplicate for each life-cycle stage. 
Only those reactions that gave reproducible profiles were considered useful for analysis. 
Based on this, seventeen primer combinations gave analysable data; the other primer 
pairs gave smears or non-reproducible fingerprints. A typical gel is shown in Figure 
4.3a. To further ensure that each profile was reproducible, second-strand synthesis and 
PCR amplification of the cDNA was carried out again under the same conditions. The 
profiles obtained from the repeat RAP-PCR were compared to those from the original 
and only those bands that were differentially amplified in both sets were considered 
useful for analysis (Figure 4.3). On average, one differentially expressed product, out of 
a total of approximately 100 bands, was found for every primer combination that gave 
reproducible data. A total of 13 differentially expressed bands was excised from the gels, 
as well as 6 bands that were common to all three life-cycle stages (Table 4.1). The latter 
bands were taken to serve as controls and to verify that they did represent mRNAs that 
were constitutively expressed. 
4.3.2 Reamplification and cloning of RAP-PCR products 
Out of the 19 bands that were cut out from the gels, only twelve were successfully 
reamplified by PCR. However, on reamplification the PCR products were not 
homogeneous necessitating their cloning and sequencing (Figure 4.4). Approximately 
ten clones were sequenced for each band (sequencing of all the clones was done by Dr D 
Johnston at the Natural History Museum, London). Only those sequences with less than 
5% ambiguous bases were considered useful for analysis. The most frequently occurring 
sequence from each set of successfully sequenced clones was taken as that corresponding 
to the excised band. In the case of band 56, three different sequences occurred with 
similar frequencies making it impossible to decide which sequence corresponded to the 
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original differentially expressed product. Therefore, clones representing each of the three 
sequences were investigated further. Only three of the 10 clones (3ALL, 10,53) had any 
significant sequence identity to any entries in the current databases (last homology 
searches done 17/02/00). Figure 4.5 shows the 10 sequences that were obtained in this 
manner. 
4.3.3 Southcm blot analysis with cloncd fragmcnts 
Southern blots of schistosome and mouse genomic DNA were probed with the inserts 
of the sequenced clones (Figure 4.6). This showed that several of the clones were 
derived from the schistosome genome (bands 62,63,3ALL, 4ALL, 53). These all seem 
to be single copy genes. Bands IAL and 10 failed to give any signal, this might be due to 
inefficient probe preparation. The probe for GST (provided by Dr. R Pierce) used as a 
positive control, gave a much stronger signal than any of the test probes, most probably 
because it was longer. 
The three different clones derived from band 56 (56.15,56.16 and 56.20) gave three 
different results on the Southern blot (Figure 4.7). The insert in 56.15 gave a strong 
signal comprising multiple bands, characteristic of a repetitive element, whereas 56.20 
and 56.16 hybridised to different fragments. 
4.3.4 Verification of differential expression of cloned fragments 
The probes that hybridised to schistosome gDNA were used to probe total RNA from 
the three life-cycle stages being investigated in order to confirm the expression patterns 
of the genes they represent. However, a signal was obtained only for actin, the positive 
control (Figure 4.8). 
As the amount of RNA available for study was limiting, further optimisation of Northern 
blots was not pursued. An RT-PCR approach was taken with primers based on the 
sequence data obtained previously. However, no product was visible for any of the RAP- 
PCR products even though the control reactions using primers for actin were successful 
(data not shown). 
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Band Primers used -Mw (bp) Present in (life-cycle stage) 
ic C2, S1 234 Cercariae 
2C SP6, C2 180 it 
IL SP6, C2 180 Lung-worms 
2L SP6, C2 190 11 
3L SP6, S4 200 if 
56 G2, SK 180 of 
1A C2, S1 107 Adult worms 
62 Gl, G2 150 If 
63 Gl, G2 155 it 
ICL C2, S6 230 Cercariae and lung worms 
IAL KS, S1 150 Lung and adult worms 
2AL C2, S6 250 
53 G2, GI 135 
IALL C2, S1 118 All 
2ALL C2, S1 286 to 
3ALL KS, S1 130 it 
4ALL KS, S1 160 it 
10 C2, G1 90 
58 G2, GI F 120 
Table 4.1: The bands that were excised from the RAP-PCR gels. 
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Figure 4.4: Reamplification of DNA from excised bands 
(a) Original RAP-PCR gel from which bands 1,2 and 3 were excised for further 
investigation. 
Bands I and 2: common to all life-cycle stages-, Band 3: lung- and adult-worins only 
(b) polyacrylamide gel of the reamplification products: 
Band I in lanes 1,2 and 3 from C, L and A respectively 
Band 2 in lanes 4,5, and 6 from C, L and A respectively 
Band 3 in lanes 7 and 8 from L and A respectively 
C: cercariae, L: lung-worms A: adult-worms Z: ý 
79 
LLAA 
4567 
3ALL (126bp) Homologous to S. mansoni EST208943 (accession number: AI067268) 
atgacgctggccttattagtgtttctatttgatatacgcaggatccgggttaaaaacctcggtattcatgg 
ccgaaactttgatgcaaaagaccggaggatagttataggataccgtcgacctcga 
10 (102bp) Homologous to S. mansoni EST SCMRAP139 (accession number: L47052) 
gaatcgctgtataaaagttatcctgtagaattcgaaaaatatttgcatttcgctcgtggtctagcttttga 
cagccttccgaccttttgtttaccagccttc 
4ALL (176bp) 
atqacqctqqccttattaqttcaaacgtatcttatatatgtggctactctgaacccattatttttacatca 
gattggtttaacattgactgtttttttgttttaacatcttgaatgtaaactatatatatattcttgagtaa 
ccgaaacagtcttctqataccqtcqacctccia 
1AL (158bp) 
atqacqctqqccttattaqttttatgagtcagatattaataaataagagtgaatatttaactttcaatatc 
cagacttatctcataatttaacttaagggtcggaagttgtaggctcattggtcagatattataagcqatac 
cqtcqacctcqa 
53 (156bp) Homologous to S. mansoni EST272077(accession number: A1977483) 
qqaaaacaaatqqtccfqqaaqggaacttatgagtgaatgttttaattaatgaattcaattcacagctaatc 
tttaattgttcaatgaaaatgatagatgataccaatctaaatggtttctccccnacttcntgtttactttt 
atncnqcqattcaq 
62.16 (115bp) 
qqaaaacaaatqqtcqqaaatacagtaggttttagagcctcagcatcatctaacaatccagtaattgctcc 
agtaaggaatccgatttgtgctccacttttatacaacaattcacr 
63(99bp) 
ctqaatcqctqtataaaaqtataaaatcagtatattaagaaatcttctcggcctgtgtaagatacagcaaa 
atctgcgccatttgcagttqcittcqctaa 
56.15 (198bp) 
qqaaaacaatqqtcqctaaqcgttatccactagatgattttgatttgatttaaccaactctctttctttatt 
atttgtacacgtttcaacgaanaaatcttcaatttcttcttcaacttcagtatcatcatcagcagcagtag 
aaattgtagtttcggtagtaccaacatttccttcatciatccactacittctaqacicci 
56.16 (87bp) 
aciaaactacitqcfatcaacagctcgtaattcgaatactcagtcattgtcatcgttgtcatcatcatcttcccI 
accatttqttttccaa 
56.20 (156bp) 
qqaaaacaaatqqtc(ictaaqtggaaaacgacccatgaaatttactcaaagggttccgagtgttttcgaaag 
ggtattccaaaatgaagaataaatccaggtatttaaatgtgtagtaatattacactaggacttcqatccac 
tattctaqaqccc 
Figure 4.5: The DNA sequence of each of the excised bands. 
The regions corresponding to RAP-PCR primers are underlined. 
See: Table 4.1 for individual primer pairs used for generation of each band 
Appendix I for complete primer list 
Several of the sequences shown represent complementary sequence of the original 
cDNAs. This is because the cloning into the TA vector is non-directional. 
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Figure 4.6: Southern blot analysis using the cloned inserts of the excised bands 
Bands can be seen for 62,63,53,3ALL, 4ALL. 
GST was used as a positive control. 
The signal seen on I AL is carry over from the molecular weight marker that was used. 
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Figure 4.7 Southern blot analysis of the three different clones from band 56. 
82 
56.20 
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Figure 4.8: Northern blot analysis of actin expression. 
I Opg total RNA from cercariae, lung-schistosomula and adult-worms were loaded side by 
side and the gel stained with ethidium bromide prior to transfer, to check both the 
integrity of the RNA and to ensure that equivalent amount were loaded onto the gels (a). 
Mouse RNA was also run and stained as a control (M), but was not transferred. No 
cercarial RNA entered this particular gel. After transfer, the membrane was probed with 
a fra ment ofthe actin gene (b). The levels of actin in lung-schistosomula and adult- 9 V. 71 
worms are the same (taking into account the difference in amounts of RNA loaded onto 
the gels). 
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4.4 DISCUSSION 
4.4.1 RAP-PCR 
The purpose of the work described in this chapter was to identify genes that were 
differentially expressed in the parasite as it matured from a cercaria to an adult worm, 
with particular interest in those that were upregulated at the lung-stage of development. 
RAP-PCR was used to compare the mRNA profiles of cercariae, lung-schistosomula and 
adult worms using pairs of arbitrary primers. Each of the primers used was a non- 
degenerate 20-mer. The rationale behind using long primers was simply that they would 
anneal to many sequences along the template with a variety of mismatches. It has been 
noted, when using 10-mers for differential display, that the majority of primer-binding 
sites on the template match only 6 out of 10 bases exactly at the 3' end with up to 4 
mismatches at the 5' end (Liang and Pardee, 1995; Bauer et al., 1993). Neto et al. (1997) 
and Welsh and McClelland (1991) have shown that the use of two different primers for 
RT and PCR results in shorter products although the number of cDNA bands is similar to 
that obtained with the use of a single primer. This result is expected as the average 
distance between adequate matches on the template is less when two oligonuleotides are 
used as primers. In addition, smaller PCR products might be expected to amplify more 
efficiently than longer molecules, suggesting that using two primers might give clearer 
results. Furthermore, PCR products that use a single primer can produce hairpins during 
renaturation, putting them at a possible disadvantage relative to PCR products amplified 
using two primers. 
A major concern with RAP-PCR is the number of false positives that arise (Debouck, 
1995). PCR amplification of each of the cDNA pools was carried out in duplicate in 
order to reduce the number of false positives identified. Only those bands present in both 
samples were considered. Although the majority of the primer combinations used gave 
reproducible profiles, some yielded smears in all of the lanes. The application of a few 
initial low stringency annealing PCR cycles followed by cycles of higher stringency 
annealing might have reduced the problem of smears and produced a greater number of 
reproducible profiles. Such an approach has been used in many DNA fingerprinting 
applications (Zhao et aL, 1995). 
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The number of differentially expressed products that were detected in this study was 
relatively low in comparison to a similar study using F. hepatica (Reed et al., 1998). 
This is probably due to the fact that full-length sequencing gels were used in the latter 
study. This allows for better separation of the fragments and thus more individual 
fragments can be visualised than on the minigels used here. The use of minigels may 
also provide an explanation for the fact that no differentially expressed products were 
seen when using some primer combinations. Alternatively, those primer sets might just 
not have annealed to any differentially expressed product. In fact, the use of a longer 
format gel (Bio-Rad midigel system) did allow for the visualisation of a significantly 
larger number of fragments. Therefore, this may represent an improvement to the 
protocol reported here. As in studies with F. hepatica (Reed et al., 1998), Leishmania 
mexicana amazonensis (Heard et al., 1996) and Eimeria bovis (Abrahamsen et al., 1995) 
the number of amplified cDNA products generated by DD was limited in comparison to 
fingerprints from mammalian cell mRNAs. This may either reflect a difference in the 
complexity of mRNA expression or be due to subtle differences in the methodologies 
used. Overall, the RAP-PCR profiles generated were reproducible and several 
differentially expressed products were identified. 
4.4.2 Selection and isolation of differential bands 
The DNA from several of the excised bands was not reamplified by PCR. This 
seemed to reflect the intensity of the band on the RAP-PCR gel; those bands that were 
more prominent amplified more easily, whereas very faint bands did not. The DNA from 
several of these faint bands gave products that were visible on silver-stained 
polyacrylamide gels after two amplification rounds each consisting of 40 PCR cycles. 
However, these products were not pursued due to the increased likelihood that PCR 
artefacts had been generated after so many rounds of PCR. Therefore, the 
reamplification of cDNAs is limited by the concentration of material that is excised from 
the RAP-PCR gel. This might be a drawback of the protocol used here if rare transcripts 
are identified. 
The PCR products of those bands that did reamplify after excision from RAP-PCR 
gels invariably contained more than one species of DNA. This has been reported 
repeatedly in the literature and several different approaches to identify the correct 
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differentially amplified product have been described (Mathieu-Daud6 et aL, 1996 and 
references therein). 
The fact that no significant matches to entries on current databases were obtained for 
the majority of the sequences is not surprising given that there is only limited sequence 
information available for parasitic trematodes. This is also similar to the data obtained 
from differential display studies on F. hepatica (Reed et aL, 1998), Angiostronylus 
cantonensis (Joshua and Hsieh, 1995) and Giardia lamblia (Que et aL, 1996). Indeed, 
one of the differentially expressed products identified by Tawe et aL (1998) from C 
elegans had no sequence homology even though over 75% of the C elegans genome had 
been sequenced at that time. 
4.4.3 Verification of differential expression 
Northern blot analysis is the best way to determine unequivocally if the expression of 
a particular gene is differentially regulated (Liang and Pardee, 1995). In addition, it 
offers information regarding the transcript size and presence of multiple species. 
However, as no signals were seen in this study it can only be assumed that the technique 
is not sensitive enough to detect the mRNAs corresponding to the differentially expressed 
bands identified (the same probes were used successfully on a Southern blot). The 
insensitivity of Northern blotting has been reported by several workers (Liang et aL, 
1993; Reed et aL, 1998; Rivas et aL, 1997; Dimopoulos et aL, 1996). All of them 
suggest that it is likely that the mRNAs of the genes being investigated are expressed at 
levels below the detection limits of Northern blot analysis. For example, Reed et aL 
(1998) were only able to detect one of their 5 differentially expressed clones by Northern 
blot analysis. Indeed, Pierrot et aL (1996) found low levels of elastase mRNA transcripts 
in adult worms by RT-PCR whereas Newport et A (1988) had not been able to detect the 
transcript by Northern blotting in the same life-cycle stage. Several alternative 
approaches which are more sensitive than Northern blots, including semi-quantitative 
PCR, RNase protection assay and in situ hybridisation can be used to verify expression 
patterns of differentially expressed genes. However, due to limiting amounts of parasite 
material, especially lung worms, it was not possible to optimise any of these approaches 
for any of the S. mansoni probes. 
There is considerable debate in the literature about the possible bias of DD and RAP- 
PCR towards abundant transcripts. Bertioli et A (1995) found that in a model system, 
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where the target mRNA was added externally, the differentially expressed target became 
undetectable when it constituted less than 1% of the total sample. In contrast, Wan et aL 
(1996) found that of the 23 differentially expressed products they identified 13 were rare 
mRNA species (i. e. each comprised less than 0.01% of total mRNA) and the expected 
abundant differentially expressed transcripts were not found. There are many variables 
including the competition for PCR primers between RNAs of different abundance, the 
length of the primers, the number of PCR cycles and the amount of starting material that 
may account for such differences. Each would have to be tested individually to optimise 
the method to identify all possible differentially expressed products in any one 
experimental system. 
Adaptations to the original protocol to enrich for products of a particular gene family, 
e. g. for zinc finger proteins in mammalian systems, by designing primers for the 
conserved amino acid region of such proteins have been reported (Stone and Wharton, 
1994; Johnson et aL, 1996). Similarly, to identify transcripts with intact 5' ends from 
trypanosomes, the second-strand synthesis primer was derived from the shared 5' mini- 
exon sequence, which is common to most trypanosome mRNAs (Murphy and Pelle, 
1994). A set of primers based on the analysis of available coding regions of mammalian 
G-protein coupled receptors (GPCRs) was used to amplify 7 known GPCRs from 30 
randomly isolated bands (Lopez-Nieto and Nigam, 1996). GPCRs possess very few 
conserved motifs making their isolation very difficult. However, the results presented by 
Lopez-Nieto and Nigam (1996) show that this approach is viable for proteins with few 
similarities. With this in mind, the signal sequences of the eight schistosome proteins 
known to be secreted prior to the work presented in chapter 3 were analysed. As 
expected no common DNA sequence was found but the amino acids leucine, isoleucine 
and valine occurred in repetitive patterns. Some primers were designed, based on these 
patterns, taking into account the codon bias of schistosomes (Ellis and Morrison, 1994) 
and used for RAP-PCR (see Appendix I for primers, SI -S6). Although these primers 
would not be expected to amplify signal sequences exclusively, it was hoped that they 
would skew the bias towards hydrophobic regions, and hence M/S proteins. The RAP- 
PCR fingerprints obtained using these primers were no better or worse than those 
obtained using totally arbitrary primers. It remains to be seen if this approach was 
successful as it is impossible to tell if any of the clones identified in this study represent 
MIS proteins based on the limited sequence data obtained. A more suitable approach 
may be to modify the system such that the 5' end of mRNAs is selected for, thereby 
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allowing for the identification of those cDNAs with a signal sequence as soon as clones 
are sequenced. This might be achieved by using a degenerate primer for the Kozak 
sequence, which occurs, at the 5' end of most genes. Martinez et al. (199 1) showed that 
this is a feasible approach using total RNA from rat embryo fibroblast cells and its 
raslp53 transformed derivatives. 
Fischer et al. (1995) described a variation of the differential display technique which 
combined restriction fragment length polymorphism technology with domain-directed 
DD. This method not only allows all members of a multi-gene family to be identified but 
also distinguishes each member of the family. This may prove to be a more sensitive 
technique for the identification of members of gene families and analysis of their 
expression patterns. Several other variations on the basic technique of DD have been 
reported including the use of class II S restriction enzymes (Kato, 1995), the PCR 
amplification of 3' end restriction fragments of biotinylated cDNA that are isolated with 
avidin beads (Ivanova and Belyavsky, 1995) and ordered DD (Matz et al., 1997). Each 
of these approaches has clear advantages over DD when a complete characterisation of an 
RNA sample is required. However, these techniques are more complicated and require 
more skill and specialised materials to produce a reproducible fingerprint in comparison 
to classical DD. 
Although the stage-specificity of the cDNAs identified in this study remains to be 
proved, comparison of the mRNA from cercariae, lung- and adult-worms by simple 
RAP-PCR has revealed that there are several genes that are transcriptionally regulated as 
the parasite matures from a cercaria to an adult worm. If any of the genes identified here 
is truly lung stage-specifically expressed, it could provide a useful marker for future 
studies of differential gene expression in schistosomes. 
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CHAPTER 5 
THE SIGNAL SEQUENCE TRAP 
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5.1 INTRODUCTION 
The use of the SignalP algorithm (Chapter 3) revealed how few NVS antigens have 
been deposited on the schistosome database. Additionally the number of sequenced 
genes that have been identified from the larval stages of the parasite (especially the 
sporocyst and lung-schistosomulum) is relatively small in comparison with those derived 
from the adult worm. This is a drawback as it is the larval stages that are the targets of 
the protective immune responses seen in the irradiated vaccine model and hence it is the 
genes expressed by these stages that are of interest. The use of algorithms such as 
SignalP is limited to only those genes that have already been tagged (e. g. by EST 
generation) and by the quality of the sequence data being analysed. Therefore, a method 
to identify NVS proteins, which is independent of the sequences on the genome database, 
would probably be more successful. 
The traditional biochemical approach for the identification of NVS proteins is the 
isolation of the proteins, usually by either electrophoresis and elution or by liquid 
chromatography, followed by peptide sequencing techniques. This, however, often turns 
out to be very challenging as the separation and sequence analysis by Edman degradation 
of peptides derived from hydrophobic proteins can be difficult. Although the sequencing 
problems may be circumvented by using proteomic technologies such as mass 
spectrometry to detennine amino acid composition of peptides (Shevchenko et aL, 1996), 
the amount of material available for study remains a problem, especially for larval stages 
of schistosomes. 
Several genomic approaches aimed specifically at the identification of NVS proteins 
from various organisms have been described. These include the use of a subtractive 
antibody screening system in which a polyclonal antiserum is depleted of antibodies that 
recognise non-target proteins (Scherer et aL, 1998) or the creation of a cDNA library 
enriched for genes encoding extracellular proteins followed by the use of high throughput 
in situ hybridisation (Kopczynski et aL, 1998). Although there are several potential 
sources from which schistosome NVS proteins could be derived, e. g. acetabular and head 
glands, the homogeneous body, the gut and the nephridial system, it would be impossible 
to produce a cDNA library enriched for NVS proteins. This is because schistosomes are 
acoelomate platylielminths, which means their different tissues cannot be separated. 
Additionally, as antibody screens are biased towards the identification of the most 
abundant or highly immunogenic proteins it is likely that only a small subset of proteins 
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would be isolated. The third approach has been coined the "signal sequence trap" (SST). 
This is a more robust method, based on the ability of signal peptides to redirect the 
expression of an export-defective reporter protein to the cell surface or medium. This 
approach relies on the fact that signal peptides can direct the secretion of heterologous 
proteins and are also interchangeable between diverse organisms (Hitzeman et aL, 1990; 
Rapoport et aL, 1996). For example, P-lactamase from E. coli can be secreted by 
Xenopus oocytes (Wiedmann et aL, 1984) and prepro-(x-mating factor of S. cerevisiae 
can be imported co-translationally by mammalian microsomes (Garcia and Walter, 
1988). 
In the first SST system described (Tac SST), a mixture of cDNAs was cloned into a 
vector such that the foreign DNA was directly upstream of a signal sequence-deficient 
IL-2 receptor gene (Tashiro et al., 1993). After transformation of the plasmid mixture 
into COS cells, surface expression of the receptor was detected by antibody staining. The 
isolation of several mammalian NVS proteins, including putative growth factors, 
receptors or adhesion molecules, has been reported (Nakamura et al., 1995; Shirozu et 
al., 1996; Kimura et al., 1998). 
Recently, the Tac SST system has been used to identify secretory proteins from the 
salivary glands of the insect Anopheles gambiae (Arca et al., 1999). The authors reported 
the identification of 15 distinct cDNAs of which six were expressed specifically in the 
salivary glands. A variation of the Tac SST system has been used to isolate various plant 
NVS proteins (Kristofferesen et al., 1996). These last two studies represent the only 
reports in which Tac SST-based systems have been used to identify non-mammalian NVS 
proteins and reinforce the fact that that secretion systems are able to process heterologous 
signal peptides. 
The immunostaining step described in the Tac SST strategy has several drawbacks 
including low sensitivity, the requirement for large, expensive pieces of equipment (e. g. 
Fluorescence activated cell sorter; FACS) and being time-consuming and labour 
intensive. In order to improve the detection system, several modifications have been 
developed. Chen and Leder (1999) have described the use of human placental alkaline 
phosphatase (PLAP) as the reporter. PLAP is only functional when it is brought to the 
cell surface (cytoplasmic PLAP is inert) and a simple colourimetric assay is used to 
identify positive clones. This reduces the number of false positives that arise when using 
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Figure 5.1: A schematic representation of the yeast-based signal sequence trap. 
the previous detection system. However, before a single positive clone is isolated, 
several rounds of screening and rescreening have to be carried out. 
Kojima and Kitamura (1999) have described a retro-virus mediated expression system 
that detects signal sequences based on their ability to redirect a mutant form of the 
thrombopoietin receptor, MPO, to the cell surface. A constitutively active MPO 
permits IL-3 independent growth of cell lines, which are normally IL-3 dependent. 
Therefore, this removes the need for multiple rounds of screening for the identification 
and isolation of positive clones as is necessary in the previous systems. 
An alternative, yeast-based SST (YSST) has also been developed (Klein et aL, 1996; 
Jacobs et aL, 1997). This system uses a single-step genetic selection to identify the 
requisite cDNAs, relying on the principle that secretion of the enzyme invertase is 
essential for cell survival in certain environments. The invertase gene codes for two 
forms of the enzyme; a constitutive cytoplasmic enzyme and a secreted, glycosylated 
enzyme. Expression of the two forms of the enzyme is differentially regulated during 
transcription (Carlson and Botstein, 1982) with the cytoplasmic form being constitutively 
expressed. Glucose concentration is thought to regulate the expression of the secreted 
form, with synthesis being upregulated in the absence of glucose (Perlman and 
Halvorson, 198 1). Therefore, it is imperative for yeast that invertase is secreted when 
growing in environments where glucose is not available as a carbon source (Carlson et 
A, 1983). Hence, invertase secretion represents a simple and sensitive selection upon 
which the yeast-based SST has been established. 
A strain of S. cerevisiae, with its chromosomal copy of the invertase gene deleted 
(SUC-), is used in conjunction with a plasmid containing a truncated invertase gene 
lacking both its signal sequence and the initiator methionine for cytoplasmic invertase. 
Foreign cDNA is cloned directly upstream of the truncated gene and the plasmid 
transformed into the mutant yeast. Only those transformants that acquire a cDNA 
encoding a functional signal peptide will grow when sucrose is the sole carbon source. 
Figure 5.1 shows a general outline of the YSST. 
The stringent requirement for both a signal sequence and initiator methionine means 
that the invertase protein is not expressed in the empty vector. Although invertase 
secretion is essential for growth under selective conditions, as little as 0.6% of wild type 
expression levels is sufficient to allow for growth on sucrose medium and 4.7% results in 
growth rates indistinguishable from that supported by a normal invertase protein (Kaiser 
and Botstein, 1986). This means that even if non-yeast signal sequences facilitate only a 
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low level of invertase export, growth will still be permitted. Kaiser et aL (1987) showed 
that 20% of the random fragments generated by the digestion of human genomic DNA 
can function, at least minimally, as signal peptides. Indeed, Jacobs et aL (1997) observed 
that many cDNAs encoding different lengths of IFNy peptides fused to invertase were 
readily isolated using the selection system. A further advantage of yeast is that, unlike 
mammalian cells, its ribosomes do not require specific nucleotide sequences to initiate 
translation thereby increasing the efficiency of heterologous gene expression (Yoon and 
Donahue, 1992). 
Although Kaiser et aL (1987) demonstrated that invertase is tolerant of amino- 
terminal extensions, Jacobs et aL (1997) have modified the plasmid used for the SST. A 
sequence encoding a Kex2 proteolytic site has been incorporated into the plasmid 
between the multiple cloning site and the invertase coding region. Kex2 is a yeast 
protease which functions in the late Golgi (Redding et aL, 1991). This allows the 
expressed fusion protein to be cleaved so that the foreign fusion partner does not interfere 
with the function of the secreted invertase. 
This aim of this chapter was to establish this yeast based signal sequence trap for the 
identification of schistosome WS proteins. Initially the system would be validated using 
schistosome cDNAs encoding proteins whose localisation within the parasite was known. 
Following this, a cDNA mixture derived from the parasite would be cloned into the 
vector and screened using the SST for novel IVVS proteins. 
5.2 MATERIALS AND METHODS 
5.2.1 Growth, maintenance and preservation of S. cerevisiae 
S. cerevisiae cells were grown in YPD liquid medium (I% B acto-yeast extract, 2% 
Bacto-peptone, 2% glucose) at 30"C with agitation (100 r. p. m. ) for preparative 
procedures. Isolation of single colonies was achieved by streaking cells onto YPD-agar 
plated (YPD medium with the addition of 2% agar) followed by incubation at 301C. 
For long term preservation, glycerol stocks (15% v/v) were prepared from liquid cultures 
and stored at -701C. 
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Figure 5.2: The yeastI. E. coli shuffle vector pSuc2t7FlorL 
This vector is designed to identify sequences in cloned cDNAs that mediate synthesis and 
transport of invcrtase into the endoplasmic reticulum. and hence into the secretory 
pathway. The vector replicates episomally both in E. coli (colE I origin, F1 origin) and 
yeast (2 micron segments 1 and 2) and carries the ampicillin resistance (P-lactamasc 
gene) and tryptophan (Trpl gene) selectable markers for E. coll and yeast respectively. 
The invertase reporter gene (lacking both its signal sequence and initiator mcthionine) is 
trancribed from the alcohol dchydrogenase promoter, a strong promoter in S. cereviside, 
and foreign ORFs can be cloned directly upstream of the invertase gene into the multiple 
cloning site. 
5.2.2 Sub-cloning of ORFs into the yeast/E. coli shuttle vector, pSuc2t7Flori 
The yeast/E. coli vector and the invertase selection system are described in Figure 5.2. 
Oligonucleotide primers were designed to amplify the sequences containing the 
required ORFs. The primers incorporated restriction enzyme sites to facilitate molecular 
manipulations and were designed to ensure that appropriate translation of the ORF would 
be maintained when ligated into the vector. All primers are shown in Appendix 1. 
Inserts were generated by PCR amplification using primers at 0.5pmol, dNTPs at 
200[imol and the plasmid template at O. Sng liv. The enzyme and excess dNTPs were 
removed after successful amplification and the inserts digested with the appropriate 
restriction enzymes followed by ligation into the appropriate vector that had been 
linearised with the corresponding restriction enzymes. Competent HB 10 1 E. coli cells 
(Stratagene) were transfortned with the ligation products and transformants were selected 
on LB agar plates containing the kanamycin (25lig ml-'). 
5.2.3 Lithium Acetate Transformation of S. cerevisiae 
Fresh cells were transformed essentially as described by Becker and Guarente (199 1). 
Briefly, I ml of an overnight culture (approximately 5x 10' cells ml-') was used to 
inoculate 25ml warm YPD and the culture grown at 30'C, with shaking, to an OD,, of 
0.8. The cells were washed twice in I Oml sdH20 after having been pelleted by 
centrifugation for 5 minutes at 5000 r. p. m. and the supernatant discarded. A final wash 
was carried out using 10ml LiAc/TE buffer (lM Lithium acetate, IOOmM Tris-Cl pH 7.5, 
ImM Na2EDTA) after which the cells were resuspended in 300pl LiAc/TE and incubated 
at 30'C for 15min. 
To each 50ýtl aliquot of cells was added 400ýtl PEG/LiAc/TE buffer (40% PEG, 
LiAc/TE), 1-5pg plasmid DNA and 50ýtg herring sperm DNA (heated to 95T and snap 
cooled just prior to use). The cells were then incubated at 300C for 30 minutes and then 
for a further 20 minutes at 42'C before being pelleted and the supernatant removed. 
Finally the cells were resuspended in 300ýtl sdH20. The S. cerevisiae strain YTK12 was 
used for all experiments described in this thesis. This strain contains a chromosomal 
mutation that makes it a tryptophan auxotroph. Therefore, this was used as the selectable 
marker for transformation. Transformants were selected for by plating onto solid 
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tryptophan dropout plates (CMD-W; YPD medium lacking tryptophan) and grown for 3 
days at 30T. 
5.2.4 Selection of transformants able to secrete invertase. 
The yeast transformants were replica-plated onto solid sucrose selective medium 
(YPD-agar without glucose, with 2% sucrose) and grown for a further 8 days at 300C. 
The resulting colonies were patched onto solid sucrose medium lacking tryptophan 
(CMD-W without glucose, with 2% sucrose) and grown for a further 8 days. Those still 
growing were then taken as invertase-secreting clones. 
5.2.5 Isolation of plasmid DNA from S. cerevisiae 
Plasmid preparations were made by pelleting cells from an overnight culture by brief 
centrifugation and resuspension in 100[d lysis buffer (2.5M LiCl, 50mM Tris-CI pH 8.0, 
6.5M EDTA, 4% (w/v) Triton X-100). An equal volume of phenol: chloroform (1: 1) and 
0.5g acid-washed glass beads (Sigma, 0.5mm) were added and the mixture vortexed 
vigorously for 2 minutes. After centrifugation the aqueous layer was taken, the DNA 
ethanol-precipitated, and resuspended in TE. 
5.2.6 Generation of a schistosome SST library 
A mixture of cDNA was generated from 10ýtg schistosome egg mRNA using the 
Stratagene cDNA synthesis kit, following the manufacturer's instructions. 
First strand cDNA syLithesis: The following components were added, in order, into a 
RNase-free microfuge tube: 5ýd IOX first-stand buffer 
3ýil first-strand methyl nucleotide mixture 
2gl linker-primer (as provided by manufacturers) 
3.5ýd DEPC-treated water 
1 ýtl RNase block ribonuclease inhibitor 
All the reagents were vortexed and spun briefly in a microfuge before 34ýtl egg mRNA 
(0.13pg ml-') was added. The reaction mixture was left to stand at room temperature for 
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10 minutes after which time 1.5ýd MMLV-RT (50U ýfl`) was added. The first strand- 
synthesis reaction was incubated at 37"C for I hour. 
Second-strand cDNA synthesis: The following reagents were added, in order, to the first- 
strand synthesis reaction: 20ýil second-strand synthesis buffer 
6ýd second-strand dNTP mixture 
1 141il sterile, distilled water 
2ýd RNase H (1.5U ýfl-') 
II ýd DNA polymerase I (9. OU ýtl-') 
The reaction mixture was vortexed gently, spun in a microcentrifuge and incubated for 
2.5 hours at 16'C. 
Blunting the cDNA termini: The following reagents were added to the second-strand 
synthesis reaction: 23pl blunting dNTP mix 
2ýtl cloned Pfu DNA polymerase (2.5U ýtl-') 
The reaction mixture was vortexed, spun briefly in a microcentrifuge and incubated at 
72*C for exactly 30 minutes. The reaction mixture was then subjected to a phenol- 
chloroform extraction, followed by one chloroform extraction and the DNA recovered by 
ethanol precipitation. The resulting DNA pellet was resuspended in 9ýtl of EcoRI 
adaptors. 
Wation of EcoRI adgptors and phosphorylation of the EcoRl ends: The following 
reagents were added to the cDNA and EcoRI adaptors: 
I ýLl I Ox ligase buffer 
1 ýtl I OmM rATP 
1 ýtl T4 DNA ligase (4U ýtl-') 
The reaction was incubated at 80C overnight and was stopped by heating to 70T for 30 
minutes. The following components were added to the reaction mix once it had cooled to 
room temperature: 
I ýd I Ox ligase buffer 
2gl lOmM rATP 
6gl sterile water 
I gl T4 polynucleotide kinase (IOU gl-') 
The reaction was incubated for 10 minutes at 37*C followed by a 30 minute incubation at 
70'C. 
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Digesting with XhoI: The following components were added to the reaction: 
28gl XhoI buffer supplement 
3pl Xhol (40U pr) 
The reaction was incubated for 1.5 hours at 37"C after which 5gl STE buffer and 125gl 
100% ethanol was added. The DNA was recovered after precipitation and resuspended in 
14pl STE buffer. 
This cDNA solution was used for ligation into the SST plasmid. Ligations were 
performed using a 1: 1 molar ratio of cDNA: plasmid using T4 DNA ligase (Promega) as 
described in section 2.3.7. 
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5.3 RESULTS 
To test the YSST system using schistosome sequences, the 5' ends of cDNAs 
encoding well characterised secreted proteins (p48, superoxide dismutase (SOD) and 
antigen 10-3), and cytoplasmic proteins (calpain and clone 11, an EST with homology to 
the schistosome phosphoglycerate kinase gene) were cloned into the vector 
pSuc2t7F I ori, in frame with the invertase coding region in the plasmid. The 5' end of 
the S. cerevisiae invertase cDNA was also cloned into the vector to serve as a positive 
control for the initial trial experiments. The DNA sequence and the corresponding 
peptide sequence of each of the inserts is shown in Figure 5.3. SUC- yeast transformed 
with vector containing the homologous invertase signal peptide grew with a plating 
efficiency of 100% after 3 days under selection for invertase secretion. Equivalent 
growth rates and plating efficiencies were obtained with the clones transformed with 
plasmids containing each of the three schistosome signal sequences (p48, SOD, 10-3). In 
contrast, SUC- yeast transformed with vector alone or with constructs containing the 5' 
ends of schistosome cDNAs for cytoplasmic proteins (calpain, clone 11) produced no 
visible colonies even after 7 days under selection (Figure 5.4). These experiments were 
repeated three times; it should be noted that on one occasion 1% of the clones capable of 
producing only cytoplasmic invertase (i. e. containing calpain or clone II cDNA) started 
to grow after 8 days under selection. Following selection on sucrose medium the cDNA 
inserts were amplified by PCR directly from the yeast clone and subsequently sequenced 
to ensure that the correct clone had been transformed (Figure 5.5). 
The cDNA prepared from the egg mRNA contained fragments ranging from 100bp to 
800bp, with the majority being -100bp. This cDNA mixture was ligated into the SST 
plasmid. After transformation of the recombinant plasmids into SUC- yeast and selection 
of transformants for invertase secretion, 4 clones were isolated out of a total of 
approximately 500 transformants. The four clones took eight days to appear on the 
selective plates. The amino acid sequence corresponding to the DNA sequence of each 
of the cDNA inserts is shown in Figure 5.6. The inserts were very short (5-11 amino 
acids), only one contained a hydrophobic amino acid and one even lacked a methionine. 
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S. cerevisige invertase: (Genbank Accession number: E00284); Insert: 3 87bp (111 aa) 
Plasmid, pRB58, provided Dr C Kaiser (Kaiser et aL, 1987) 
ttc tct cag aga aac aag caa aac aaa aag ctt ttt ctt tca cta acg tat atg 
atg ctt ttg caa gct ttc ctt ttc ctt ttg gct ggt ttt gca gcc aaa ata tct 
mLL0APLFLLAGFAAKIs 
gca tca atg aca aac gaa act agc gat aga cct ttg gtc cac ttc aca ccc aac 
ASXTNETSDRPLVHFTpN 
aag ggc tgg atg aat gac cca aat ggg ttg tgg tac gat gaa aaa gat gcC aaa 
KGWMNDpNGLWYDEKDAK 
tgg cat ctg tac ttt caa tac aac cca aat gac acc gta tgg ggt acg cca ttq 
wHLyF0YNPNDTVWGTpL 
ttt tgg ggc cat gct act tcc gat gat ttg act aat tgg gaa gat caa Ccc att 
FwGHATSDDLTNwED0pI 
gct atc gct ccc aag cgt aac gat tca ggt gct ttc tct ggc tcc atg gtg gtt 
AIAPXRNDsGAFsGsmvv 
gat tac aac 
DyN 
S mansoni p48- (Genbank Accession number: M74170); Insert: 139bp (27aa) 
Plasmid provided by Dr P LoVerde (Chen et al., 1992) 
gcttttgtataaacaatcg 
aat tta tta gta ttc 
NLLvF 
gga tac aat gga tat 
GYNGY 
tagti 
agt 
s 
act 
T 
gtattcgaaaatttctgttgttcaggattgaaaaa atg 
m 
ata cta ata act tgt tta ctg aac agc gtt tat agt 
ILITCLLNsvY 
-S aat gga 
NG 
S. mansoni SOD: (Genbank Accession number: M28543); Insert: 240bp (80aa) 
Plasmid, pBABY-SP-SOD, provided by Dr P LoVerde (Hong et aL, 1993) 
atg 
m 
aca 
T 
gta 
v 
tat 
y 
tcc 
s 
tat 
y 
tta 
L 
gtt 
v 
ata 
I 
tta 
L 
ttt 
r 
att 
I 
ctt 
L 
ctt 
L 
gat 
D 
aat 
N 
tat 
y 
tgt 
C 
tcc gca tat gga tat ggt tac tca tat tat cat cgt aga cat ttt gat ccg - gct 
s A y G Y G Y s y y H R R H F D p A 
att gct tca ttt acg aag gaa cca tat ata ggt gcg gtg tgg ttc aca caa cat 
I A s F T X 9 p y I G A V W F T Q H 
gga gat tat atg tac gtt aat gga agc gtg gca gga ctc cca cct gga aaa ctg 
G D y M Y V N a S V A G L p p G K L 
ttg ggt aca cat gtt cat cgt tat 
L G T H v H R y 
S. mansoni 10-3:, (Genbank Accession number: M22346); Insert: 300bp (89aa) 
Plasmid, pUR288, provided by Dr W Kunz (unpublished) 
cattatacaggacggaagttgaaattcaacaat atg aat atc tac ctt att ggt 
mNI y L I G 
ata tta tgt att gtg ggt ttg att att tca caa ggg tct act gct aac gga agt 
I L C I v a L I I s 0 G S T A N G s 
cca ctt gac gat cga ttc aat gat gtt aat acc ata aac aag aaa caa ttc acc 
p L D D R F N D V N T I N K K Q F T 
gaa gag gaa ttt tcc aga ctg ata aat tcc atg tta aag aag tat atc gaa gac 
E E E F s R L I N S X L K K y I E D 
aaa aac gtt gat atc cgc ata att gga aat aag aag gat aaa cag cct act cag 
K N v D I R I I G N X X D x P T 
aaa aca act ccc aaa cct aca aca cca aag 
K T T p K p T T p K 
S mansoni call2ain: (Genbank Accession number: ); Insert: 279bp (74aa) 
Plasmid, pRizklC, provided by Dr M Eberl (Andresen et aL, 1991) 
tgg tgt aga aaa ctt gaa aaa acc cta att cat tca tta taa ttt cta aga ata 
ata atg gga cga ata caa att gtt tat tct cct gat gaa aat gta tct gga cga 
mGR101vyspDENvsGR 
act aac cgt cct ggt aaa gag gta gtg gat cca cgt act ggt aga ata atc aaa 
TNRpGKEvvDpRTGRIIK 
gtg aaa cga gaa act cca gat gat tac ttg aat gta tta aaa ccc atc aaa ggt 
VXRETpDDYLNVLKpIXa 
cca aag cgt atg gaa ttt aat cca tat ctt cct aaa aca ctt act cca aaa gga 
pKRmEFNpyLpKTLTpXa 
tat gct aag 
YAX 
Clone 11:, (lung-schistosomulum EST; Genbank Accession number: AW499465); Insert: 
141bp (41aa) 
ggaattgccgatggttgg atg gga tta gat att ggt cca aaa aca att gaa gaa ttc 
M G LD IGpKTIEEF 
a9t aaa gtg att agt cgt gcc aaa act att gtt tgg aac ggt ccg atg ggt gtt 
SKVIS R A KT IVWNGPMGV 
ttt gaa atg gac aaa ttt gca aca gga aca 
FEmDK F A TG T 
Figure 5.3: DNA and p eptide sequences of each of the inserts cloned into the 
plasmid pSuc2t7F1ori. 
The signal peptides are underlined. 
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Figure 5.5: PCR of insert cDNAs directly from yeast clones. 
Invertase (lane 1), p48 (lane 2), SOD (lane 3) and 10-3 (lane 4) cDNAs were amplified 
froin their respective clones after selection on sucrose inedium. Calpain (lane 5) and 
clone II (lane 6) cDNAs were amplified from their respective clones after selection on 
Trp, medium. Lane 7 is the PCR contamination control into which no template DNA was 
added. 
Clone 5.1 
ATG AAT TCG GCA CGA GAG 
mNsARE 
Clone 5.2 
ATG ATT CGG CAC GAG 
mIRHE 
Clone 5.3 
GAA TTC GGC ACG AGA 
EFGTR 
Clone 5.4 
ATG GAA TTC GGC ACG AGC TGG TGC CGA ATT CGG 
mEFGTswcRIR 
Figure 5.6: Sequence of the cDNA PCR amplified from the four clones positively 
selected on sucrose medium. 
The hydi-ophohic aiiiiiio acid is widerfined. 
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5.4 DISCUSSION 
The results presented in this chapter demonstrate that the YSST is effective for the 
selection of schistosome cDNAs encoding NVS proteins as clones with intact signal 
sequences were able to grow on sucrose medium whereas those clones without did not 
grow. These results also show that the YSST is not affected by the 5' UTR of 
schistosome sequences (p48,10-3) and that it is able to process relatively long cDNA 
fragments encoding schistosome proteins efficiently (SOD, 10-3). The occurrence of 1% 
of clones that are able to grow after 8 days, when producing only cytoplasmic invertase, 
is similar to the results shown by Jacobs et aL (1997) where 2% of such clones grew after 
selection on sucrose medium for 8 days. 
The four cDNAs isolated from the egg cDNA mixture using the YSST code for none 
of the hallmark features of signal peptides as described in Chapter 3. However, the 
growth of the four clones was slow (8 days on sucrose medium); equivalent to that of the 
1% spurious clones containing calpain or II cDNA. Short fragments of DNA that do not 
code for hydrophobic peptide regions have been trapped in all of the SST systems so far 
described. The reason for this remains unknown but this highlights the importance of 
size fractionation of the cDNA being screened. Simply reducing the number of short 
cDNA fragments can reduce the number of such false positives. Kaiser et aL (1987) 
noted that such slow growing transformants produce high levels of non-glycosylated 
invertase (i. e. cytoplasmic invertase). Therefore, taking only those colonies that are able 
to grow before day 5 post-replica-plating could also reduce the number of false positives. 
True signal sequences, fused in frame to the invertase gene, should be able to direct 
secretion of the enzyme and allow growth of the colony within this time. 
As the cDNA mixture used in this study was oligo d(T) primed, it is likely that the 
four cDNA clones identified represent schistosome 3' UTRs. This can be deduced as 
every cDNA cloned into the YSST vector would have contained an in-frame stop codon 
before the poly(A) tail, that is present on most mRNAs. Therefore, the yeast translation 
machinery would have stopped before reaching the invertase transcript further 
downstream, resulting in no invertase protein being produced. However, those cDNAs 
which fortuitously have an in-frame methionine codon in the 3' UTR (after the stop 
codon) will allow for translation of the invertase mRNA to produce functional, 
cytoplasmic enzyme. Therefore, it is essential to use cDNA that has been synthesised 
from mRNA that was reverse transcribed by random-hexamer priming as this reduces the 
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frequency of stop codons and 3'UTRs. This also increases the number of cDNAs with 
intact 5' ends in the library. Screening was carried out using the oligo d(T) primed egg 
cDNA before the importance of random-hexamer priming had been fully appreciated. 
All of the schistosome cDNA libraries available to the scientific community have been 
constructed using oligo d(T) primed reverse transcription (Johnston et aL, 1999). 
Therefore, before the YSST can be applied effectively to schistosomes, new cDNA 
libraries will have to be constructed using random-hexamer priming. 
More recently, there have been further publications reporting the use of the YSST to 
identify M/S proteins from Arabidopsis (Goo et aL, 1999a) and from Drosophila (Goo et 
aL, 1999b). These reports show that the yeast system is versatile and can be used for the 
identification of M/S proteins from a diverse range of organisms. A comparison of the 
data from these two papers and the Klein et aL (1996) and Jacobs et aL (1997) papers 
reveals that of the total number of unique clones identified, on average, 88% represent 
M/S proteins. This percentage seems to vary with the quality and/or source of the 
starting mRNA used for library construction. However, in comparison to random 
sequencing or antibody screening, this represents a much more efficient method for the 
isolation of M/S proteins. In addition, the number of redundant clones reported in the 
four publications was relatively small with no one molecular species predominating. 
This is in contrast to antibody screening where several highly immunogenic molecules 
are identified repeatedly (Harrop et aL, 1999). If when applied to schistosomes, a few 
cDNAs predominate after the first transformation, then a simple screen to remove these 
before sequencing can be used. For example, PCR amplification of the inserts from all 
positive clones, followed by gridding onto nylon membranes and probing with the 
previously identified abundant cDNAs- 
Goo et aL (1999a) state that only 0.1% of the total cDNAs are isolated by the YSST. 
Although the percentage of cDNAs encoding NVS proteins identified was much lower 
than the expected frequency ratio (10%) of NVS proteins among total expressed proteins, 
the study by Jacobs et aL (1997) demonstrated that particular genes are isolated partly as 
a function of sample size. As the majority of genes coding for WS proteins are likely to 
be expressed at relatively lower levels than those genes coding for proteins involved in 
protein metabolism, the number of cDNAs corresponding to NVS proteins in the library is 
likely to be small. Therefore, this suggests that the YSST would allow for the 
identification of rarely expressed genes. Another reason for the low percentage might be 
that many of the cDNAs cloned into the vector were out of frame with the invertase gene. 
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A simple modification to the current vector to create a series of three plasmids, each of 
which allows for the fusion of cDNAs in a different reading frame, would increase the 
probability of a particular cDNA being in-frame with the invertase gene. This might 
increase the total number of cDNAs encoding NVS proteins identified. 
Finally, it will be necessary to determine the localisation, in the parasite, of each NVS 
protein identified before deciding which ones to pursue as vaccine candidates. In situ 
hybridisation, using the cDNAs isolated by the YSST as probes, is one such option. 
However, past experience in the laboratory has shown that the ProteinaseK treatment step 
damages the tissues to such an extent that individual structures cannot be identified (R A 
Wilson, pers. comm. ). Therefore, an immunocytochemical approach will be used. 
Before this can be done, expression and purification of each protein would have to be 
carried out in order to obtain sufficient protein to permit antibodies to be raised in mice. 
However, this is a lengthy and often difficult process as recombinant protein expression 
may fail for many reasons (see section 3.4.3). A more direct way to purify the expressed 
proteins would be modify the yeast plasmid further by adding a sequence encoding an 
affinity purification tag in front of the Kex2 recognition site, i. e. at the C-terminus of 
each expressed schistosome polypeptide. This would allow the secreted protein to be 
captured from the culture medium either using monoclonal antibodies or by IMAC. As 
only 1 Oýtg recombinant protein are needed to raise antibodies in mice using TitreMax 
Gold (Sigma) as adjuvant, this seems a feasible approach. However, yeast has a cell wall 
and most secreted proteins remain in the periplasmic space between the plasma 
membrane and the cell wall itself. Therefore, even though the invertase is secreted into 
the culture medium in this system, there is no guarantee that the schistosome 
polypeptides will be treated in the same way. If the schistosome polypeptides do remain 
in the periplasm, it should be possible to purify adequate amounts of protein by isolating 
the periplasmic fraction first by removing the cell wall only, leaving an intact 
spheroplast. 
Overall, the YSST has been shown to identify secreted proteins, various different 
types of membrane proteins and proteins that are present in the ER, or other structures 
downstream of the ER, from an evolutionary diverse set of organisms. Application of 
this system to schistosomes should lead to the isolation of a diverse group of NVS 
proteins, many of which have not been described previously. 
104 
CHAPTER 6 
CONCLUDING DISCUSSION 
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This chapter summarises the achievements of this investigation, the application of 
alternative approaches and the implications for future work. 
In contrast to the large body of information available on the protective mechanisms 
which operate against S. mansoni in the murine host, there is still very little known about 
the antigens involved. Given that the schistosome genome contains 15 000 to 20 000 
expressed genes, there is an enormous pool of potential vaccine candidates, making the 
task of pinpointing the relevant antigens difficult. The problem is compounded by the 
fact that many somatic antigens are highly immunogenic but are unlikely to be involved 
in protection (Harrop et aL, 1999). Based on detailed information available on the 
induction and effector phases of immunity in the R-A vaccine model, it has been 
hypothesised that the proteins released from schistosomula (i. e. WS proteins) would 
provide a source of potential vaccine candidates. The limited amount of parasite material 
available for study, particularly for the larval stages, makes NVS antigen characterisation 
by conventional biochemistry difficult. Immunoscreening of cDNA libraries with serum 
raised against the released proteins of schistosomula has been carried out, but 
unfortunately, the majority of clones isolated encoded the same somatic antigens 
identified in other studies, and of the few unknowns only one coded for a putative signal 
peptide (Harrop et aL, 1999). Therefore, the aim of this thesis was to use several 
strategies to identify and clone WS antigens from schistosomes. 
Computational Biology 
As the schistosome genome project gathers momentum an increasing number of genes 
are being sequenced without any further characterisation of the products they encode. 
Many computational methods have been developed to predict protein function. The two 
main approaches are sequence alignments (Altschul et al., 1990; Pearson et al., 1996) and 
sequence-motif methods (Bairoch et al., 1996; Henikoff and Henikoff, 1994; Attwood et 
al., 1997). Several of these programmes have been used to identify protein functions in 
those organisms whose complete genome sequence is available, e. g. C. elegans (Hutter et 
al., 2000) and Mycoplasma genitalium (Koonin et al., 1996). One such sequence-motif 
algorithm, SignalP, was applied to all of the 427 sequences in the schistosome protein 
database (Chapter 3). This revealed how little information is available for WS proteins 
from schistosomes (only 23 well characterised proteins). The method clearly pinpoints 
those schistosome proteins that are targeted to the secretory pathway, plasma membrane, 
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or for export. It has not identified any non-NVS proteins, and as far as I am aware, it has 
not missed any published M/S sequences. 
The subsequent application of SignalP to the schistosome EST dataset (Chapter 3) has 
revealed 218 DNA sequences that may encode putative signal peptides, thereby 
increasing dramatically the number of novel DNA sequences from schistosomes that 
code for M/S proteins (approximately 10 fold). Therefore, this approach represents a 
relatively simple, cost-effective method to screen large amounts of sequence data for 
putative NVS encoding genes. However, as discussed by Schneider et A (1999) and 
Nielsen et aL (1999), atypical signal peptides will not be detected by such algorithms. In 
order to ensure that all schistosome signal peptides are detectable it would be necessary 
to train the algorithm on a large set of schistosome signal peptides that had been 
experimentally determined. At present, with only 23 schistosome signal peptides a large 
enough set is not available to train a predictive algorithm. 
Although this approach works very well when analysing full-length cDNA sequences, 
the data obtained from EST analysis has to be considered carefully. As ESTs are usually 
obtained by single-pass sequencing any errors in the DNA sequence could lead to the 
generation of false stop codons and hence to the selection of the wrong reading frame for 
analysis. Therefore, the use of other prediction methods such as those for start codons (to 
eliminate trans-membrane fragments) and ORFs (to eliminate untranslated regions) in 
tandem with SignalP should reduce the number of false annotations. This should allow 
for effective analysis of the schistosome ESTs prior to the availability of the complete 
genome sequence. 
Differential gene expression 
Experimental approaches to analyse gene function are currently based on the study of 
the transcriptome (DeRisi et al., 1997), the proteome (Blackstock and Weir, 1999) and 
the metabolome (Oliver et al., 1998). Currently, the analysis of the transcriptome is the 
most easily achieved, as the technology to manipulate DNAs and RNAs is much simpler 
than that for proteins. Subtractive hybridisation, differential screening and DD were the 
first techniques that made it possible to identify differentially expressed genes by 
comparison of the levels of mRNAs found in various cell types or developmental stages 
of an organism. As DD and RAP-PCR are based on PCR, small amounts of mRNA are 
required. This is an important advantage when working with parasites, as they are often 
only available in small quantities, especially the larval stages of schistosomes. 
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Therefore, RAP-PCR was used to identify those genes that were stage-specifically- 
expressed in 
' 
schistosomes (Chapter 4). This study showed that several transcripts are 
differentially expressed as the parasite matures from a cercaria to an adult worm. A total 
of 9 stage-specific cDNAs and 4 differentially expressed cDNAs (i. e. those that were 
present in only 2 of the 3 life-cycle stages) were excised from gels. Several of these 
cDNAs were used to probe Southern blots of schistosome DNA. The majority of them 
represent genes derived from the schistosome genome as they gave single bands on the 
Southern blot. However, the expression pattern of each one remains to be verified by 
Northern blotting or quantitative RT-PCR. However, the application of RAP-PCR is not 
without technical problems and practical limitations. The numbers, sizes and intensities 
of amplified fragments are extremely sensitive to small changes in reaction conditions. 
Cycling parameters, specifically the number of amplification cycles and annealing 
temperatures may also affect banding patterns. This makes the technique very labour- 
intensive to ensure that all variable parameters have been controlled and/or optimised and 
the possibility of generating PCR-artefacts kept to a minimum. In addition, a 
considerable amount of time and resources often has to be expended before any 
information about the function of the differentially expressed transcripts is found. 
More recently, techniques such as suppression-subtractive hybridisation (Diatchenko 
et aL, 1996), serial analysis of gene expression (SAGE, Velculescu et aL, 1995) and its 
variants e. g. tandem-arrayed ligation of expressed sequence tags (TALEST, Spinella et 
aL, 1999) have been described. Such techniques now represent more efficient, high- 
throughput methods for the determination of expression profiles of various genes and as 
such may be the methods of choice for the future. Although these techniques offer much, 
the cost of sequencing the required number of fragments/genes is very high; hence these 
are not presently viable for individual research groups. However, these techniques could 
be incorporated into the schistosome genome network programme together with the 
cDNA microarray approach that is already being used (Williams and Johnston, 1999). 
Limitations remain with respect to the number of genes that can be analysed in a single 
microarray, and of course the method is applicable only to those genes whose sequence is 
already available. An additional drawback of all of these applications, as with the 
computational approach (described in Chapter 3), is that once a cDNA is identified a lot 
of work has to be done to characterise the protein function before its potential as a 
vaccine candidate can be assessed. Therefore an experimental method that allows for 
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isolation of clones based on protein function would probably be more fruitful in the hunt 
for genes coding for M/S proteins. 
Signal sequence trap 
Genomic assays which select ORFs from a pool of genes based on the function of the 
encoded protein are another possible route to identify those of particular interest. Two 
basic types of functional assay exist: (i) those based on purified, expressed proteins and 
their effect in an extrinsic assay (ii) those based on the transformation of a host cell, with 
protein expression of each cloned gene allowing for selection on the basis of a suitable 
assay of the host cell. 
The YSST described in Chapter 5 is a gcnomic assay, which selects ORFs based on 
the ability of the corresponding protein to direct secretion in yeast. Therefore, this 
functional assay overcomes the major limitation of the two previously discussed 
approaches, as any clone identified by YSST can be annotated as encoding a NVS protein 
without any further verification. In addition, only enough parasite material to make one 
random-primed cDNA library from each life-cycle stage is required. This overcomes the 
problem of obtaining large amounts of parasite material repeatedly. Therefore, the YSST 
should allow for the efficient isolation of M/S proteins from schistosomes. Also, it may 
be possible to purify recombinant protein directly from clones, thus removing the need to 
sub-clone each cDNA into a high-level expression vector (a significant saving of time 
and money). 
The results presented in Chapter 5 show that the yeast secretion machinery recognises 
the schistosome signal peptides and is able to discriminate between secreted and 
cytosolic proteins. As the classical secretion pathway is conserved, even between 
prokaryotes and eukaryotes (reviewed by Walter and Johnson, 1994), this system should 
also allow for the isolation of those TvVS proteins with atypical signal sequences, unlike 
the computational approach. The sequences obtained from the YSST would also provide 
a set of schistosome signal peptides that could be used to train computational prediction 
methods such as SignalP in the future. 
It is thought that the majority of WS proteins are targeted to their final destinations by 
the N-terminal signal sequence via the classical pathway described in this thesis. 
However, it must be noted that both prokaryotes and eukaryotes have a small number of 
TVVS proteins that do not have classical signal peptides and reach their final destinations 
via other pathways (Rapoport et aL, 1996 and references therein). Therefore, it is 
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unlikely that the YSST or SignalP will identify every single WS protein from 
schistosomes. At present very little is known about the alternative secretion pathways. 
Therefore no suitable methods to identify those proteins that are secreted via these 
pathways can be developed. Overall, of the three approaches used in this study, the 
YSST represents the most efficient method to isolate the majority of the schistosome 
genes encoding IVVS proteins. 
Proteomic techniques could be used to identify and characterise the subset of proteins 
of interest directly. However, as NVS proteins tend to have hydrophobic regions, which 
means that such proteins often do not go into solution, prior to separation by 2-D 
electrophoresis. Therefore, there are no suitable techniques available at present that 
allow for the enrichment of this subset of proteins from total parasite proteins. 
Additionally, the amount of parasite material available for study is still a limiting factor 
for such analyses. For those proteins that are identified by 2-D electrophoresis and mass 
spectrometric analysis, their subsequent analysis is hindered by the lack of DNA 
sequence available for schistosome genes. 
The application of YSST to schistosomes and the use of several computer algorithms 
to analyse the schistosome DNA sequences should lead to the identification of many 
genes coding for M/S proteins. Characterisation of each of these proteins, in terms of its 
function and expression pattern, may lead to a better understanding of basic parasite 
biology, including signalling pathways in the parasite, parasite-parasite and host-parasite 
relationships. In order to focus on those proteins most likely to be involved in the 
induction and priming of the relevant immune responses, a preliminary screen will have 
to be carried out, prior to their evaluation as potential vaccine candidates. 
Immunolocalisation studies, to identify only those proteins that localise to parasite tissues 
from which such proteins could be derived (e. g. the head gland, larval tegument), are 
likely to be the most informative. 
In summary, this thesis describes the development of several different approaches to 
identify the antigens that have been implicated as important stimulators of the immune 
response elicited by the RA vaccine model. It is hoped that the YSST will allow for the 
identification of NVS proteins and that further characterisation of some of those proteins 
will eventually lead to trial vaccination experiments in mice. 
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APPENDIX 1 
Primers used for Reneration of ESTs 
M13R CAGGAAACAGCTATGAC 
T7 TTARACGACTCACTATAGGG 
Primers used for PCR to generate inserts for high level eUression vector. pET30 
CL15' CCGGAATTCACAACTTCATATGGACTAAAGATGAAT 
CL13' CCGCTCGAGTTCGTTATAATGTCCTCT 
0465' CGGGGTACCAATGTCTGAATTTTTCGGA 
0463' CCGCTCGAGTTCTGAGTGATTTAAATTGGC 
17mer 
20mer 
36mer 
27mer 
28mer 
30mer 
1235' CCGGAATTCACGAGATACTTAACAATCTTCTTACAAACT 39mer 
1233' CCGCTCGAGTTTATTTATTTTGTTTAAGTCCCCACTTTC 39mer 
Primers used for RAP-PCR 
C2 GAAGGCTGGTAAACAAAAGG 20mer 
Gl CTGAATCGCTGTATAAAAGT of 
G2 GGAAAACAAATGGTCGGAAG it 
KS TCGAGGTCGACGGTATC of 
SK CGCTCTAGAACTAGTGGATC of 
SP6 GATTTAGGTGACACTATAG of 
M13R CAGGAAACAGCTATGAC 17mer 
T7 TTARACGACTCACTATAGGG 20mer 
Signal sequence primers 
Sl ATGACGCTGGCCTTATTAGT 20mer 
S2 ATGCTTATTAGTGTTTTAGT 20mer 
S3 ATGACGTTAATTTCATTAGT 20mer 
S4 ATGGCTTTGTTAGTTATTTC 20mer 
S5 AGCTTATTA 9mer 
S6 ATGAATACTCTGGTTATTAT 20mer 
III 
Primers used for PCR to generate fragments for plasmid VSUC2t7F I ori 
SUCSIG5' CGGAATTCCGTTCTCTCAGAGAAACAAGCA 30mer 
SUCSIGY CCGCTCGAGCGGTTGTTGTAATCAACCACCAT 32mer 
p48SIG5' CGGAATTCCGGCTTTTGTATAAACAATCGTAGTGT 35mer 
P48SIGY CCGCTCGAGCGGCATTGTATCCACTATAAACGCTGT 36mer 
SODSIG5' GGAATTCCATGACAGTATATTCCTATTTAG 30mer 
SODSIGY CCGCTCGAGCGGCATAACGATGAACATGTGTA 32mer 
10-3SIG5' GGAATTCCCATTATACAGGACGGAAGTT 28mer 
10-3SIGY CCGCTCGAGCGGAGTAGGCTGTTTATCCTTCT 32mer 
CalpainSIGY CGGAATTCCGTGGTGTAGAAAACTCGAAAAAACC 34mer 
CalpainSIGY CCGCTCGAGCGGACTTAGCATATCC = 29mer 
Clone II SIG5' CGGAATTCCGCCGATGGTGGATGGGAT 27mer 
Clonel. I SIG3'CCGCTCGAGCGGGAGTACTTCATCCAT 27mer 
Sequencing primers for yeast signal sequence trap 
SUC2a TTCTGCACAATATTTCAAGA 20mer 
SUM GCTTCAGCTTCTCTTCTA 18mer 
112 
APPENDIX 2 
Genotypes of E. coli strains 
XL1-Blue (Stratagene): recAl end Al gyrA96 thi- 1 hsdR17 supE44 relAl lac 
{F! proAB lacPZAM15 TnIO (TetD)' 
BL21(DE3)pLysS (Novagen): F ompT hsdSB (rB- MB-)gal dcm (srl-recA) 306:: 
Tn 10 (Tc) (DE3) pLysS (CmR) 
INV(xF'(Invitrogen): FendAl recAl hsdR17(rý, Mk')supE44 thi-I gyrA96 
relAl ý801acZAM15 A(lacZYA-argF)U169 
HBIOI (Statagene): supE44 aral4 gaIK2 lacYl A(gpt-proA)62rpsL20 (Str) 
xyl-5 mtl-l recA13 A(mcrC-mrr) HsdS-(tm-) 
Genotype of S. cerevisiae strain 
YTK12: suc2A9 ade2-101 trp2-52 
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